Announcements

10 April 2024
Meet Us at the 48th FEBS Congress, 29 June–3 July 2024, Milan, Italy


Conference:
The 48th FEBS Congress
Date: 29 June–3 July 2024
Location: Milan, Italy

MDPI will be attending the 48th FEBS Congress at Booth #30, and we welcome researchers from different backgrounds to visit us and share their latest ideas.

The Italian Society of Biochemistry and Molecular Biology (SIB), founded in 1951, will host the event. The 48th FEBS Congress—“Mining biochemistry for human health and well-being”—welcomes scientists from Europe and other parts of the world.

The 48th FEBS Congress will present a broad-spectrum and ground-breaking scientific program in a fruitful collaboration with FEBS journals and representatives from FEBS Constituent Societies. The SIB and biochemical community are focusing on human health and well-being through molecular and cellular science approaches; this is a key social issue amid ongoing global transitions. Besides presenting the latest and emerging developments in biochemical sciences, the Congress will include dedicated education-oriented sessions, symposia organized by young biochemists, and biochemistry-related economic discussions. Industry representatives will also give presentations on the latest advances in commercial instrumentation.

The following MDPI journals will be represented:

If you plan to attend this conference, please start an online conversation with us. Our delegates look forward to meeting you in person and answering your questions. For more information about the conference, please visit the following website: https://2024.febscongress.org/.

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

29 March 2024
Meet Us at the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024), 16–20 June 2024, Osaka, Japan


MDPI will be attending the 20th Annual International Conference of the Metabolomics Society (Metabolomics 2024) held in Osaka, Japan, from 16 to 20 June 2024. The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. This is the third time that the conference will be held in Japan, following the 2005 and 2014 conferences held in Tsuruoka. We look forward to welcoming the metabolomics community, building strong connections, and discussing world-class research in a relaxed collegial environment. Let us build on the momentum of the incredible Niagara Falls and Valencia conferences that brought us back together in person, and make it the best meeting of 2024 together!

During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest views and research with us.

The following MDPI journals will be represented:

  • Metabolites;
  • Biomolecules;
  • Plants;
  • IJMS;
  • Life;
  • Cells;
  • Agronomy;
  • Nutrients;
  • Cancers;
  • CIMB;
  • Genes;
  • Antioxidants.

If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: https://www.metabolomics2024.org/.

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

18 February 2024
Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen Appointed Editors-in-Chief of Biomolecules

We are pleased to announce that Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen have been appointed Editors-in-Chief of Biomolecules (ISSN: 2218-273X).

Biomolecules lies at the intersection between chemistry, biology, molecular medicine, and material science. We publish studies that involve basic research, in vitro and in vivo investigations, and pre-clinical studies that focus on the structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications, and biomaterials and their applications.

Prof. Dr. Kurgan’s research is at the intersection of bioinformatics, protein science, and machine learning, focusing on the development of modern tools and resources for the high-throughput prediction and characterization of the function, structure, and intrinsic disorder of proteins. He has published well over 200 peer-reviewed articles, around 30 book chapters, and 2 books. Prof. Dr. Kurgan was elected a Fellow of the Royal Society of Biology (2023), a Member of the European Academy of Sciences and Arts (2022), and a Fellow of the American Institute for Medical and Biological Engineering (2021); he is also a Member of the Faculty Opinions in the field of bioinformatics, biomedical informatics and computational biology. He has been involved with Biomolecules since 2018, recently serving as the Section Editor-in-Chief for the “Bioinformatics and Systems Biology” Section. He is also deeply grateful to the outgoing Editor-in-Chief, Prof. Dr. Uversky, for his many years of leadership that have grown the reputation and reach of Biomolecules. He hopes to further strengthen the position of Biomolecules so that it becomes a preferred destination for high-impact research on biomolecules and bioactive and biogenic compounds.

Prof. Dr. Peter E. Nielsen has been affiliated with the University of Copenhagen since 1980, where he became a full professor in 1995. He is one of the inventors of peptide nucleic acid (PNA) (1991) and has further studied and developed this DNA mimic over the last 30 years in relation to chemistry, molecular biology, and drug discovery. Presently, his research is centered around the delivery and bioavailability of PNA and other potential gene therapeutic drugs with a strong focus on novel antimicrobial agents.

Prof. Dr. Peter E. Nielsen is the co-author of more than 400 scientific papers, reviews, and book chapters (with over 17000 citations). In addition to holding over 20 patents and patent applications, he is the editor of six books, and he serves on the advisory board of several scientific journals. He holds an M.Sc. in biochemistry, a Ph.D. in chemistry, and an honorary doctoral degree, all from the University of Copenhagen. He is the co-founder of two biotech companies in Denmark. He is a member of the EMBO (the European Molecular Biology Organization) and the Danish Academy of Technical Sciences (ATV), and he has received several national and international scientific prizes.

His aim is to make Biomolecules an even more attractive scientific journal that publishes high-quality, high-impact scientific papers on biologically relevant molecules for the benefit of global science. He recognizes that this is a self-reinforcing process.

As we welcome our new Editors-in-Chief, we express our gratitude to the outgoing Editor-in-Chief, Prof. Dr. Vladimir Uversky, for his dedication and continuing support of Biomolecules. We are confident that Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen will continue to offer invaluable input and support and will maintain the high standards of qualitative scientific communications in Biomolecules.

We warmly welcome Prof. Dr. Lukasz Kurgan and Prof. Dr. Peter E. Nielsen as our Editors-in-Chief and look forward to their collaboration and input for the continued success of Biomolecules.

6 February 2024
Meet Us at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024), 27–30 April 2024, Barcelona, Spain


MDPI will attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) as an exhibitor. This conference will be held in Barcelona, Spain, from 27 to 30 April 2024.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.eccmid.org/.

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

31 January 2024
Acknowledgment of the Reviewers of Biomolecules in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Biomolecules. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Biomolecules received 6050 review reports, from 5377 reviewers. This past year, we worked with reviewers from 82 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Biomolecules family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

Andrei. L. Mulyukin Kiran Lokhande
Abbirami Elangovan Kiril Mishev
Abdel Razzaq Mohammad Al Tawaha Kirsten Haastert-Talini
Abdul Rajjak Shaikh Kirsten Brandt
Abdul Sadiq Konstantin Agladze
Abed Saady Konstantin Moiseenko
Abhinav Jain Krishna Sharma
Abhishek Anant Kulkarni Krzysztof Dołowy
Abraham Escobedo-Moratilla Ksenia Tereshkina
Abraham Pouliakis Kuldeep Gupta
Abraham Wall-Medrano Kumar Katragunta
Abril Gijsbers Kun Lei
Adam Benham Kyeong-Man Kim
Adam Krysztofiak Laihua Xie
Adam Reich Laiza T. Poskus
Addolorata Pisconti Lalith Perera
Adelina Vlad Larisa Ryskalin
Adina Chis László Hazai
Adina Roceanu Laura Gatti
Aditya Sharma Laura López-Pingarrón
Aditya Singh Laura Marroqui
Adriana Erica Miele Laure Poquet
Adriana Geisinger Laure Yatime
Adriana Urcan Laurence Bresson-bepoldin
Agnieszka Potęga Laurence Lagneaux
Agnieszka Żebrowska Laurentiu M. Pop
Ahlam Alhusaini Leggy Arnold
Ahmad Jalili Lenard Farczadi
Ahmed B. Abdelwahab Leonid Bystrykh
Ahmed Hamdan Leonor Guerra-Guimarães
Ahmed Mekkawy Lev Prasov
Ahrar Khan Li Sun
Ajna Hamidovic Li Xiao
Akinori Morita Liang-Jun Yan
Akshyaya Pradhan Lidia Caporossi
Alaa Adawy Liga Lauberte
Alain Le Faou Liliana Argueta-Figueroa
Alba Grayston Liliana Dain
Alberto Baldelli Liliana Torres-López
Alberto Marra Liliya Nikitina
Alberto Martínez-Castelao Lindsey Haute
Aleksandar Ž. Kostić Lisa Gianesello
Aleksandr Ivanov Lisa Ryan
Aleksandra Zeljkovic Liubov Gorbacheva
Aleksey Yakovlev Livio Vitiello
Alessandra Ferramosca Liviu Macovei
Alessandra Sinopoli Loïc Dayon
Alessandro Leparulo Loredana Bergandi
Alessandro Maugeri Lorena Saelices Gomez
Alexander Baykov Lothar Brecker
Alexander Dietrich Lourdes M. Varela
Alexander Gusev Luca Colucci-D'Amato
Alexander Kartashov Luca Giordano
Alexander Ljubimov Luca Potestio
Alexander Sapozhnikov Luca Vanella
Alexander Shtil Lucia Baldino
Alexander Trujillo Luciana Xavier
Alexander Zhgun Luis Cobos Puc
Alfons Nadal Luís Crisóstomo
Alfredo Jiménez-Pérez Luis M. Quirós
Alfredo Téllez Valencia Luisa Dalla Valle
Ali Waryah Luísa Mateus
Alicia Viloria-Petit Lukas Mikolaj Simon
Alida Veloo Lukasz Dobrek
Alina Serb (Georgescu) Łukasz Szeleszczuk
Aline Fernanda de Souza Lukhanyo Mekuto
Almerinda Di Venere Luz Del Razo
Amanda Iglesias Lyudmila Bel'skaya
Amaro Saco Muhammad Junaid Dar
Amena Archer María Luisa Soto Montenegro
Amit Kumar Maciej Przybyłek
Ammar Saleem Maciej Zdun
Amrinder Singh Madhurima Chatterjee
Amrita Sarkar Magdalena Dunowska
Amritlal Mandal Magdalena Kurnik-Łucka
Amy MacNeill Magdalena Martinez-Cañamero
Ana Cláudia Martins Cavaco Magnus Monné
Ana Feregrino-Perez Mahmood Mozaffari
Ana Florencia Vega-Benedetti Mahmoud Abdallah
Ana Garcia-Deibe Mahmoud Azzam
Ana Mutis Tejos Mai Mostafa
Ana Podolski-Renić Małgorzata Gajewska
Ana Rilak Simović Mamdouh Samy
Ana Rita Jesus Manikandan Samidurai
Ana Segura Manohar Kodavati
Anastasia A. Anashkina Mansoor Hussain
Anastassios Papageorgiou Manuela Correia
Anatoly Zherdev Marawan Abdelbaset
Anca Toiu Marc Muller
Andaleb Kholmukhamedov Marc-André Lécuyer
André Filipe Gonçalves Gabriel Marcelo Nieto
Andrea Lipińska Marcin Kozuch
Andrea Mastinu Marco Milanese
Andrea Re Cecconi Marco Velasco-Velazquez
Andrea Summer Marek Kiliszek
Andrea Wangorsch Margalida Monserrat-Mesquida
Andreas Brodehl María Ayelén Pagani
Andreas Doetsch María Behrens
Andreas Werner Maria Botelho
Andreas Zwergal Maria Camilla Bergonzi
Andrei A. Eliseev Maria Carmela Bonaccorsi Di Patti
Andrej Perdih Maria Golikova
Andrés Uc-Cachón María Pérez
Andrêssa Fernandes Maria Romanelli
Andrew Leask Maria Rubtsova
Andrey V. Sybachin Maria Russo
Andrey Zamyatnin Maria Skibińska
Andrzej Szutowicz María Teresa Hernández-Huerta
Angel Josabad Alonso-Castro Maria Xilouri
Angel Llamas Mariano Venanzi
Ángel Núñez Maribel Acién
Angel Vértiz-Hernández Marie Černá
Angela Fleischhacker Marie-Louise Ward
Angela Messina Marie-Paule Gonthier
Àngels González-Lafont Marina Bouche
Anh Quynh Le Marina Holyavka
Aniello Maiese Marina Piscopo
Aniruddha Das Marino Paroli
Aniruddha Panda Mario Congiu
Anjali Geethadevi Mario Fruschelli
Anna Fialová Mario Ščetar
Anna Kitaeva Mario Vega
Anna Marabotti Marisa Colone
Anna Maria D’Ursi Marisol Fernández Ortiz
Anna Przybylska-Balcerek Marius Moga
Anna Ruszczynska Mariusz Stasiolek
Anna Sannino Mariya Smetanina
Annalisa Pecoraro Mark B. Frampton
Annamaria Aloisio Mark McCormick
Annarita Stringaro Markus Leo
Anne Zeck Markus Wehland
Annette Graham Marlene Santos
Annette Kaiser Marta Fiołka
Anoop Rawat Marta Kepinska
Antimo Cutone Marta Pawłowska
Antoinette Van Der Kuyl Marta Riera
Anton Jetten Marta Vitorino
Anton S. Tsybko Marta Zagrebelsky
Antonina Giammanco Martín González-Andrade
Antonio Facchiano Martin Michel
António Ferreira Martin Raspor
Antonio Massa Martin Wawruch
Antonio Raffone Martina Colombo
Antonio Rosales Martínez Maryam Ardalan
Antonio Sanchez-Amat Marzia Gariboldi
Antonio Trovato Masaaki Wachi
Anu Paul Masahiko Tanaka
Aram Megighian Masaki Hata
Ari Meerson Masaki Nagaya
Arianna De Mori Masoud Negahdary
Armindo Salvador Masoud Sadeghi
Artem Badasyan Massimiliano Meli
Arthur Kopylov Massimo D'Archivio
Artur Słomka Mathieu Gonin
Arturo Bevilacqua Mathilde Body-Malapel
Arturo Medrano-Soto Matija Rijavec
Arun Kumar Rajendran Matteo Mozzicafreddo
Ashish Kabra Matthew Merski
Ashley Bennett Mattia Volta
Ashraf Madhoun Mattias Collin
Astri Faizah Maxim Filatov
Ateeq Rahman Maxim Karagyaur
Atefeh Najafi Mayank Choubey
Athanasios A. Panagiotopoulos Mazen Saleh
Athar Ansari Md. Abu Saleh
Atta Rahman Md. Sharker
Attila Frigy Meenakshi Sharma
Attila Zsolnai Meerambika Mishra
Augustin C. Moţ Mehdi Montazer
Aurélie Philippe Mehdi Rezaei
Avinash Rai Mehmet Kaya
Aydi Abdelkarim Mehrdad Behmanesh
Aydin Eresen Melanie Foecking
Ayman Elsamanoudy Mengdi Bao
Babak Chehroudi Mengze Lyu
Badr Alshomrani Menno Hoekstra
Bahadar Srichawla Mercedes Garayoa
Baiyan Li Mi Kyung Park
Balenahalli Ramesh Michael Agaphonov
Bangfu Zhu Michael Breitenbach
Barbara De Filippis Michael Eccles
Barbara Hausott Michael Kim
Barbara Ruaro Michael Koval
Barry Cooperman Michael Madigan
Bartłomiej Barczyński Michael Pedersen
Bartłomiej Potaniec Michael Schirmer
Bartłomiej Zapotoczny Michael Van Dyke
Barun Maity Michal J. Dabrowski
Basant Puri Michal Ordak
Bassam Elgamoudi Michał Rurek
Basveshwar Gawali Michal Zeman
Beata Bystrowska Michel Hanania
Bénédicte Ballanger Michele Samaja
Benedict-Tilman Berger Miguel Santana
Benjamin Jantzen Mihaela Niculae
Bernard Haendler Mihai Babotă
Bert Bosche Mikhail Dubinin
Bertrand Liagre Mikhail Kostik
Beshay Zordoky Mikhail Pyatibratov
Bharadwaja Srimat Tirumala Peddinti Mikko Uusi-Oukari
Bihe Cai Milan D. Perovic
Binfeng Yin Milan Stankovic
Binu Jacob Minhyeok Lee
Bipradas Roy Minjia Wang
Birol Akbaş Mircea Rivis
Boel De Paepe Miriam F. Scelza
Boleslaw T. Karwowski Miriam Hickey
Boris Stambuk Mitsue Nishiyama
Borja Herrero de la Parte Mohamed El Yaagoubi
Bouchra Edderkaoui Mohamed Khalifa
Brandon Gassaway Mohamed Mahdi
Brateen Shome Mohamed S.A. Darwish
Brendan Duggan Mohamed Sharaf
Bruce A. Shapiro Mohamed Soltan
Bruno Ramos-Molina Mohammad Khan
Cai Roberts Mohammad Mohsenzadeh
Carla di Stefano Mohammad Sadraeian
Carla Ferreri Mohammed Ali
Carla Mucignat Mohammed Hawash
Carlo Morelli Mohammed M. Alanazi
Carlo Santambrogio Mohammed Ramadan
Carlos Jimenez Mohd Hanafi Mat Som
Carlos Rocha-de-Lossada Mona Freidin
Carsten Carlberg Monica Berrondo
Carsten Theiss Mostafa Shooshtari
Caterina Gagliano Moumita Datta
Catherine Davis Moustafa Fouda
Cathy Lazarus Mudasir Rashid
César López-Camarillo Muhammad Jameel Mughal
Chadi Abdul Kader El Farran Muhammad Rehman
Chandra Mishra Muhammad Sohaib
Chandra Sekhar Yadavalli Munendra Tomar
Chang Lei Nadine Nagy
Chang-Hyun Kim Naghmeh Mahmoodian
Changli Zhao Nahum Rosenberg
Chao Deng Nancy Saad
Chao Wu Naoki Morita
Charis Theodoridis Narakorn Khunweeraphong
Charles Norton Naresh Poondla
Cheng Wang Naser Alsharairi
Chenrong Yu Natalia Belkova
Chennaiah Ande Natalia Díaz-Valdivia
Chenqi Tao Natalia Golender
Chiara Suffritti Natalia Kreshchenko
Chi-Chih Hung Natalia Ninkina
Chien-Chung Yang Natalia Soriano-Sarabia
Chih-Hsing Chou Natalia Ukleja-Sokołowska
Chiranjeev Sharma Natalya Zinkevich
Chloé Prunier Natércia Conceição
Choon Young Kim Nebojsa Prijovic
Christelle Dantec Neelam Sharma
Christian Bailly Nehru Viji Sankaranarayanan
Christian Gernhardt Nenad Bukvic
Christine Allmang Nicola Armstrong
Christine Chuang Nicola Manfrini
Christophe Ampe Nicolas Casadei
Christopher Garnham Nicoleta Anton
Christopher Kobierzycki Nik Tsotakos
Christos Kontos Nikita Minaev
Chuanming Xu Nikolai Ravin
Chung Lin Lee Nikolaos Kadoglou
Chunmin Lo Nikolaos Labrou
Chunyan Wang Nikolaos Pitsikas
Chuqian Liang Nina Anfinogenova
Cinzia Rotondo Nirav Patel
Ciprian Rezus Nitesh Shashikanth
Ciprian Silaghi Nobuhiro Kanemura
Claudia Fallini Nobuo Shimamoto
Cláudia Leopoldina Mieiro Noélia Custódio
Claudia Ricci Nordine Helassa
Claudia Segal-Kischinevzky Noriaki Iijima
Constantin Munteanu Noriko Takegahara
Corinne Prevostel Noula Shembade
Corneliu Ovidiu Vrancianu Nuno Ferreira
Cornelius Krasel Oksana Rymar
Cristian Sandoval Oksoo Han
Cristina Maccallini Oleg M. Demchuk
Cristina Manuela Dragoi Oleh Pochynyuk
Cristina Martín Olesia Makhutova
Cristina Oprean Olga Ciepiela
Daisy Shu Olga Tarasova
Dalius Vitkus Olga Tsivileva
Damien Arnoult Olgica Mihaljevic
Dana Akilbekova Oliver Tusevski
Dane Wolf Oliviero Italo Carugo
Daniel Caetano Oliviu Vostinaru
Daniel Guendel Omar Porras
Daniel Rodriguez Ondrej Cehlár
DANIEL San Juan Orta Oscar Briz Sanchez
Daniel Sánchez de Alcázar Melendo Oscar Campuzano
Daniel Wilson Oscar Pérez-Méndez
Daniela Buchaim Otávio Augusto Chaves
Daniela Montesarchio Othmane Merah
Daniela Opriş-Belinski Ovidiu Pop
Daniela Rossi Ovidiu Samoila
Daniela Sousa Oxana Dobrovinskaya
Danijela Laketa Pablo Guardado-Calvo
Danila Di Meo Pablo Martín-Vasallo
Danilo da Silva Pandiyan Muthuramalingam
Danilo Swann Matassa Panthakarn Rangsinth
Danyang Wang Paola Cappello
Daotong Li Paola Fini
Daria Chudakova Paola Galozzi
Dario Mizrachi Paolo Cascio
Darya Novopashina Paolo Lauriola
David Centruion Paolo Paoli
David Davis Paolo Pelliccioni
David Hall Paolo Polidori
David Hunt Paolo Tortora
David Li-Kroeger Partha Narayan Dey
David Mills Pasquale Scarcia
David Schwartz Pasquale Stano
David Sergeevichev Patrick Pale
David Snyder Paul Héroux
Davide Gabellini Paula Fernández-Palanca
Dawei Xue Paulina Dumnicka
Dean Gilham Paulo Carmo
Deborah Keszenman Paulo Gavaia
Deborah Penque Pavan Kripashankar Patel
Deepak Kasote Pavel Nazarov
Deepak Kulkarni Pavel Rehak
Deepanker Yadav Pavel Volynsky
Deependra Singh Payal Ganguly
Denilce Lopes Pedro Araujo
Denis Beliaev Pedro Esbrit
Denis Silachev Pedro Gomes
Denitsa Teofanova Pedro Morais
Dennis Grayson Pedro Vaz
Dhananjay Yadav Peli Foka
Dharmendra Choudhary Pengfei Ding
Dhiraj Srivastava Petar Eftimov
Diana Amantea Peter Kusch
Diego Castro Musial Peter Piko
Dilip Kumar Swain Peter Szatmary
Dimitri Pestov Petr Menshanov
Dimosthenis Lykouras Petr Zamostny
Dina Manetti Philip Calder
Divya Ail Pierfrancesco Visaggi
Dmitrii Levitsky Pierre Moffatt
Dmitriy Yambulatov Pingfan Hu
Dmitry Bogolyubov Pingyuan Wang
Dmitry Verbenko Piotr Dobrowolski
Dnyaneshwar Garad Piyush Baindara
Dominik Dłuski Prabhanjan Giram
Donatella Delle Cave Prashant Damke
Dongliang Huang Prashant Kaushik
Dongsheng Lei Preston Bratcher
Dongxu Wang Priyanka Banerjee
Dóra K. Menyhárd Pushpa Rao
Dorota Bartusik-Aebisher Qi Xiang
Douglas Glazier Qiuwang Zhang
Douglas J. H. Shyu Qiwei Li
Dragana Dekanski R. Jurgen Dohmen
Dragana Komnenov Radu Racovita
Dragana Kopanja Raed Seetan
E. Cristina Quispe Chávez Rafael Baltiérrez-Hoyos
Édouard Gerbaud Rafael Kuradomi
Eduardo Rial Rafael Moreno-Gómez-Toledano
Eduardo Zatarain Nicolas Rafael Salto
Edwige Voisset Raffaele Serra
Edyta Sutkowska Raghu Ramanathan
Egor Plotnikov Rahul Gauttam
Egor Verbitskiy Rahul Kumar
Eileen Roulis Rajesh Parsanathan
Einas Yousef Ram Kumar Selvaraju
Eirini Anastasaki Ramachnadran Samivel
Elamparuthi Ramasamy Ramón Santamaría
Elena Berezhnaya Ramses Santacruz-Marquez
Elena Ermakova Ramya Tokala
Elena Panizza Randy Dinkins
Eleni Mavrogonatou Raquel Sanchez-Varo
Eleni Rebelos Raquel Soares
Eli Ehrenpreis Rashmi Panigrahi
Elisa Belluzzi Ravi Sharma
Elisa Fasani Ravi Sonani
Elisa Russo Ravindra Thakkar
Elisabeth Jacobsen Rebeca Busto
Elizabeth Coyle Rebeca Fernandez-Carrion
Elnaz Faghfouri Recai Ergun
Előd Nagy Rekha Jagadapillai
Elżbieta Łopieńska-Biernat Renan Dal-Fabbro
Eman M. Othman Renata Ciccarelli
Emanuele Bernardinelli Renata Siedlecka
Emerson Soares Bernardes Rene Herrera Diaz
Emma Burgos-Ramos Renshi Xu
Emmanouil Magiorkinis Renzhe Bi
Emmanuel Hermans Riccardo Moretti
Emmanuel Moyse Richard Naftalin
Emre Bektik Rina Bandopadhyay
Enrique Castano Rita Businaro
Eric Peeples Rita Teodósio
Erica Ferrandi Rob McCorkle
Erik Behringer Robert A. Linsenmeier
Erika Guerrero Robert Berkecz
Erna Karalija Robert Burghardt
Etsuo Niki Robert E. Lewis
Eugene Permyakov Robert L. Meisel
Eva Kudova Robert Matos
Eva Lieto Robert Stryiński
Evert Van Schothorst Robert Weinzierl
Evgen Multia Roberta Antonia Diotti
Evgenia Rapoport Roberta Fiume
Evgeny Ermakov Roberto Scarpioni
Ewa M. Kalemba Roberto Scicali
Ewelina Semik-Gurgul Rodica Olar
Fabiano Poswar Rodrigo Rodrigues
Fabio Del Duca Rogelio Rodríguez Rodríguez
Fabrizia Cesca Rohit Kumar
Fabrizia Tittarelli Ronald Garner
Fabrizio Anniballi Ronald Nelson
Fanfan Hao Ronghai Cheng
Fatima Awwad Roopa Biswas
Federico Gulluni Rosa Purgatorio
Felipe Chaves Rosa Vona
Ferdinando Fiorino Rosanna Mallamaci
Ferenc Erdodi Rosaria Meccariello
Fernanda Priviero Rosario Gonzalez-Muñiz
Fernando Capela e Silva Rosemeire Pietro
Fernando Cardona Rossella Bruno
Fernando Farfán Roxana Liana Lucaciu (Stan)
Filipe Abreu Roxana Medina
Filippo M. Sarullo Roy Kirsch
Fleming Martinez Rodriguez Rudiger Woscholski
Florence Van Tienen Ruslan Kalendar
Fnu Asaduzzaman Ruta Lavinia
Fotis Baltoumas Sabab Khan
Francesca Gatto Sabine Matou-Nasri
Francesca Rinaldi Sabira Mohammed Jazir
Francesca Spinella Sabrina Bossio
Francesco Dondi Sabrina Lisi
Francesco Lodola Saeed Mohammadi
Francesco Pezzella Saima Imran
Francesco Suriano Sainitin Donakonda
Francesco Tomassoni Ardori Sakthivel Muniyan
Francisco Conceição Salar Vaseghi
Francisco J. Romero Salvatore Crimi
Francisco Navarrete Samuel Lawman
Friedrich Altmann Samuel N. Heyman
Fulvio Saccoccia Sandra Donnini
Gábor Nagy Sang Tae Choi
Gabriel Navarrete-Vazquez Sanika Suvarnapathaki
Gabriel Rufino Estrela Sanja Ivkovic
Gabriela Barrientos Sanja Ražić
Gabriella Guerrini Sanjay Patel
Gaetan Jego Sanjin Kovacevic
Galina Aleshina Sankha Bhattacharya
Galina Kovalenko Santiago Imperial
Galina Shepelkova Sara Casati
Gamal Mohamed El-Sherbiny Sara Correia
Garry Kerch Sarah Sabatinos
Gauri Kulkarni Sari Mattila
Georg Damm Saroj Basak
George Gamov Savvas Lampridis
George Livanos Sazan Rasul
George Paraskevas Scott Eblen
Georgiana Nitulescu Sebastián Chávez
Georgios Panos Sebastian Werneburg
Gerald Audette Sébastien Prévost
Gerhild Euler Semer Maksoud
Germán Domínguez-Vías Senthilkumar Palanisamy
Gessica Sala Seongjae Jang
Ghassan Ghssein Sercan Karav
Gheorghita Isvoranu Serge P. Bottari
Gian Luigi Russo Sergei Gaidin
Gianandrea Pasquinelli Sergey Levitskii
Gianfranco Bocchinfuso Sergey V. Kozyrev
Gianfranco Natale Sergey Vatsadze
Gianni Lazzarin Sérgio Alves
Gilbert Lim Sergio Daishi Sasaki
Gill Diamond Sergio Hidalgo
Gilles Lemaître Sergio Minucci
Gina Mendez-Callejas Sergio Recalde
Giorgio Caserta Shabana Bibi
Giorgio Lenaz Shabnam Bakhshalizadeh
Giorgio Mangino Shailesh Kumar
Giou-Teng Yiang Shakir Khan
Giovanna Salata Shasha Yin
Giovanni Cicceri Shehwaz Anwar
Giovanni La Penna Shek Man Chim
Giovanni Pallio Shichao Ding
Gisela Gerardi Shifali Shishodia
Giulia De Riso Shih-Chao Lin
Giulia Festa Shihyu Chang
Giulia Ricci Shilpi Agrawal
Giulio Cabrini Shimaa Amer
Giulio Fortuna Shoji Tsuji
Giuseppe Biagini Shokrollah Elahi
Giuseppe Lanzarone Shujat Ali
Giuseppina Andreotti Shushu Huang
Gleiston Dias Shuyun Li
Grzegorz Jakubiak Shuzhen Wang
Grzegorz Zurek Siddharth Sunilkumar
Guangliang Xing Silvia Angelova
Guanglin Zhang Silvia Giatti
Guangning Zong Silvia Sgambellone
Guanjun Yang Silvio Maringhini
Guglielmo Sorci Simona Dedoni
Guilherme Montes Simona Tomaselli
Guillermo Raúl Pratta Simone Morselli
Gülsüm Yaldiz Sina Naserian
Guoping Guan Sneha Pillai
Guowei He Snježana Kaštelan
Gustavo Kashiwagi Sobia Niazi
Guy R. Adami Sodeif Azadmard-Damirchi
Gyula Batta Sofia Moran-Ramos
Haijun Liu Sofía Solórzano
Hailong Hu Sofie Lautrup
Haim Breitbart Soma Ghosh
Haina Huang Song Chen
Haiqiu Huang Sonia Do Carmo
Hak Jun Kim Sonia Gera
Halilibrahim Ciftci Sophia Theodossiou
Hana Popelka Sotirios-Spyridon Vamvakas
Hans Binder Sounak Bagchi
Hans Christian Beck Sree Krishna Chanumolu
Hans-Christian Kolberg Sreelakshmi Vasudevan
Hao Tian Stamatia Papoutsopoulou
Harald Krentel Stanislav Naryzhny
Harald Mischak Stanislawa Bazan-Socha
Haruhiko Sugimura Stavroula Tsitkanou
Harvey Pollard Stefan Naydenov
Hassan Ishqi Stefano Bellosta
Hatem El-Shanti Stefano Pascarella
Hayato Terayama Stephane Esnault
Hazwani Oslan Stephen Randall
He Zhang Steven Pascal
Heba Sahyon Su Datt Lam
Héctor Quezada Sudheer Annepu
Heinz D. Osiewacz Sulev Kõks
Helioswilton Sales-Campos Sulin Zhang
Hemant Giri Suman Lama
Hemraj Chhipa Suresh Subramani
Herbert Ryan Marini Susana Fernández
Hesham Haffez Susana Lechuga
Hideki Uosaki Sushil K. Mishra
Hilal Rather Sushil Shakyawar
Hilda Petrs-Silva Swanand Koli
Hirokazu Tsuji Swarnalatha Manickavinayaham
Hoang-Thanh Le Syed Mahmood
Hong Yu Syed Mohd Faisal
Honghe Liu Sylvain Bourgoin
Huatao Chen Tada-aki Kudo
Huining Kang Tadayoshi Kagiya
Huiyin Tu Tadeusz Kaminski
Hung-Chi Cheng Tae-Hong Kang
Hyuck Jin Lee Tahira Sultan
Hyun-Ok Song Takaaki Mizuguchi
Ichiro Kawahata Takashi Ono
Idoia Gallego Takuichi Sato
Ifigenia Kostoglou-Athanassiou Takumi Ishizuka
Ignacio Díez López Talha Demirci
Ignacio Rintoul Tamara Lazarevic-Pasti
Ignacio Rodríguez-García Tamas Lazar
Igor Eliseev Tania Fontanil
Igor Turkiewicz Tânia Soares Martins
Ilya Ozhogin Tanja Vojvoda Zeljko
Immacolata Pietraforte Tao Chen
Immacolata Speciale Tatiana Antipova
Ines Drenjancevic Tatiana Ilchibaeva
Ingo Rustenbeck Tatiana Rakitina
Inna Solyanikova Tatiana Rogasevskaia
Innokenty Mokhosoev Teleky Bernadette-Emoke
Ioan Petean Teling Lu
Ioana Stanculescu Teresa Zoladek
Ioannis Giantsis Thanigaivelan Kanagasabai
Iogann Tolbatov Theodore Wensel
Ionel Alexandru Checherita Theodoros Karalis
Iqra Bano Chandio Thierry Cens
Irena Nalepa Thirumalini Vaithianathan
Irene Valasi Thomas Van Groen
Iria Gonzalez-Dopeso Tianfu Han
Irina Kuzikova Tingming Liang
Irina Le-Deygen Tomas Kacergius
Irina Leonova Tomasz Frączyk
Isaac Sundar Tomasz Gębarowski
Istvan Koncz Tomasz Sadkowski
Istvan Zupko Tomoyuki Soma
Itzel López-Rosas Torben Redmer
Iuliia Taskaeva Torbjörn Ledin
Ivaldo Itabaiana Jr. Toru Togawa
Iveta Bernatova Tracy Murray Stewart
Ivona Djurkin Kušec Tsukasa Okiyoneda
Ivonne Loeffler Tulio L. Campos
Iwona Jarocka-Karpowicz Tuoxian Tang
Jacopo Lamanna Tusty-Jiuan Hsieh
Jacques Fantini Tzu-Ping Ko
Jae Kyu Ryu Uener Kolukisaoglu
Jakub Kryczka Ufuk Okkay
Jakub Żurawski Ulf Anderegg
Jan Bocianowski Uma Gautam
Jan Šrámek Umesh Desai
Janet Kumita Una Riekstiņa
Janosch P. Heller Urszula Karczmarczyk
Jaroslav Pejchal Uwe Rudolph
Jarosław Bryk Vadim Elagin
Jasmin Knopf Valentin Năstasă
Javier Manzano-López Valeria D'Argenio
Javier Saenz-Medina Valeria Visconte
Javier Ventura-Juárez Valerio Leoni
Jayanti Tokas Van Pham
Jayesh Ahire Van-An Duong
Jean Boutin Vangelis Daskalakis
Jean Defourny Vasantha Kumar
Jean E. Schwarzbauer Vasileios P. Papadopoulos
Jean-Marc Lobaccaro Vehary Sakanyan
Jean-Michel Savoie Velia Cassano
Jeannette Hübener-Schmid Velmarini Vasquez
Jeff Bronstein Vendrell Joan
Jeff Sands Venkata Krishna Kowthavarapu
Jelena Korać Prlić Venkateswarlu Kanamarlapudi
Jen-Chih Tseng Veronica Marrella
Jennifer Norman Verónica Martín
Jessica L. Mueller Véronique Giudicelli
Jessica Mountford Viatcheslav Martemyanov
Jevrosima Stevanovic Vicky Sophianopoulou
Jianyou Wang Victor G. Almendro-Vedia
Jianchao Zhang Victor Kuz'min
Jianfeng Xiang Vignesh Sundararajan
Jianguo Wu Vijay Kumar
Jianmin Zhang Vikash Singh
Jianyang Du Violeta Popovici
Jie Ying Visnja Stepanic
Jie Zhuang Vitalii Timofeev
Jiekai Yin Vito Calderone
Jifa Zhang Viviana Maffeis
Jimin Han Vlad Porumb
Jin Zhang Vladimir Babenko
Jindong Xie Vladimir Jurisic
Jingan Li Vladimir Kalinin
Jiri Hejnar Vladimir Tesar
Jitendra Kumar Tripathi Volkmar Lessmann
Joana Machado Vyacheslav Arlyapov
Joanna Listos Waihang Cheng
Joanna Sobiak Wanderley De Souza
Joanna Wyszkowska Wei Lei
João Gama Marques Wei Wang
João Miguel Correia Teixeira Wei Yan
João Miguel Marques dos Santos Weimin Chen
Joaquín Cordero-Martínez Weiwei Xu
Joaquin González Marrero Wenbin Bao
Joel Bumgardner Wenbo Zhi
Joelle Coumans Wenjun Shen
Joëlle Wiels Wenlin Yang
Johann Klare Werner Seebacher
Johan-Owen De Craene Wildan Mubarok
John Hildyard William T. Heller
John Lalith Charles Richard Wojciech Plazinski
John Oas Wojciech Szypuła
John Torcivia Wolfgang Sippl
Jonathan Bogan Wolfram Antonin
Jong Kook Park Xavier Xifró
Jong Myong Park Xiang Li
Jordi Marti Xiang Ma (China)
Jorge Serment-Guerrero Xiang Ma (USA)
Jose A. Fontenla Xiao Lin
José Antonio Mirón-Canelo Xiaoan Wu
José Bernardo Noronha-Matos Xiaohui Zhang
Jose Carlos Cameselle Xiaoning Zhang
José Inácio Xiaosheng Tan
José Luis Vázquez-Ibar Xiaoye Liu
José M. Mancheño Xin Bi
Jose M. Romero-Márquez Xin Liu
José Manuel Jaramillo Ortiz Xingjia Shen
Jose Miguel-Hidalgo Xingjun Feng
José Rafael de Almeida Xinhong Chen
Jose Tudela Xinli Li
Joshua Keller Xinyi Lu
Jovanka Gencel-Augusto Xristo Zarate
Jozsef Dudas Xuchang Zhou
József Mihály Xue Dong
Juan C. Luis Yan Kazakov
Juan Miguel Gonzalez Yan Zhang
Juan R. De Los Toyos Yanan Liu
Judit Marsillach Yann Gallot
Julian Freen-van Heeren Yasukazu Nakahata
Julian Muñoz Yasumasa Okazaki
Julio Plaza-Diaz Yaxiong Tao
Julita Minasiewicz Ye Peng
Jun Kobayashi Yenchun Peng
Junheon Kim Yihang Wang
Jupi Li Yinghuai Zhu
Kai Zheng Yingpeng Hua
Kaili Ma Yingpeng Xie
Kaimeng Huang Yingxue Zhang
Kanwal Rehman Yong Chen
Karan Arora Yongsheng Chen
Karel Petrzik Yongxin Liu
Karen Kyuregyan Yordanka Uzunova
Karen Mendez Lara Yoshiaki Tsuji
Kari Naylor Yoshimitsu Kiiriyama
Kari Stone Youakim Saliba
Karoly Mirnics Young Hye Song
Karunakar Reddy Pothula Youri Pavlov
Katarzyna Bączek Yu Wen Hsu
Katarzyna Bergmann Yue Wang
Katarzyna Gawron Yuji Nagatomo
Katarzyna Kabala Yuliang Zhang
Katarzyna Komosinska-Vassev Yunfeng Zhao
Katherina Psarra Yunhong Li
Katherine Hixon Yuridia Mercado Flores
Katherine Theken Yusuf S. Althobaiti
Katsuya Satoh Zengqian Shi
Kawase Masami Zhan Shu
Kazunori Kanemaru Zhanchao Li
Kazuya Kusama Zhao Cheng
Ke Cheng Zhaoxi Sun
Ke Cong Zheng Fu
Keigi Fujiwara Zhengwei Huang
Kenneth N. White Zhenning Ren
Kentaro Okamoto Zhidong Hu
Kevin Bain Zhihong Yang
Khadija Batool Zhipeng Xu
Khalid Muhammad Zhipeng Yan
Khawar Siddiqui Zhiwei Yang
Khuliso Ravhuhali Zhongshan Cheng
Kielan McAlinden Zoltán Rakonczay
Kim Jin-chul Zuohui Zhang
King Hei Stanley Lam Ivan N. Zorov

29 January 2024
Interview with Ms. Elizabeth Hill—Winner of the Best Young Academic Talk Award at Prion 2023 Sponsored by Biomolecules

Ms. Elizabeth (Lizzie) Hill is the winner of the Best Young Academic Talk Award at Prion 2023, which was sponsored by Biomolecules (ISSN: 2218-273X), and she is a final year Ph.D. student at the MRC Prion Unit at UCL in London, UK. She is particularly interested in the mechanisms underlying neurodegeneration with a long-term goal of being involved in facilitating disease-modifying therapies. Ms. Hill has also been involved in long-standing volunteer and public engagement work related to prion diseases and Parkinson’s disease.

The following is an interview with Ms. Elizabeth Hill:

1. Could you provide an overview of the research project that led to the award?
I am investigating the role of a recently identified genetic risk factor, syntaxin-6 (STX6), in prion diseases and related tauopathies. Using a functional genetics approach, I have generated both cellular and mouse models with manipulated syntaxin-6 expression for thorough characterization of both prion and tau phenotypes to further our knowledge of the molecular mechanisms through which syntaxin-6 affects disease susceptibility.

2. How did you come to choose this particular field of research?
Due to being personally touched by dementia in my family, I became incredibly motivated to contribute to research into neurodegeneration. I was fascinated by the concept of prions and how prion-like mechanisms are increasingly being unraveled in the more common neurodegenerative diseases.

3. Can you describe a specific challenge you have faced/are facing while conducting research and how you have overcome/are overcoming it?
When I started my Ph.D., I found public speaking extremely anxiety-provoking. However, by consistently putting myself in that uncomfortable position through institute-wide presentations, public engagement events, and also attending public speaking training, I have greatly improved.

4. How do you envision the impact of your research on the broader community or society?
My research informs on the mechanisms underlying disease susceptibility and the pathogenesis of prion diseases and tauopathies. I hope that this will provide another puzzle piece to further our understanding of these complex diseases, eventually aiding the development of disease-modifying treatments.

5. What is your impression of Biomolecules and open access publishing?
It allows research to reach a broader audience, allowing more people to access science from non-academic or low- and middle-income settings. Ultimately, I believe this results in scientific progress being maximized.

6. What are your overall thoughts about the conference, and besides winning the award, is there a moment that you particularly cherish from Prion 2023?
It was a wonderful conference with lots of exciting talks and insightful conversations. The moment I cherish the most is the overwhelming level of support I got from my work colleagues prior to presenting, who went over and above what I would have expected.

7. How did you celebrate winning the award, and do you have rituals to mark your accomplishments?
I shared my success with friends and family, and the accomplishment was warmly recognized by my institute.

8. What advice would you give to young researchers who are just starting their careers?
Take every opportunity to talk to people about your research and gain useful insights and expertise. Find good mentors. Take time to celebrate both the little and big successes.

9 January 2024
Meet Us at the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 18–21 March 2024, Vienna, Austria


Conference: The 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Date: 18–21 March 2024
Location: Vienna, Austria

MDPI will be attending the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology at Booth #06, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has had an ever-increasing impact among pharmaceutical scientists, and it is organized every two years, in March or April of even years.

The entire spectrum of topics ranging from engineering aspects of the manufacturing process, the portfolio of commercially available excipients enabling the formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.

Young and experienced scientists from academia and industry will present their latest research achievements in the form of poster presentations, allowing for fruitful scientific exchanges with the authors.

The meeting is intended to bring together people working in fundamental and applied academic research, in the chemical and pharmaceutical industry and the regulatory field, offering the opportunity to initiate fruitful discussions and collaborations.

The following MDPI journals will be represented:

  • Pharmaceutics;
  • Pharmaceuticals;
  • IJMS;
  • DDC;
  • Molecules;
  • Biomedicines;
  • CIMB;
  • Applied Biosciences;
  • BioMedInformatics;
  • Medicines;
  • Cosmetics;
  • Biomolecules.
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.worldmeeting.org/home/about-world-meeting/

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

26 December 2023
Biomolecules | Interview with Dr. Alessandro Paiardini, the Session Chair of the 3rd International Electronic Conference on Biomolecules

1. Can you please briefly introduce yourself?
My name is Alessandro Paiardini. I am an Associate Professor of biochemistry and bioinformatics at Sapienza University, Rome. I have built a strong national and international reputation as an expert in drug design and computational structural biology. I completed my formal training with a Ph.D. in biochemical sciences in 2005, under the guidance of Prof. Francesco Bossa, a prominent figure in protein biochemistry. Throughout my doctoral studies, I developed significant expertise in various computational tools such as homology modeling, molecular dynamics, docking, and evolutionary analysis. These experiences laid the foundation for my enduring interest in structural biology.
Following my Ph.D., I pursued post-doctoral research on “Post-genomic Structural Biology” in the laboratory of Prof. Stefano Pascarella, a renowned expert in bioinformatics. This opportunity allowed me to delve deeper into my field. In 2006, I was appointed as a Research Scientist at the Department of Biochemical Sciences at Sapienza University. In the subsequent years, my research focused on unraveling the molecular intricacies of Pyridoxal-5’-phosphate-dependent enzymes. I explored various aspects, including the structure/function relationship, ligand binding, catalytic mechanisms, evolution, and folding of these enzymes. My work aimed to understand these processes at a molecular level and contribute valuable insights for developing therapeutic agents.
To tackle these complex challenges, I honed my skills in protein bioinformatics and gained proficiency in programming languages such as C, C++, Python, and Perl. I also designed algorithms for structural bioinformatics analysis. Additionally, I developed expertise in IT problem solving and management, enhancing my overall capabilities in the field.

2. What do you think of the development status and trends of open access publishing?
In a nutshell, open access has changed the way in which we share and access knowledge. It is making research more accessible, transparent, and collaborative. In the coming years, we can expect open access to become even more entangled in our daily work: it is not just about research papers anymore but also about educational materials, textbooks, early drafts of studies and online free congresses.

3. What is your impression of the Biomolecules journal?
In my opinion, Biomolecules is a reputable, peer-reviewed, scientific journal covering a wide range of topics in the fields of biochemistry, molecular biology, cell biology, and biophysics. In my experience as an editor, it has a rigorous review process and contributes to the scientific community by publishing high-quality research articles, reviews, and communications.

4. What do you think will be the research hotspots in the field of biomolecules in the next few years, and can you describe them to us?
Predicting specific research hotspots in any scientific field is of course challenging. However, the following topics are gaining momentum and could continue to be significant in the next few years:
1) Precision medicine and personalized therapies: Tailoring treatments based on a person’s genetic makeup and biomolecular profiles is likely to be a focus, leading to more effective and personalized therapies;
2) Structural biology and cryo-electron microscopy (Cryo-EM): Cryo-EM technology has revolutionized structural biology, allowing researchers to visualize biomolecular structures with unprecedented detail. Continued developments in this area may reveal new insights into complex biomolecular interactions, leading to drug discovery and targeted therapies;
3) Synthetic biology and bioengineering: The design and construction of novel biological parts, devices, and systems for useful purposes;
4) RNA biology: Research in this area is expanding. Understanding the roles of RNAs in gene regulation, disease processes, and therapeutics is likely to be a focus;
5) Bioinformatics and big data: The integration of biomolecular data with computational methods like AI will likely continue to be a significant area of research.

5. Can you give any advice on academic research for young scholars in related fields?
Scholars should build a strong foundation in biology, chemistry, mathematics, and computer science. Understanding the fundamentals is crucial for advanced studies in structural biology and bioinformatics. It is necessary to learn programming languages commonly used in bioinformatics, such as Python or R. Also, it is important to be familiar with relevant software tools and databases used in structural biology and bioinformatics. Most importantly, stay persistent, be resilient in the face of failures, and maintain your passion for the subject.

6. What are your expectations and outlook for this e-conference?
I would expect it to be a dynamic and interactive platform. The youngest scientists should have the most space and time to bring new ideas. It is nice to have workshops and panel discussions to provide opportunities for in-depth learning and knowledge exchange. Participants could delve into specific techniques and tools, for example. Virtual poster sessions would also be welcomed.

25 December 2023
Meet Us at the International Conference on Nanomedicine and Nanobiotechnology (ICONAN 2024), 15–17 January 2024, Barcelona, Spain


Nanomedicine and nanobiotechnology have tremendous potential for tomorrow’s patient care in a wide variety of disease management, and numerous theoretical concepts are currently being translated into preclinical and clinical studies. The fifth edition of the ICONAN conference brings together high-profile plenary speakers and world-class researchers who have successfully developed and translated nanomedicines over the last decades, offering a vibrant platform for oral and poster presentations, sponsor exhibits, and networking. The conference topics include targeted drug delivery, organ biodistribution and nanocarriers, nanomedicine for the immune system and cancer diagnosis and therapy, biological and medical nanodevices and biosensor 3D models, tissue engineering and regenerative nanomedicine toxicology, risk assessment of nanomedicine systems nano-imaging for diagnosis, etc.

MDPI will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2024); we welcome researchers from different backgrounds to visit and share their latest ideas.

The following MDPI journals will be represented:

If you plan to attend this conference, please contact us online. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/.

19 December 2023
Biomolecules | Interview with Prof. Dr. Jürg Bähler, the Session Chair of the 3rd International Electronic Conference on Biomolecules

1. Can you please briefly introduce yourself?
I completed my Ph.D. at the University of Bern (Switzerland), followed by postdoctoral stints at the University of North Carolina (USA) and Imperial Cancer Research Fund (UK). After working at the Wellcome Sanger Institute as a Group Leader, I was appointed as Professor of Molecular Systems Biology at University College London (UK) in 2009, and as Director of UCL’s Institute of Healthy Ageing in 2019. Our laboratory studies cellular quiescence and aging using fission yeast and, recently, the turquoise killifish as model systems. We apply diverse genetic/genomic, cell biological, and computational approaches toward a systems-level understanding of genome regulation and function, ageing-associated processes, and the complex relationships between genotype, phenotype, and environment.

2. What do you think of the development status and trends of open access publishing?
I am a big fan of open access publishing and making research results available without delay on preprint servers. New approaches to peer review as pioneered by Review Commons or eLife, for example, are also promising to improve the publishing experience for authors and readers.

3. What is your impression of the Biomolecules journal?
Biomolecules underwent astonishing growth while maintaining quality peer review and rapid decision times.

4. What do you think will be the research hotspots in the field of biomolecules in the next few years, and can you describe them to us?
Single-cell approaches will become ever more important, including multi-omics and live-cell methods, and much progress may also be achieved at the interface of different disciplines, e.g., between biophysics and cell biology.

5. Can you give any advice on academic research for young scholars in related fields?
Pursue what interests you most rather than what is fashionable, and be resilient because research careers involve frequent rejections (papers, grant proposals, job positions).

6. What are your expectations for this e-conference?
I hope there will be stimulating, fresh insights and inspiring discussions.

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

13 November 2023
Prof. Dr. Hang Fai (Henry) Kwok Appointed Section Editor-in-Chief of Section “Natural and Bio-inspired Molecules” in Biomolecules

We are pleased to announce that Prof. Dr. Hang Fai (Henry) Kwok has been appointed Section Editor-in-Chief of the Section “Natural and Bio-inspired Molecules” in Biomolecules (ISSN: 2218-273X).

The Section “Natural and Bio-inspired Molecules” focuses on papers in the area of natural product research. Contributions may be related to the chemistry and/or biochemistry of naturally occurring compounds or the biology of living systems from which they are sourced, as well as the chemistry and biological properties of synthetic natural compounds derivatives and/or structurally related compounds. For example, they may be articles that describe specific secondary metabolites of microorganisms, including antibiotics and mycotoxins; physiologically active compounds from plants or animal sources; and biochemical studies, including biosynthesis and microbiological transformations and the isolation, structure elucidation, chemical synthesis, and pharmacology of compounds from natural sources.

Articles related to the design and synthesis of new structures, inspired by those of natural compounds, in order to study and modulate their biological activities are also welcome. When new compounds are reported, manuscripts describing their biological activity are much preferred. Studies on complex mixtures of natural products must focus on specific compounds in regard to the pharmacological properties of the mixture.

Prof. Dr. Hang Fai (Henry) Kwok is an associate head and professor in the Department of Biomedical Sciences, Faculty of Health Sciences at the University of Macau, China. His research interests are focused on the areas of proteins (antigens), natural-based peptides (venom-based), and antibodies (targeted therapy/immunotherapy) in the battle against infectious diseases and cancer for novel drug discovery, development, and treatment.

The following is a short Q&A with Prof. Dr. Hang Fai (Henry) Kwok, who shared his vision for the journal with us, as well as his views on the research area and open access publishing:

1. What appealed to you about the journal that made you want to become its Section Editor-in-Chief?
I was thrilled by the journal with a specific Section focusing on natural and bio-inspired molecules, as it provides an ideal platform for conducting research spanning various areas, ranging from fundamental biomedical science and pharmacology studies to clinical investigations.

2. What is your vision for this Section?
This Section aims to serve as an excellent platform for biologists, pharmacists, and clinicians to showcase their cutting-edge research on natural and bio-inspired molecules, thereby expanding the frontiers of the field.

3. What does the future of this field of research look like?
Research on natural and bio-inspired molecules/compounds is a highly dynamic field encompassing a wide range of investigations. It involves understanding the intricate mechanisms by which these remarkable structural molecules interact with our biological systems, as well as exploring how the body responds to them as potential prototype drugs. This field explores the sources, biological effects, chemical properties, and diagnostic/therapeutic applications of natural and bio-inspired molecules. Being actively involved in this field is truly captivating, and the journal's Section “Natural and Bio-inspired Molecules” serves as a vital platform for researchers worldwide, facilitating effective communication and collaboration among experts in the field.

4. Do you have any suggestions for young researchers in this field?
Research is a journey of continuous learning and growth. Be persistent, curious, and open to new ideas and approaches. Young researchers should always stay updated and collaborate with others to keep themselves updated with the latest advancements, trends, and publications in their research area. In addition, attend conferences and join professional networks to stay connected with the research community to seek fruitful collaborations with other researchers both within and outside your institution. In my experience, collaborations provide opportunities for exchanging knowledge, learning from others' expertise, and conducting interdisciplinary research.

5. What do you think of the development of open access in the publishing field?
It is an essential trend in the field of publication. We can continue working together through the open access platform to get our peer-reviewed research to serve the scientific community.

We warmly welcome Prof. Dr. Hang Fai (Henry) Kwok as the Section Editor-in-Chief for “Natural and Bio-inspired Molecules”, and we look forward to him leading Biomolecules to achieve many more milestones.

1 November 2023
MDPI Insights: The CEO’s Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

2 October 2023
MDPI Insights: The CEO’s Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

19 September 2023
Meet Us at the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress, 19–22 October 2023, Hefei, China


MDPI will attend the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress. This event will be held from 19 to 22 October 2023 in Hefei, China, and is hosted by the Chinese Society of Biochemistry and Molecular Biology.

This event includes invited reports of the conference, branch (special topic) reports, and posters. The theme of this conference is gene expression and regulation; RNA function and regulation; protein modification and function; metabolic homeostasis and networks; frontier technology and application, etc.

The following MDPI journals will be represented:

  • Biomolecules (leading);
  • Genes (leading);
  • IJMS (leading);
  • Cancers;
  • Cells;
  • Pharmaceutics;
  • CIMB;
  • Biology;
  • Symmetry.

If you plan on attending this conference, please feel free to stop by our booth (#C07) and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.csbmb.org.cn/2023/.

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

30 August 2023
MDPI Insights: The CEO’s Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

24 August 2023
Meet Us at the ASHG Annual Meeting 2023, 1–5 November 2023, Washington D.C., USA


MDPI will attend the ASHG Annual Meeting 2023, held in Washington, D.C., USA, from 1 to 5 November 2023.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

  • Genes;
  • JPM;
  • Biomolecules;
  • Medicina;
  • Diagnostics;
  • Cancers;
  • Biomedicines;
  • Humans;
  • Applied Biosciences;
  • DNA;
  • IJMS;
  • Brain Sciences;
  • Cardiogenetics;
  • Vaccines;
  • Life;
  • Epigenomes;
  • BioTech;
  • Biology;
  • CIMB;
  • Biomedinformatics.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.ashg.org/meetings/.

14 August 2023
MDPI’s 2022 Young Investigator Awards in Biology and Life Sciences—Winners Announced


MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in biology and life sciences. The winners were selected by the journals’ Award Evaluation Committee.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Agriculture:

  • Thomas Hartinger, University of Veterinary Medicine Vienna, Austria

Agronomy:

  • Leontina Lipan, Universidad Miguel Hernández, Spain

Animals:

  • Daniel Stec, Polish Academy of Sciences, Poland

Brain Sciences:

  • Dibyadeep Datta, Yale Medical School, USA
  • Giacomo Valle, ETH Zurich, Switzerland
  • Morgan H. James, Rutgers University, USA

Foods:

  • Xiaonan Lu, McGill University, Canada

Genes:

  • Alfredo Iacoangeli, King's College London, UK
  • Elisa De Franco, University of Exeter, UK
  • Riccardo Pecori, German Cancer Research Center, Germany
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Horticulturae:

  • Massimiliano Renna, University of Bari Aldo Moro at Bari, Italy

Insects:

  • Adam G. Dolezal, University of Illinois Urbana-Champaign, United States

Microorganisms:

  • Carla Rodrigues, Institut Pasteur, France
  • Lorena Rodriguez-Rubio, University of Barcelona, Spain
  • Kevin Solomon, University of Delaware, USA

Nutrients:

  • Colleen Deane, University of Southampton, UK

Toxins:

  • Paz Otero Fuertes, University of Vigo, Spain

Pathogens:

  • Marta Giovanetti, National Reference Laboratory of Flavivirus in the Oswaldo Cruz Foundation, Brazil
  • Carrie M. Long, National Institute of Allergy and Infectious Diseases (NIAID), USA

Vaccines:

  • Carina Joe, University of Oxford, UK

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Travel Awards in Biology and Life Sciences—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in biology and life sciences for their outstanding presentations.

MDPI journals regularly offer travel awards to encourage junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of the 2022 Travel Awards and wish them the greatest success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • Liloia Donato, University of Turin, Italy
  • Roberta Bettoni, University of Milano Bicocca, Italy

Diversity:

  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

IJMS:

  • Carlo Matera, University of Milan, Italy
  • Elisabetta Coppi, University of Florence, Italy
  • Ilaria Tonazzini, Nanoscience Institute—National Research Council (CNR) @ NEST in Pisa, Italy

MPs:

  • Pere Catala, University Eye Clinic Maastricht, Maastricht University Medical Center, the Netherlands

Sports:

  • Angela Blasimann, University of Antwerp, Belgium
  • Angelo Sabag, Western Sydney University, Australia

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Biology and Life Sciences—Winners Announced


In order to acknowledge our reviewers, who demonstrate diligence, professionalism, and timeliness when generously dedicating their time to reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer review process.

We are proud to recognize the winners for the year 2022 in biology and life sciences for their outstanding contributions, among extensive competition, by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Agronomy:

  • Ewa Ropelewska, The National Institute of Horticultural Research, Poland
  • Marek Rašovský, Slovak University of Agriculture in Nitra, Slovakia
  • Prakash Jha, Kansas State University, USA
  • Vasileios Greveniotis, Institute of Industrial and Forage Crops, Greece

Biology:

  • Alberto Collareta, University of Pisa, Italy
  • Francisco Curate, University of Coimbra, Portugal
  • Gianpiero Greco, University of Study of Bari, Italy
  • Luca Poli, University of Study of Bari, Italy
  • Shaohua Chen, South China Agricultural University, China

Brain Sciences:

  • Chong Chen, Yamaguchi University Graduate School of Medicine, Japan

Children:

  • Marco Sapienza, University of Catania, Italy
  • Sabina Barrios-Fernández, University of Extremadura, Spain

Diversity:

  • Corrado Battisti, Torre Flavia LTER (Long Term Ecological Research) Station, Italy
  • Daniel Stec, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Emilia Grzędzicka, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Igor Zelnik, University of Ljubljana, Slovenia

Endocrines:

  • Eva S. Liu, 1Harvard Medical School, USA 2Brigham and Women’s Hospital, USA

Fermentation:

  • Aleksandra Szydlowska, Warsaw University of Life Sciences (WULS), Poland
  • Mohamed Ali Abdel-Rahman, Al-Azhar University, Egypt

Fishes:

  • Andrew G. Jeffs, University of Auckland, New Zealand
  • Mohamed Samy-Kamal, Universitat d'Alacant, Spain

Foods:

  • Baskaran Stephen Inbaraj, Fu Jen Catholic University, Taiwan
  • Marzena Włodarczyk-Stasiak, University of Life Sciences in Lublin, Poland
  • Minaxi Sharma, Haute Ecole Provinciale de Hainaut-Condorcet, Belgium
  • Viviani Ruffo de Oliveira, Federal University of Rio Grande do Sul (UFRGS), Brazil

Genes:

  • Federico Manuel Giorgi, University of Bologna, Italy
  • Jan Bocianowski, Poznań University of Life Sciences, Poland
  • Magdalena Mroczek, Center for Cardiovascular Genetics and Gene Diagnostics, Switzerland

IJMS:

  • Keigi Fujiwara, University of Texas MD Anderson Cancer Center, USA
  • Tomasz W. Kaminski, University of Pittsburgh, USA
  • Takujiro Homma, Yamagata University, Japan
  • William Bryan Terzaghi, Wilkes University, United States
  • Zong-jie Cui, Beijing Normal University, China

Insects:

  • Abraão Almeida Santos, University of Florida, USA
  • Agata Kaczmarek, Polish Academy of Sciences, Poland
  • Miguel A. García-Martínez, Universidad Veracruzana, Mexico

Life:

  • Andrei S. Rodin, Diabetes and Metabolism Research Institute, USA
  • Kazuhiko Kotani, Jichi Medical University, Japan

Metabolites:

  • Jianing Mi, King Abdullah University of Science and Technology, Saudi Arabia
  • Nguyen Phuoc Long, Inje University College of Medicine, Republic of Korea
  • Xian Luo, University of Alberta, Canada

Pathogens:

  • Guillaume Fiches, Ohio State University, USA
  • Jianxuan Wu, Gilead Sciences, USA
  • Tomasz M. Karpiński, Poznań University of Medical Sciences, Poland

Plants:

  • Alicia Ayerdi Gotor, Institut Polytechnique UniLaSalle, France
  • Andrea Mastinu, University of Brescia, Italy
  • Edyta Paczos-Grzeda, University of Life Sciences in Lublin, Poland
  • Narayan Bhusal, Seoul National University, Republic of Korea
  • Mohsen Hesami, University of Guelph, Canada

Toxins:

  • Christian Müller, University of Greifswald, Germany
  • Margarita Fernández-Tejedor, IRTA, Spain

Vaccines:

  • Christian Napoli, “Sapienza” University of Rome, Italy
  • Federico Marchesi, University of Parma, Italy
  • Roger E. Thomas, University of Calgary, Canada

Veterinary Sciences:

  • Fun-In Wang, National Taiwan University, Taiwan
  • Valeria Grieco, University of Milan, Italy

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Biology and Life Sciences—Winners Announced


MDPI’s Best PhD Thesis Awards are presented to recognize the young scholars who are judged to have completed the most outstanding PhD thesis in their field of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to warmly congratulate the winners of the 2022 Best PhD Thesis Awards and wish them success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • “CYP2D in the Brain Alters Response to Drugs and Neurotoxins”
    by Marlaina R. Stocco, University of California, USA
  • “Neural Encoding of Prior Experience in Sensorimotor Behavior”
    by Nicolas Meirhaeghe, Institut de Neurosciences de la Timone, France
  • “Perinatal Stem Cell: Epigenetic, Biological and Differentiative Characteristics”
    by Giulia Gaggi, University "G.D'Annunzio" of Chieti-Pescara, Italy

Genes:

  • “Uncovering the Genetic Variation Involved in Asthma Exacerbations through Multiple Genomic Approaches”
    by Esther Herrera Luis, Universidad de La Laguna, Spain

Veterinary Sciences:

  • “Development of Novel Tools for Monitoring Antimicrobial Resistance in Complex Microbial Communities and Their Application to Improving Our Stewardship of Antimicrobials in Livestock”
    by Ashenafi Feyisa Beyi, Iowa State University, United States

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s Best Paper Awards in Biology and Life Sciences—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as scientific merit, overall impact, and the quality of presentation.

We are honored to present the winners for the year 2022 in biology and life sciences, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Agronomy:

Biology:

Brain Sciences:

Diversity:

Genes:    

IJMS:     

Insects:  

Life:

Metabolites:          

MPs:

Pathogens:

Plants:

Toxins:

Vaccines:               

Veterinary Sciences:

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

27 July 2023
MDPI Insights: The CEO’s Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

26 July 2023
Meet Us at the 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023), 5–8 September 2023, Zaragoza, Spain


Conference:
The 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023)
Date: 5–8 September 2023
Place: University of Zaragoza Faculty of Medicine, Zaragoza, Spain
Booth: #30

MDPI journals will be attending the 45th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2023) as an exhibitor. This meeting will be held in Zaragoza, Spain, from 5 to 8 September 2023.

SEBBM contributed significantly to the creation of the Federation of European Biochemical Societies (FEBS) in 1964, represents Spain in the International Union of Biochemistry and Molecular Biology (IUBMB), is one of the founding members of the Confederation of Spanish Scientific Societies (COSCE) and belongs to the Spanish Association of Biocompanies (ASEBIO), which develops activities in the field of biotechnology in Spain.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.acs.org/meetings/acs-meetings/fall-2023.html.

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

4 July 2023
Meet Us at the CRS 2023 Annual Meeting, 24–28 July 2023, Las Vegas, USA


The conference is the 50th annual conference of the Controlled Release Society. The annual CRS conference is the most important conference in the pharmaceutics field. The main topics of the conference include drug delivery and controlled release, nanomedicine and nanotechnology, and biopharmaceutics. The conference organizer has a full program for the duration of the conference with highly prominent plenary talks, technical sessions covering a wide scope of topics, industry-led workshops, and technical forums.

Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with eleven other MDPI journals.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #409. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.eventscribe.net/2023/CRSAnnualMeeting or contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.

3 July 2023
MDPI Insights: The CEO’s Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

14 June 2023
Meet Us at the 2023 Chinese Biophysics Congress, 19–23 July 2023, Changsha, China
 


Conference:
2023 Chinese Biophysics Congress
Date: 19–23 July 2023
Place: Changsha, China

MDPI will be attending the 2023 Chinese Biophysics Congress, which will be held from 19 to 23 July 2023 in Changsha, China.

The Chinese Biophysics Congress is the largest and most developed academic event in the field of biophysics in China. Prof. Tao Xu, the chairman of the Chinese Society of Biophysics, will be the chair of the organizing committee. The main theme is Biophysics and Human Health, focusing on the latest research progress and development trend of biophysics and related research fields.

The following MDPI journals will be represented:

  • IJMS;
  • Biophysica;
  • Biomedicines;
  • Physics;
  • CIMB;
  • Bioengineering;
  • Biomolecules.

Please do not hesitate to reach out (ijms@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have. For more information about the conference, please visit the following website: https://www.bsc.org.cn/2023/.

16 May 2023
Meet Us at the 19th Annual International Conference of the Metabolomics Society, 18–22 June 2023, Niagara Falls, Ontario, Canada


Conference: 19th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

Please do not hesitate to reach out (metabolites@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.

15 May 2023
Meet Us at the 10th FEMS Congress of European Microbiologists, 9–13 July 2023, Hamburg, Germany

FEMS was established in 1974 and is now an active and diverse federation of 55 European learned societies that includes around 30,000 professionals who are committed to advancing microbiology for the benefit of society. Located in 38 European countries, around half of these professionals are early career researchers, and the remainder include industry scientists, established academics, educators and campaigners. The 10th FEMS Congress of European Microbiologists will take place in Hamburg, Germany, from 9 to 13 July 2023. This event is dedicated to showcasing the latest developments in microbiology and to connecting microbiologists from all over the world.

Main topics:

  • Environmental Microbiology & Ecology;
  • Biotechnology & Synthetic Microbiology; 
  • Food Microbiology; 
  • Infection Biology & Pathogens; 
  • Infectious Diseases; 
  • Taxonomy & Systematics;
  • Genetics & Genomics;
  • Virology;
  • Microbiology Education & Profession;
  • Molecular Microbiology & Biochemistry.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth #B18 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://www.fems2023.org/.

11 May 2023
Strolling through the Porticoes: A Conversation with Prof. Dr. Lucio Cocco

Interviewer: Dr. Stephen B. Shears, Inositol Signaling Group, Signal Transduction Laboratory, National Institute of Environmental, Health Sciences, Research Triangle Park, NC, 27709 USA

I am delighted to have been given the opportunity to interview Prof. Dr. Lucio Cocco for the Special Issue of Biomolecules, “Versatility of a Cellular Signaling Scaffold: The Inositol Ring Rules! – Honorary Special Issue Commemorating the Work of Prof. Lucio I. M. Cocco”, that honors his seminal work, which began in the late 1970s with his identification of nuclear phospholipids. During the following decade, Lucio pursued a new concept that, within the nuclear matrix, there are pools of inositol lipids with distinct cell-signaling activities. As noted elsewhere [1], this hypothesis was initially greeted with some skepticism; at that time, the inositol lipid field was preoccupied with the canonical functions of these signaling molecules at the plasma membrane. But Lucio persisted. He and his colleagues subsequently published a considerable and highly influential body of work that has furthered the understanding of the role of this nuclear signaling pathway during myogenic differentiation, giving new insight into its role in myotonic dystrophies, as well as during haemopoietic differentiation, and envisaging the pathophysiological significance of nuclear phosphoinositide signaling in myelodysplastic syndromes.

Dr. Stephen B. Shears (SBS): Hi, Lucio, thanks for agreeing to this interview. Can I begin by asking you to describe the career path that introduced you to phospholipid research?

Prof. Dr. Lucio Cocco (LC): In the mid-1970s I was an undergraduate at the University of Chieti Medical School. As part of my studies in medicine and surgery, Antonio Manzoli became my mentor in the Histology Laboratory. Others [2] had published studies stating that the phospholipid content of active chromatin was 5-fold higher compared to repressed chromatin. We were interested in pursuing the biological significance of this observation with regard to cell cycle regulation, but the stumbling block was the persisting controversy over the extent to which these phospholipids might arise by contamination from non-nuclear membranes. Antonio and I investigated this problem, and we concluded that non-contaminating phospholipids were genuinely associated with non-histone chromosomal proteins (NCHP), perhaps regulating DNA stability and replication. We also reported that NHCP fractions prepared from leukemic B-lymphocytes contained 40% less sphingomyelin and 4-fold higher levels of phosphatidylcholine compared to normal B-cells [3]. This work is also the origin of my interest in cancer research.

SBS: And after you graduated?

LC: I remained at Chieti and studied for a Ph.D. in sports medicine. It seemed such a qualification might provide good employment prospects. I must confess I was also tempted by the possibility of sharing time with famous football players: one of my friends was Leonardo Vecchiet, a university physician who worked with Fino Fini. They were the doctors for the Italian National Football Team, and Fini was also the Director of the Specialty in Sports Medicine.

But my passion for studying the biochemistry and functionality of nuclear lipids prevailed, and in 1978 I accepted a tenured position at the University of Bologna.

SBS: This was a significant change in your academic lifestyle; you swapped an institution that had not yet reached its 20th birthday for a position at the oldest university in the Western world.

LC: Bologna was a very attractive opportunity; to live in a medieval city that is so rich in history, science and culture, and yet is compact and walkable, in no small part due to its 38 kilometers of porticoes, which were recently added to the UNESCO World Heritage List. It is a wonderful walk to and from the laboratory.

SBS: But almost immediately you took off to Glasgow, Scotland.

LC: In 1979 I began a series of sabbaticals at the Beatson Institute for Cancer Research. The late John Paul was Director at the time. Under his leadership, a small research team, originally housed in the one-time servant’s quarters of a local cancer hospital, had been transformed into a newly constructed, purpose-built institute within the picturesque grounds of Glasgow University; it had attracted several internationally reputed scientific teams and was considered the top place to study gene regulation.

SBS: Our paths almost crossed in the late 1970s; I worked just 74 km from you, at the Edinburgh Medical School. I found it challenging to follow the Edinburgh version of the Scottish accent, but Glaswegian can be incomprehensible.

LC: I had assumed I would be better prepared. English is my second language, courtesy of my father having placed me in an English primary school. However, my wife Erminia and I both struggled at first. Nevertheless, eventually we successfully adapted to this new way of communicating.

SBS: Stewart Gilmour was your colleague at the Beatson; how did he come to share your enthusiasm for nuclear phospholipids?

LC: Stewart and John Paul were studying the regulation of beta-globin genes. I recall a meeting in which I convinced them it could be instructive to investigate if there could be a role for nuclear phospholipids. In 1980, Stewart and I published our first paper together, which described the analysis of Triton-treated nuclear material to remove nuclear membranes [4]. We felt this short paper presented an important finding that put to bed the criticism that phospholipids in our nuclear preparations must have arisen from contaminating membranes: now we had shown nuclear phospholipids need not even be associated with membranes.

SBS: After your return to Bologna in 1983, what specifically drew your attention to the inositol lipids?

LC: The emergence of inositol lipids as cellular signals [5] initially escaped my attention. After all, they are present at very low levels and at that time were canonical plasma membrane signals. However, my enthusiasm for these particular phospholipids changed following the description by Smith and Wells in 1983 [6] of nuclear inositol lipid synthesis.

SBS: And you returned to the UK to pursue this…

LC: In 1985, I visited Stewart, who had relocated to the Institute of Animal Physiology in Babraham, Cambridge, and through him I met Robin Irvine. I asked Robin if we could work together to study nuclear inositol lipids. That was despite us both having our doubts; Smith and Wells had concluded inositol lipid synthesis occurred in the nuclear envelope, which we both thought was probably contaminated by the endoplasmic reticulum. Our hesitancy evaporated when we used 0.4% Triton to prepare membrane-free nuclei that were able to synthesize PtdIns(4,5)P2 in a cytoplasm-independent manner; this work was published in 1987 [7].

SBS: From looking at your resume, it seems this period was a very busy time: you were Chair of the Anatomy Department at the University of Chieti, and then you became the Director of their post-graduate School in Hygiene.

LC: It was a very interesting time. I took on a number of academic commitments while still remaining active in research, part of which was still going on in Bologna. During this time Stewart and I co-authored several follow-up papers that helped our ideas become more generally accepted, and then others also began to publish studies into nuclear phosphoinositide signaling [8,9].

I would also like to acknowledge Stewart’s continuing guidance as I performed more experiments with Alberto M. Martelli in our Bologna laboratory; we had identified a nuclear-specific species of Phospholipase PLCβ that was activated within 2 minutes’ treatment of 3T3 mouse fibroblasts with insulin-like growth factor-1. These data yielded a manuscript that we submitted to Nature in 1992. The reviewers were positive but demanded additional experiments. Alberto didn't think these were necessary, but I did. However, the journal office put us under pressure to return the manuscript promptly. It was the Easter weekend, which in Italy is the second most important holiday after Christmas. I remember spending Good Friday and Easter Eve in the lab making dozens of Western blots; we were all relieved and excited when the work was accepted for publication in early April of 1992 [10].

SBS: Were there any immediate benefits from the Nature publication?

LC: Naturally, all of the members of our lab were excited by the novelty of the observations, and by the recognition that we were performing research that was deemed to be important to the scientific world. The publication of this work in a journal as prestigious as Nature gave me visibility and subsequently the opportunity to successfully request that our Cellular Signaling Laboratory be set up in Bologna. The location of the laboratory has historical significance in that the space was once occupied by Professor Oliviero Mario Olivo, a distinguished embryologist and labmate of Nobel Laureate Rita Levi Montalcini at the renowned School of Giuseppe Levi in Turin.

Our new setup encouraged generous financial support from the Italian Ministry for Research. Sadly, fundraising in my country is now very difficult; support from private institutions has become very important.

SBS: Another of your important scientific contributions in Bologna has been to organize annual symposia, Advances in Biological Regulation.

LC: This symposium series—originally Advances in Enzyme Regulation—was founded in the United States in the 1960s by George Weber and Sir Hans Krebs. I gave my first presentation in 1978 on the possible role of phospholipids in the nucleus in normal and neoplastic cells [11]. Beginning in 1995, I collaborated with George in the organization of these symposia in Indianapolis. Then, in 2005, George asked me if I felt like continuing his work, and so the symposium was renamed and moved to Bologna.

My feeling is that the success of this so-called closed conference is to bring together a group of scientists that are obliged for two days to communicate with each other, exchange ideas and hopefully initiate new collaborations. I have also been honored that a number of Nobel Laureates accepted my invitations to present plenary lectures. They seemed to have enjoyed the experience, always warmly thanking me for having had the opportunity to participate in this "historic" symposium.

SBS: I would like to express my gratitude for the privilege to attend several of these meetings. I must also thank your lab staff that perform much organizational work behind the scenes, but my special thanks go to Erminia, who is the most generous and gracious hostess each time we have been invited to your apartment in downtown Bologna. I can also testify that an evening stroll through the porticoes is fun too!

I won’t forget one year when attendees were also invited to the anatomical wax museum in Bologna; fortunately, its visitors are no longer treated to a public dissection of freshly executed criminals! I recently learned of this 16th-century practice from reading your 2000 account of the history of this museum [12].

LC: I was involved in writing this article because as a doctor I had acquired a deep knowledge of anatomy, which is also one of the fundamental disciplines of our department. It was instructive to go back in history and discover that research activities in the eighteenth century took place not in the University but at the Academy of Sciences of the Bologna Institute.

SBS: Another collateral benefit of my attending your Bologna meetings has been to keep me informed of the significant body of work that you have published on the links between nuclear inositol lipid signaling and myelodysplastic syndromes.

LC: In this area of work, Matilde Follo’s paper in the Journal of Clinical Oncology [13] has been particularly important. She and her co-workers determined that mono-allelic deletion of PLCβ1 is associated with worse clinical outcomes in myelodysplastic syndromes. This study captured the attention of hematologists, while also paving the way for further epigenetic analysis that demonstrated how PLCβ1 mRNA levels are predictive of whether the response to azacitidine therapy will be either clinically favorable or lead to a worsening condition; this work was published in PNAS and the Journal of Leukocyte Biology [14,15].

SBS: Recent years have seen considerable documentation of the extent to which women continue to be under-represented in senior scientific positions. Any who might not appreciate your efforts to counter this bias will find it instructive to direct their attention to the list of authors on the publications that you just mentioned.

LC: Throughout my career, I have simply tried to recruit the best scientists. It just worked out that many of these were female. The reward for me has been to mentor a number of female scientists who have attained important and successful academic positions.

SBS: Your most recent publications confirm that you continue to explore new areas of phosphoinositide pathogenesis.

LC: In addition to hematological diseases, my current work is focused on the possible role of abnormalities of PLCs in the pathogenesis of glioblastoma: it is the most common and most malignant of adult gliomas, and hence it also carries the worst prognosis. The first data are very encouraging [16].

SBS: As I reflect upon our brief conversation, I am led to guess you must be deeply satisfied that your early championing of the importance of nuclear inositol lipids has been rewarded with a wealth of data describing their regulation of chromatin remodeling, DNA repair, RNA processing, and gene transcription. Nevertheless, I find it intriguing that recent reviews by you and your colleagues (e.g., [17]) pose some of the same fundamental questions about inositol lipids that you were asking 40 years ago; for example, concerning their origins (nuclear delivery vs. nuclear synthesis?), their biophysical presentation (protein bound and/or present in biomolecular condensates?), and, of course, their mechanisms of action.

LC: We know so much more than we knew in the 1980s, yet full understanding is yet to be achieved. I believe that the most important thing we should solve is the total comprehension of how inositol lipids and other signal transduction systems are responsible for cell growth and differentiation processes. It is the pursuit of this information and the hope of providing new weapons for medical therapy that keeps me inspired and enthusiastic.

SBS: Many of my scientific publications owe much to the collegiate nature of our field and the generosity of my many colleagues. Are there any that were particular sources of inspiration that you would like to acknowledge?

LC: Among the colleagues who have inspired me in the continuation of my research activity, I wish to make particular mention of Robin Irvine, Daniel Raben, John York, Vytas Bankaitis, and last but not least, Sue Goo Rhee and Pann-Ghill Suh, who shared with me their own antibodies against PLCs, which are far superior to any of the commercial ones. I am keen to thank the organizations that have supported me financially in my research: the Italian Ministry of Research, the Italian Association for Cancer Research, the CARISBO Foundation, the Intesa San Paolo Foundation, and the Italian National Research Council.

But the biggest thanks go to my wife Erminia, who has totally supported me since the early years of my career, who followed me to Glasgow and who continues to be a precious stone in the social part of the Advances in Biological Regulation Symposia.

SBS: Thank you very much, Lucio! 

Acknowledgment: This interview was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences, USA. 

References

  1. Irvine, R. Nuclear lipid signaling. Sci STKE 2000, 2000, re1, doi:10.1126/stke.2000.48.re1.
  2. Rose, H. G.; Frenster, J. H. Composition and metabolism of lipids within repressed and active chromatin of interphase lymphocytes. Biochim Biophys Acta 1965, 106, 577-591, doi:10.1016/0005-2760(65)90073-1.
  3. Manzoli, F. A.; Maraldi, N. M.; Cocco, L.; Capitani, S.; Facchini, A. Chromatin phospholipids in normal and chronic lymphocytic leukemia lymphocytes. Cancer Res 1977, 37, 843-849.
  4. Cocco, L.; Maraldi, N. M.; Manzoli, F. A.; Gilmour, R. S.; Lang, A. Phospholipid interactions in rat liver nuclear matrix. Biochem Biophys Res Commun 1980, 96, 890-898, doi:10.1016/0006-291x(80)91439-4.
  5. Michell, R. H.; Kirk, C. J.; Jones, L. M.; Downes, C. P.; Creba, J. A. The stimulation of inositol lipid metabolism that accompanies calcium mobilization in stimulated cells: defined characteristics and unanswered questions. Philos. Trans. R. Soc. Lond. [Biol] 1981, 296, 123-138.
  6. Smith, C. D.; Wells, W. W. Phosphorylation of rat liver nuclear envelopes. II. Characterization of in vitro lipid phosphorylation. J Biol Chem 1983, 258, 9368-9373.
  7. Cocco, L.; Martelli, A. M.; Gilmour, R. S.; Ognibene, A.; Manzoli, F. A.; Irvine, R. F. Rapid changes in phospholipid metabolism in the nuclei of Swiss 3T3 cells induced by treatment of the cells with insulin-like growth factor I. Biochem. Biophys. Res. Commun 1988, 154, 1266-1272.
  8. Divecha, N.; Banfic, H.; Irvine, R. F. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J 1991, 10, 3207-3214, doi:10.1002/j.1460-2075.1991.tb04883.x.
  9. Payrastre, B.; Nievers, M.; Boonstra, J.; Breton, M.; Verkleij, A. J.; Van Bergen en Henegouwen, P. M. P. A differential localization of phosphoinositide kinases, diacylglycerol kinase and phospholipase c in the nuclear matrix. J. Biol. Chem 1992, 267, 5078-5084.
  10. Martelli, A. M.; Gilmour, R.S.; Bertagnolo, V.; Neri, L.M.; Manzoli, L.; Cocco, L. Nuclear localization and signalling activity of phosphoinositidase Cb in swiss 3t3 cells. Nature 1992, 358, 242-245.
  11. Manzoli, F. A.; Capitani, S.; Maraldi, N. M.; Cocco, L.; Barnabei, O. Chromatin lipids and their possible role in gene expression. A study in normal and neoplastic cells. Adv Enzyme Regul 1978, 17, 175-194, doi:10.1016/0065-2571(79)90013-x.
  12. Maraldi, N. M. M., G.; Cocco L.; Manzoli, F.A. Anatomical Waxwork Modeling: The History of the Bologna Anatomy Museum. The Anatomical Record 2000, 261, 5-10.
  13. Follo, M. Y.; Finelli, C.; Clissa, C.; Mongiorgi, S.; Bosi, C.; Martinelli, G.; Baccarani, M.; Manzoli, L.; Martelli, A.M.; Cocco, L. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. J Clin Oncol 2009, 27, 782-790, doi:10.1200/JCO.2008.19.3748.
  14. Follo, M.Y.; Finelli, C.; Mongiorgi, S.; Clissa, C.; Bosi, C.; Testoni, N.; Chiarini, F.; Ramazzotti, G.; Baccarani, M.; Martelli, A. M.; et al. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. Proc Natl Acad Sci U S A 2009, 106, 16811-16816, doi:10.1073/pnas.0907109106.
  15. Cocco, L.; Finelli, C.; Mongiorgi, S.; Clissa, C.; Russo, D.; Bosi, C.; Quaranta, M.; Malagola, M.; Parisi, S.; Stanzani, M.; et al. An increased expression of PI-PLCbeta1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes. J Leukoc Biol 2015, 98, 769-780, doi:10.1189/jlb.2MA1114-541R.
  16. Ratti, S.; Marvi, M. V.; Mongiorgi, S.; Obeng, E. O.; Rusciano, I.; Ramazzotti, G.; Morandi, L.; Asioli, S.; Zoli, M.; Mazzatenta, D.; et al. Impact of phospholipase C beta1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness. Cell Mol Life Sci 2022, 79, 195, doi:10.1007/s00018-022-04198-1.
  17. Xian, J.; Owusu Obeng, E.; Ratti, S.; Rusciano, I.; Marvi, M. V.; Fazio, A.; De Stefano, A.; Mongiorgi, S.; Cappellini, A.; Ramazzotti, G.; et al. Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes. Cells 2020, 9, doi:10.3390/cells9030697.

30 March 2023
Meet Us at the 2023 American Society for Microbiology Annual Meeting (ASM Microbe 2023), 15–19 June 2023, Houston, USA


The 2023 American Society for Microbiology Annual Meeting (ASM Microbe 2023) will be held in Houston, USA, from 15 to 19 June 2023. This annual meeting is the largest gathering of microbiologists in the world, and it is expected that nearly 8,000 professionals from all over the world will attend the meeting. Founded in 1899, the American Society for Microbiology (ASM) is the oldest and largest single life science society in the world, consisting of more than 50,000 scientists and health professionals, of which more than one-third of the members are from countries and regions outside the United States. The mission of the American Society for Microbiology is to promote and advance the science of microbiology.

Topics include:

  • Disaster Microbiology;
  • Emerging Infections – What is the next pandemic? (Focus on Nipah and Marburg);
  • Natural Product Discovery and Synthesis;
  • Combating the Climate Crisis with Critters: Microbial Carbon Capture;
  • Powering the Future: Applied Microbiology in the Energy Industry;
  • Equity and Access in Laboratory Diagnostics;
  • Microbiome Management in a Changing World.

The following MDPI journals will be represented:

  • Microorganisms;
  • Journal of Fungi;
  • Viruses;
  • Applied Biosciences;
  • MPs;
  • IJMS;
  • Vaccines;
  • Fermentation;
  • Diversity;
  • Metabolites;
  • Biomolecules;
  • Antibiotics;
  • Pathogens;
  • Life.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth number #2504 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://asm.org/Events/ASM-Microbe/Home.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

14 February 2023
Meet Us at the 11th National Conference on Bioinformatics and Systems Biology, 25–27 February 2023, Guangzhou, China


Conference
: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

21 December 2022
Meet Us at the 100th Anniversary Annual Meeting of The Physiological Society of Japan, 14–16 March 2023, Kyoto, Japan


Conference: The 100th Anniversary Annual Meeting of The Physiological Society of Japan
Date: 14–16 March 2023
Venue: Kyoto International Conference Center *Hybrid Format, Kyoto, Japan

MDPI will be attending the 100th Anniversary Annual Meeting of The Physiological Society of Japan as the exhibitor. This meeting will take place from 14 to 16 March 2023 in Kyoto, Japan.

This meeting has been organized by the Physiological Society of Japan (PSJ), and will thus mark the 100th meeting of the society—the 100th Memorial meeting. This meeting has been given the theme of “Homeostasis for Sustainability—Toward the Next Century of Physiological Sciences”.

The following MDPI journals will be represented:

If you are planning to attend this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions you may have.

For more information about the conference, please visit the following website: https://www2.aeplan.co.jp/psj2023/en_index/.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

18 November 2022
Editorial Board Members from Biomolecules Featured in Stanford’s List of the World's Top 2% Scientists

Stanford University has recently published an update of the list of the top 2% most widely cited scientists—The World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 172 Editorial Board Members from MDPI’s Biomolecules (ISSN: 2218-273X) were featured in Stanford University’s list of the World’s Top 2% Scientists in 2022.

Name

Affiliation

Prof. Dr. A. Joshua Wand

Texas A&M University, USA

Prof. Dr. Akira Nakagawara

Heavy Ion Beam Cancer Therapy Center, Japan

Dr. Albert J. Sinusas

Yale University School of Medicine, USA

Prof. Dr. Alessandra Bitto

University of Messina, Italy

Prof. Dr. Alex Zelikovsky

Georgia State University, USA

Prof. Dr. Alois Jungbauer

University of Natural Resources and Life Sciences, Austria

Prof. Dr. Anna Orlova

Uppsala University, Sweden

Dr. Annamaria Colao

Federico II University Medical School of Naples, Italy

Prof. Dr. Antonio Evidente

Università di Napoli Federico II, Italy

Dr. Armen Y. Mulkidjanian

Osnabrueck University, Germany

Prof. Dr. Attila Fehér

University of Szeged, Hungary

Dr. Avraham Raz

Wayne State University, USA

Prof. Dr. Ayyalusamy Ramamoorthy

University of Michigan, USA

Dr. Bahman Anvari

University of California Riverside, USA

Dr. Barbara Borroni

University of Brescia, Italy

Prof. Dr. Bart A. Ellenbroek

Victoria University of Wellington, New Zealand

Prof. Dr. Ben A. Bahr

University of North Carolina-Pembroke, USA

Dr. Bridget Carragher

Columbia University, USA

Dr. Carla Cicala

University of Naples Federico II, Italy

Dr. Carlo Perricone

University of Perugia, Italy

Prof. Dr. Carmen Formisano

University of Naples Federico II, Italy

Prof. Dr. Carmen Socaciu

University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania

Prof. Dr. Carola Yvette Förster

Julius-Maximilians-Universitat Wurzburg, Germany

Dr. Cédric Rébé

University of Bourgogne Franche-Comté, France

Dr. Chrisostomos Prodromou

University of Sussex, UK

Prof. Dr. Christian Schulz

Ludwig Maximilian University

Dr. Christophe Hano

Université ď Orléans, France

Prof. Dr. Chryssostomos Chatgilialoglu

Consiglio Nazionale delle Ricerche, Italy

Prof. Dr. Claes Wahlestedt

University of Miami Miller School of Medicine, USA

Prof. Dr. Corrado Angelini

University of Padova, Italy

Dr. Cristina Martínez-Villaluenga

Institute of Food Science, Spain

Prof. Dr. Daniela Grimm

Otto-von-Guericke-University Magdeburg, Germany

Prof. Dr. David Hui

University of New Orleans, USA

Dr. David Montani

Hopital de Bicetre, France

Prof. Dr. Dirk Grimm

University of Heidelberg, Germany

Prof. Dr. Dongqing Wei

Shanghai Jiao Tong University, China

Prof. Dr. Eben Alsberg

University of Illinois at Chicago, USA

Prof. Dr. Emanuela Masini

University of Florence, Italy

Dr. Fabio Di Domenico

Sapienza University of Rome, Italy

Dr. Ferdinando Nicoletti

Sapienza University of Rome, Italy

Prof. Dr. Francesco Giorgino

University of Bari Aldo Moro, Italy

Dr. Francesco Lotti

University of Florence, Italy

Prof. Dr. Francesco Scaglione

Università degli Studi di Milano, Italy

Prof. Dr. Francisco Domínguez-Adame

Universidad Complutense de Madrid, Spain

Prof. Dr. Francisco J. Blanco

Centro de Investigaciones Biologicas, Spain

Prof. Dr. Frank Grosveld

Erasmus University Rotterdam, the Netherlands

Dr. Gaetano T. Montelione

Rensselaer Polytechnic Institute, USA

Dr. Gal Bitan

David Geffen School of Medicine at UCLA, USA

Dr. Gang Hu

Nankai University, China

Prof. Dr. George Kokotos

National and Kapodistrian University of Athens, Greece

Dr. Gernot Riedel

University of Aberdeen, UK

Prof. Dr. Gert Lubec

Paracelsus Private Medical University, Austria

Dr. Gian Gaetano Tartaglia

Istituto Italiano di Tecnologia, Italy

Dr. Gilda Varricchi

University of Naples Federico II, Italy

Prof. Dr. Giuseppe Legname

Scuola Internazionale Superiore di Studi Avanzati, Italy

Dr. Giuseppe Limongelli

University of Campania Luigi Vanvitelli, Italy

Prof. Dr. Gordon G. Carmichael

University of Connecticut Health Center, USA

Prof. Dr. Gunnar Jeschke

Laboratory of Physical Chemistry, Switzerland

Dr. Guohua Zhao

Southwest University, China

Prof. Dr. Gurmit Singh

McMaster University, Canada

Prof. Dr. Gyeong Hoon Kang

Seoul National University College of Medicine, South Korea

Prof. Dr. Håvard Jenssen

Roskilde Universitetscenter, Denmark

Prof. Dr. Hiroshi Nakagawa

Chubu University, Japan

Prof. Dr. Hiroyuki Shimada

Stanford University Medical School, USA

Dr. Hong Lu

University of Kentucky, USA

Prof. Dr. Hongbin Li

The University of British Columbia, Canada

Prof. Dr. Israel Silman

Weizmann Institute of Science, Israel

Prof. Dr. Jesús Balsinde

Consejo Superior de Investigaciones Científicas (CSIC), Spain

Dr. Jesús Pérez-Gil

Complutense University Madrid, Spain

Prof. Dr. Jiangning Song

Monash University, Australia

Prof. Dr. Jianlin Cheng

University of Missouri, USA

Prof. Dr. Jijie Chai

Tsinghua University, China

Prof. Dr. Joachim Frank

Columbia University, USA

Prof. Dr. João Ramalho-Santos

University of Coimbra, Portugal

Prof. Dr. John A. Carver

The Australian National University, Australia

Prof. Dr. John McDermott

York University, Canada

Prof. Dr. John Mitrofanis

University of Sydney, Australia

Dr. Jonathan Kerr

Norfolk & Norwich University Hospitals NHS Foundation Trust, UK

Dr. Jordana T. Bell

King's College London, UK

Dr. Jordi Camps

Institut d’Investigació Sanitària Pere Virgili, Spain

Prof. Dr. Jorge Joven

Institut d’Investigació Sanitària Pere Virgili, Spain

Prof. Dr. José de la Fuente

Instituto de Investigación en Recursos Cinegéticos, Spain

Prof. Dr. José L. Medina-Franco

National Autonomous University of Mexico, Mexico

Dr. José Menéndez

Universidad Complutense of Madrid, Spain

Dr. Jun Hee Lee

University of Michigan, USA

Prof. Dr. Jun Lu

Auckland University of Technology, Auckland

Prof. Dr. Jürgen Brockmöller

University Medicine Göttingen, Germany

Prof. Dr. Karoly Mirnics

Munroe-Meyer Institute for Genetics and Rehabilitation, USA

Prof. Dr. Karsten Melcher

Van Andel Research Institute, USA

Prof. Dr. Kyoungwhan Back

Chonnam National University, South Korea

Prof. Dr. Lucilla Parnetti

University of Perugia, Italy

Prof. Dr. Lukasz Kurgan

Virginia Commonwealth University

Dr. Mark Harrison

Queensland University of Technology, Australia

Prof. Dr. Mark Johnson

Åbo Akademi University, Finland

Prof. Dr. Marta Ruiz-Ortega

Universidad Autónoma de Madrid (UAM), Spain

Dr. Masaru Yamaguchi

Ginza Orthodontic Clini, Japan

Dr. Mathias Ziegler

University of Bergen, Norway

Dr. Matteo Cameli

University of Siena, Italy

Dr. Mauro Mandrioli

University of Modena and Reggio Emilia, Italy

Prof. Dr. Michael Ibba

Ohio State University, USA

Prof. Dr. Michael R. Brent

Washington University, USA

Prof. Dr. Michele Fornaro

Midwestern University, USA

Prof. Dr. Mikhail A. Anisimov

University of Maryland, USA

Prof. Dr. Miroslaw Janowski

University of Maryland, USA

Prof. Dr. Neven Zarkovic

Institute Ruder Boskovic, Croatia

Prof. Dr. Nicolas Foray

INSERM U1296, France

Prof. Dr. Nuno M. Neves

University of Minho, Portugal

Dr. Nuno Vale

University of Porto, Portugal

Dr. Nurhayat Tabanca

Subtropical Horticulture Research Station, USA

Dr. Olga Corti

Paris Brain Institute (ICM), France

Prof. Dr. Omar Cauli

University of Valencia, Spain

Dr. Pablo Argüeso

Tufts University School of Medicine, USA

Prof. Dr. Paolo Ascenzi

Roma Tre University, Italy

Prof. Dr. Paolo Pinton

University of Ferrara, Italy

Prof. Dr. Paolo Sassone-Corsi

University of California, USA

Dr. Patrick Tso

University of Cincinnati College of Medicine, USA

Dr. Pedro J. Ballester

INSERM U1068, France

Dr. Peter Boag

Monash University, Australia

Dr. Peter Celec

Comenius University, Slovakia

Prof. Dr. Peter E. Nielsen

University of Copenhagen, Denmark

Prof. Dr. Peter Kaiser

University of California, USA

Dr. Petr Novák

Institute of Microbiology, Czech Republic

Dr. Piergiorgio Gentile

Newcastle University, UK

Prof. Dr. Piergiorgio Messa

Università degli Studi di Milano, Italy

Dr. Pierre Germain

Université de Montpellier, France

Dr. Ralf J. Ludwig

University of Lübeck, Germany

Prof. Dr. Reinhard Schweitzer-Stenner

Drexel University, USA

Dr. Robert E. London

National Institute of Environmental Health Sciences, USA

Dr. Robert J. Kreitman

National Institutes of Health, USA

Prof. Dr. Robert W. Sobol

University of South Alabama, USA

Dr. Ronny Drapkin

University of Pennsylvania Perelman School of Medicine, USA

Prof. Dr. Roosmarijn E. Vandenbroucke

Ghent University, Belgium

Dr. Rosanna Squitti

AFaR Fatebenefratelli Hosp San Giovanni Calibita, Italy

Prof. Dr. Ruhong Zhou

Zhejiang University, China

Prof. Dr. Ruth Nussinov

National Cancer Institute, USA

Prof. Dr. Salvador Ventura

Autonomous University of Barcelona, Spain

Prof. Dr. Seth Blackshaw

Johns Hopkins University, USA

Prof. Dr. Shigeo Murata

The University of Tokyo, Japan

Prof. Dr. Shinji Sakai

Osaka University, Japan

Prof. Dr. Shiroh Futaki

Kyoto University, Japan

Dr. Sonia Longhi

Aix-Marseille University, France

Prof. Dr. Sudhir Kumar

Temple University, USA

Prof. Dr. Suk Woo Nam

The Catholic University of Korea, South Korea

Prof. Dr. Sunil S. Badve

Indiana University School of Medicine, USA

Dr. Tao Liu

Children's Cancer Institute Australia for Medical Research, Australia

Dr. Tao Lu

Indiana University School of Medicine, USA

Prof. Dr. Ted Hupp

University of Gdansk, UK

Dr. Theodoros Eleftheriadis

University of Thessaly, Greece

Prof. Dr. Thomas Helleday

Karolinska Institutet, Sweden

Prof. Dr. Thomas Müller

St. Joseph Hospital Berlin-Weissensee, Germany

Dr. Trond Aasen

Universitat Autònoma de Barcelona, Spain

Prof. Dr. Undurti N. Das

UND Life Sciences, USA

Dr. Vaibhav Tiwari

Midwestern University, USA

Dr. Vicente Rubio

Institute of Biomedicine of Valencia of the Spanish Research Council (IBV-CSIC), Spain

Prof. Dr. Viswanathan Natarajan

University of Illinois, USA

Dr. Vito Verardo

University of Granada, Spain

Dr. Vsevolod Katritch

University of Southern California, USA

Prof. Dr. Walid A. Houry

University of Toronto, Canada

Dr. Wei Seong Toh

National University of Singapore, Singapore

Dr. Wei Zhong

University of North Carolina at Greensboro, USA

Prof. Dr. Wim Van den Ende

KU Leuven, Belgium

Prof. Dr. Xiaobo Zhou

The University of Texas Health Science Center at Houston (UTHealth), USA

Dr. Xuri Li

Sun Yat-sen University, China

Dr. Yan Li

Florida State University, USA

Prof. Dr. Yang Zhang

University of Michigan, USA

Dr. Yasuhiro Maejima

Tokyo Medical and Dental University, Japan

Prof. Dr. Yong Sang Song

Seoul National University College of Medicine, South Korea

Prof. Dr. Yong Yeon Cho

The Catholic University of Korea, South Korea

Prof. Dr. Yosef Shaul

Weizmann Institute of Science, Israel

Prof. Dr. Yunjun Yan

Huazhong University of Science and Technology, China

Prof. Dr. Yusuf A. Hannun

Stony Brook University, USA

Dr. Zhengxin Wang

Clark Atlanta University, USA

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Biomolecules.

29 September 2022
Meet Us at the 2022 BMES Annual Meeting, 12–15 October 2022, San Antonio, Texas, USA


Conference: 2022 BMES Annual Meeting
Date: 12–15 October 2022
Place: San Antonio, Texas, USA
Booth: #346

MDPI will be attending the 2022 BMES Annual Meeting as an exhibitor from 12 to 15 October 2022 in San Antonio, Texas, USA.

BMES holds an annual meeting where they have hosted up to 5,500 biomedical engineers who attend more than 2,500 scientific presentations on cancer treatment, heart disease, women’s health, global health disparities, and more. The meeting allows members to advocate for their innovative solutions, demonstrating their commitment to the society’s core value of health equity for all individuals. In addition, BMES shares scientific information to inspire the up-and-coming generation through four scientific journals, three special interest groups, and collaborations with other scientific societies to elevate the visibility and significant impact that the biomedical engineering community has worldwide as the thought leaders behind the future of human health.

From 12 to 15 October 2022, in the vibrant multicultural city of San Antonio, we will celebrate the tremendous contributions made by BMES members in research, teaching, education, and the workforce that directly impact many sectors of our society. We also aim to highlight equity issues in healthcare and education, stemming from racial and socioeconomic diversity, gender and sexual orientation, and disabilities.

The following MDPI journals will be represented:

Please do not hesitate to reach out if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.bmes.org/annualmeeting.

28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

7 September 2022
Meet Us at the ASHG Annual Meeting 2022 (ASHG 2022), 25–29 October 2022, Los Angeles, USA


MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link:

https://www.ashg.org/meetings/2022-annual-meeting/.

26 July 2022
Meet Us at the 44th Congress of the Spanish Society of Biochemistry and Molecular Biology (SEBBM 2022), 6–9 September 2022, Malaga, Spain


MDPI will be attending SEBBM 2022, held in Malaga, Spain, from 6 to 9 September 2022.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth #25. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://congresos.sebbm.es/malaga2022/.

28 June 2022
2021 Impact Factors - Released

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

Journal Impact Factor Rank Category
Antioxidants 7.675 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 7.666 Q2 Cell Biology
Nutrients 6.706 Q1 Nutrition & Dietetics
Cancers 6.575 Q1 Oncology
Pharmaceutics 6.525 Q1 Pharmacology & Pharmacy
International Journal of Molecular Sciences 6.208 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Marine Drugs 6.085 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Biomolecules 6.064 Q2 Biochemistry & Molecular Biology
Batteries * 5.938 Q2 Electrochemistry
Energy & Fuels
Materials Science, Multidisciplinary
Viruses 5.818 Q2 Virology
Biosensors 5.743 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Journal of Fungi 5.724 Q1 Mycology
Q2 Microbiology
Nanomaterials 5.719 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Metabolites 5.581 Q2 Biochemistry & Molecular Biology
Foods 5.561 Q1 Food Science & Technology
Drones * 5.532 Q2 Remote Sensing
Remote Sensing 5.349 Q1 Geosciences, Multidisciplinary
Imaging Science & Photographic Technology
Q2 Remote Sensing
Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 5.318 Q2 Business
Antibiotics 5.222 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Pharmaceuticals 5.215 Q1 Pharmacology & Pharmacy
Q2 Chemistry, Medicinal
Biology 5.168 Q1 Biology
Fermentation 5.123 Q2 Biotechnology & Applied Microbiology
Toxins 5.075 Q1 Toxicology
Q2 Food Science & Technology
Bioengineering * 5.046 Q2 Engineering, Biomedical
Polymers 4.967 Q1 Polymer Science
Journal of Clinical Medicine 4.964 Q2 Medicine, General & Internal
Vaccines 4.961 Q2 Immunology
Medicine, Research & Experimental
Molecules 4.927 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Microorganisms 4.926 Q2 Microbiology
Journal of Functional Biomaterials * 4.901 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.757 Q2 Medicine, Research & Experimental
Pharmacology & Pharmacy
Biochemistry & Molecular Biology
Plants 4.658 Q1 Plant Sciences
International Journal of Environmental Research and Public Health 4.614 Q1 Public, Environmental & Occupational Health (SSCI)
Q2 Public, Environmental & Occupational Health (SCIE)
Environmental Sciences (SCIE)
Membranes 4.562 Q1 Polymer Science
Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Pathogens 4.531 Q2 Microbiology
Catalysts 4.501 Q2 Chemistry, Physical
Toxics 4.472 Q2 Toxicology
Environmental Sciences
Gels 4.432 Q1 Polymer Science
Journal of Cardiovascular Development and Disease 4.415 Q2 Cardiac & Cardiovascular Systems
Chemosensors 4.229 Q1 Instruments & Instrumentation
Q2 Chemistry, Analytical
Q3 Electrochemistry
Genes 4.141 Q2 Genetics & Heredity
Diagnostics 3.992 Q2 Medicine, General & Internal
Agronomy 3.949 Q1 Agronomy
Plant Sciences
Land 3.905 Q2 Environmental Studies
Sustainability 3.889 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Q4 Green & Sustainable Science & Technology (SSCI)
Sensors 3.847 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Materials 3.748 Q1 Metallurgy & Metallurgical Engineering
Q2 Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Biomimetics * 3.743 Q2 Engineering, Multidisciplinary
Q3 Materials Science, Biomaterials
Tropical Medicine and Infectious Disease * 3.711 Q1 Tropical Medicine
Q2 Parasitology
Q3 Infectious Diseases
Lubricants * 3.584 Q2 Engineering, Mechanical
Fractal and Fractional 3.577 Q1 Mathematics, Interdisciplinary Applications
Water 3.530 Q2 Water Resources
Q3 Environmental Sciences
Micromachines 3.523 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Journal of Personalized Medicine 3.508 Q2 Medicine, General & Internal
Health Care Sciences & Services
Agriculture 3.408 Q1 Agronomy
Processes 3.352 Q2 Engineering, Chemical
Separations 3.344 Q2 Chemistry, Analytical
Magnetochemistry 3.336 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Brain Sciences 3.333 Q3 Neurosciences
Buildings 3.324 Q2 Construction & Building Technology
Engineering, Civil
Forests 3.282 Q1 Forestry
Energies 3.252 Q3 Energy & Fuels
Life 3.251 Q2 Biology
Coatings 3.236 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
Animals 3.231 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Journal of Intelligence * 3.176 Q2 Psychology, Multidisciplinary
Fishes 3.170 Q1 Marine & Freshwater Biology
Q2 Fisheries
Healthcare 3.160 Q2 Health Policy & Services (SSCI)
Health Care Sciences & Services (SCIE)
Inorganics * 3.149 Q2 Chemistry, Inorganic & Nuclear
Insects 3.139 Q1 Entomology
Atmosphere 3.110 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Current Oncology 3.109 Q3 Oncology
ISPRS International Journal of Geo-Information 3.099 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Diversity 3.029 Q2 Biodiversity Conservation
Ecology
Tomography 3.000 Q3 Radiology, Nuclear Medicine & Medical Imaging
Current Issues in Molecular Biology 2.976 Q3 Biochemistry & Molecular Biology
Medicina 2.948 Q3 Medicine, General & Internal
Symmetry 2.940 Q2 Multidisciplinary Sciences
Horticulturae 2.923 Q1 Horticulture
Machines 2.899 Q2 Engineering, Mechanical
Engineering, Electrical & Electronic
Systems * 2.895 Q2 Social Sciences, Interdisciplinary
Applied Sciences 2.838 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Children 2.835 Q2 Pediatrics
Minerals 2.818 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Universe 2.813 Q2 Astronomy & Astrophysics
Q3 Physics, Particles & Fields
Journal of Marine Science and Engineering 2.744 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Entropy 2.738 Q2 Physics, Multidisciplinary
Fire * 2.726 Q2 Forestry
Q3 Ecology
Metals 2.695 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Electronics 2.690 Q3 Engineering, Electrical & Electronic
Computer Science, Information Systems
Physics, Applied
Crystals 2.670 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Aerospace 2.660 Q1 Engineering, Aerospace
Mathematics 2.592 Q1 Mathematics
Photonics 2.536 Q3 Optics
Actuators 2.523 Q2 Instruments & Instrumentation
Q3 Engineering, Mechanical
Veterinary Sciences 2.518 Q2 Veterinary Sciences
Behavioral Sciences * 2.286 Q3 Psychology, Multidisciplinary
Axioms * 1.824 Q2 Mathematics, Applied

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

 

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)

 

9 June 2022
2021 CiteScores - Released


The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Journal

CiteScore

Quartile

Category

Non-coding RNA

10.1

Q1

Genetics

Journal of Functional Biomaterials

10.0

Q1

Biomedical Engineering

Marine Drugs

8.1

Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Batteries

7.9

Q1

Electrical and Electronic Engineering

Nutrients

7.9

Q1

Nutrition and Dietetics

Remote Sensing

7.4

Q1

General Earth and Planetary Sciences

Drones

7.2

Q1

Computer Science Applications

International Journal of Molecular Sciences

6.9

Q1

Inorganic Chemistry

Journal of Sensor and Actuator Networks

6.9

Q1

Computer Networks and Communications

Cells

6.7

Q1

General Biochemistry, Genetics and Molecular Biology

Nanomaterials

6.6

Q1

General Chemical Engineering

Toxins

6.6

Q1

Health, Toxicology and Mutagenesis

Viruses

6.6

Q1

Infectious Diseases

Antioxidants

6.5

Q1

Food Science

Fibers

6.5

Q1

Civil and Structural Engineering

Resources

6.4

Q1

Nature and Landscape Conservation

Sensors

6.4

Q1

Instrumentation

Big Data and Cognitive Computing

6.1

Q1

Management Information Systems

Molecules

5.9

Q1

Chemistry (miscellaneous)

Polymers

5.7

Q1

Polymers and Plastics

Biosensors

5.6

Q1

Engineering (miscellaneous)

Catalysts

5.5

Q1

General Environmental Science

Smart Cities

5.5

Q1

Urban Studies

Future Internet

5.4

Q2

Computer Networks and Communications

Beverages

5.3

Q1

Food Science

Fermentation

5.3

Q1

Plant Science

Environments

5.2

Q1

Ecology, Evolution, Behavior and Systematics

Inventions

5.2

Q1

General Engineering

Journal of Open Innovation: Technology, Market, and Complexity

5.1

Q1

Development

Colloids and Interfaces

5.0

Q1

Chemistry (miscellaneous)

Energies

5.0

Q1

Control and Optimization

ISPRS International Journal of Geo-Information

5.0

Q1

Geography, Planning and Development

Sustainability

5.0

Q1

Geography, Planning and Development

Fire

4.9

Q1

Forestry

Robotics

4.9

Q1

Control and Optimization

Soil Systems

4.9

Q1

Soil Science

Geosciences

4.8

Q1

General Earth and Planetary Sciences

Journal of Manufacturing and Materials Processing

4.8

Q1

Mechanical Engineering

Tropical Medicine and Infectious Disease

4.8

Q1

Public Health, Environmental and Occupational Health

Water

4.8

Q1

Geography, Planning and Development

International Journal of Environmental Research and Public Health

4.5

Q1

Public Health, Environmental and Occupational Health

Sports

4.5

Q1

Physical Therapy, Sports Therapy and Rehabilitation

Entropy

4.4

Q1

Mathematical Physics

Journal of Clinical Medicine

4.4

Q1

General Medicine

Symmetry

4.3

Q1

General Mathematics

Cosmetics

4.2

Q1

Surgery

Foods

4.1

Q1

Health Professions (miscellaneous)

Journal of Fungi

4.1

Q1

Plant Science

ChemEngineering

4.0

Q1

General Engineering

Forests

4.0

Q1

Forestry

Journal of Intelligence

4.0

Q1

Education

Antibiotics

3.9

Q1

General Pharmacology, Toxicology and Pharmaceutics

Cryptography

3.9

Q1

Applied Mathematics

Behavioral Sciences

3.8

Q1

Development

Buildings

3.8

Q1

Architecture

Metals

3.8

Q1

Metals and Alloys

Publications

3.5

Q1

Communication

Social Sciences

3.4

Q1

General Social Sciences

Mathematics

2.9

Q1

General Mathematics

Fractal and Fractional

2.8

Q1

Analysis

Animals

2.7

Q1

General Veterinary

Axioms

2.6

Q1

Algebra and Number Theory

Heritage

1.8

Q1

Conservation

Religions

1.0

Q1

Religious Studies

Philosophies

0.9

Q1

Philosophy

Source: 2021 CiteScores™ (Elsevier)

2 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Biology & Life Sciences”—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Biology & Life Sciences” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all the winners on their achievement.

MDPI will continue to provide support and recognition to the academic community.

Biology:

  • Enrico Vito Perrino, CIHEAM, Mediterranean Agronomic Institute of Bari, Italy
  • Dhirendra Kumar, National Institute of Environmental Health Sciences, Research Triangle Park, USA
  • Carlos A. Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
  • Yuri Shavrukov, Flinders University, Australia
  • Bipin Gaihre, Mayo Clinic, USA

Brain Sciences:

  • Craig D. Workman, University of Iowa, USA
  • Vivian Ciaramitaro, University of Massachusetts Boston, USA
  • Yang Zhang, University of Minnesota, USA

Cells:

  • Bonam Srinivasa Reddy, Université de Paris, France
  • Homma Takujiro, Yamagata University, Japan
  • Hwang, In Koo, Seoul National University, South Korea
  • Kobeissy Firas, University of Florida, USA
  • Rebelo, Sandra, University of Aveiro, Portugal

Diversity:

  • Günter Gollmann, University of Vienna, Austria
  • Stephan Koblmüller, University of Graz, Austria
  • Emiliano Mori, Istituto di Ricerca sugli Ecosistemi Terrestri, Italy

Horticulturae:

  • Joshua D. Klein, Agricultural Research Organization—The Volcani Center, Israel
  • Ana Cristina S Figueiredo, Faculdade de Ciências da Universidade de Lisboa, Portugal

Insects:

  • Carmelo Peter Bonsignore, Università Mediterranea di Reggio Calabria, Italy
  • Klaus H. Hoffmann, University of Bayreuth, Germany
  • Ivan Milosavljević, University of California, USA

Metabolites:

  • Remigiusz Bachor, University of Wrocław, Poland
  • Nguyen Phuoc Long, Inje University College of Medicine, South Korea
  • Chi Chen, University of Minnesota, USA

Nutrients:

  • Jadwiga Hamułka, Warsaw University of Life Sciences, Poland
  • Grace Campbell, University of Sydney, Australia
  • Nicholas Norwitz, Harvard Medical School, USA
  • Stefan Kabisch, Charité University Hospital Berlin, Germany
  • Luis Rodrigo, University of Oviedo, Spain

Veterinary Sciences:

  • Carlos Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
  • Arvind Sharma, The University of Queensland, Australia

2 June 2022
MDPI’s 2021 Young Investigator Awards in “Biology & Life Sciences”—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the 2021 winners in the “Biology & Life Sciences” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions.

MDPI will continue to provide support and recognition to the academic community.

Agriculture:

  • Carlos Guzmán, University of Cordoba, Spain

Animals:

  • Katharina Hohlbaum, Freie Universität Berlin, Germany

Cells:

  • Uri Ben-David, Tel Aviv University, Israel

Diversity:

  • Enrico Lunghi, Institute of Zoology Chinese Academy of Sciences in Beijing, China

Foods:

  • Guodong Zhang, University of Massachusetts Amherst, USA

Horticulturae:

  • Luke Bell, Temperate Horticulture, University of Reading, UK

International Journal of Molecular Sciences:

  • Alessandro D’Urso, University of Catania, Italy.
  • Apostolos Zaravinos, University of Cyprus, Cyprus
  • Cesar de la Fuente-Nunez, University of Pennsylvania, USA
  • Maria Teresa Caccamo, Messina University, Italy
  • Tiziana Bonifacino, University of Genoa, Italy

Journal of Fungi:

  • Federico Baltar, University of Vienna, Austria
  • Rebecca Drummond, University of Birmingham, UK
  • Miriam Oses-Ruiz, Public University of Navarre, Spain

Life:

  • João Pedro da Silva Machado Lobo, University of Porto, Portugal
  • Vincenzo Russo, University of Campania Luigi Vanvitelli, Italy

Metabolites:

  • Gabriele Rocchetti, Catholic University of Sacred Heart, Italy

Nutrients:

  • Fiona Lavelle, Queen's University Belfast, UK
  • Matthew Snelson, Monash University, Australia

Pathogens:

  • Si Ming Man, Australian National University, Australia
  • Jasper Fuk-Woo Chan, University of Hong Kong, China

Plants:

  • Stefania Sut, University of Padova, Italy
  • Mohamed Ahmed El-Esawi, Tanta University, Tanta, Egypt

Vaccines:

  • Nicholas M. Provine, University of Oxford, UK

Viruses:

  • Nicholas S. Heaton, Duke University, USA

2 June 2022
MDPI’s 2021 Travel Awards in “Biology & Life Sciences”—Winners Announced

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Biology & Life Sciences” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of 2021 Travel Awards and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Agriculture:

  • Zahra Bitarafan, Norwegian Institute of Bioeconomy Research (NIBIO), Norway
  • Nikolaos Tsoulias, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), Germany

Fermentation:

  • Michela Verni, University of Bari, Italy
  • Philipp Demling, RWTH Aachen University, Germany

Horticulturae:

  • Jagveer Singh, Punjab Agricultural University, India
  • Ibrar Hussain, State University of Londrina, Brazil

Microorganisms:

  • Francis Muchaamba, University of Zurich, Switzerland

Methods and Protocols:

  • Tanja Eisemann, SBP Medical Discovery Institute, USA

Nutrients:

  • Mrinalini Dey, National Institute for Health Research, UK
  • Ben Kirk, University of Melbourne, Australia
  • Kirrilly Pursey, University of Newcastle, Australia
  • Dieuwertje Kok, Wageningen University, the Netherlands
  • Hanna Huber, University of Bonn, Germany
  • Marlene Lages, University of Porto, Portugal
  • Zohra S. Lassi, University of Adelaide, Australia
  • Rik Olde Engberink, Amsterdam University Medicial Center, the Netherlands
  • Sarah Warkentin, University of Porto (ISPUP), Portugal
  • Álvaro Hernáez, Norwegian Institute of Public Health, Norway
  • Leila Abdelhamid, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, USA
  • Maria Michela Cesare, University of Siena, Italy
  • Kaisa Hiippala, University of Helsinki, Finland

Pathogens:

  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
  • Hejun Liu, Scripps Research Institute, USA
  • Tomokazu Tamura, Princeton University, USA

Toxins:

  • Cecilie Knudsen, Technical University of Denmark, Denmark
  • Laura Biessy, Cawthron Institute, New Zealand
  • Marcelo Mendes Rabelo, University of Florida, USA

Vaccines:

  • Hee Chun Chung, Seoul National University, South Korea
  • Alejandro Marin Lopez, Yale University, USA

2 June 2022
MDPI’s 2021 Best Paper Awards in “Biology & Life Sciences”—Winners Announced

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the subject areas of “Biology & Life Sciences”, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Animals:

by Wenchao Liu, Yilin Yuan, Chenyu Sun, Balamuralikrishnan Balasubramanian, Zhihui Zhao and Lilong An

Animals 2019, 9(8), 506, doi 10.3390/ani9080506

by Peter Coals, Dawn Burnham, Andrew Loveridge, David W. Macdonald, Michael ’t Sas-Rolfes, Vivienne L. Williams and John A. Vucetich

Animals 2019, 9(2), 52; doi 10.3390/ani9020052

by Giovanni Sogari, Mario Amato, Ilaria Biasato, Silvana Chiesa and Laura Gasco

Animals 2019, 9(4), 119; doi 10.3390/ani9040119

Antibodies:

by Mark L. Chiu; Dennis R. Goulet; Alexey Teplyakov and Gary L. Gilliland

Antibodies 2019, 8(4), 55; doi 10.3390/antib8040055

Antioxidants:

by Luca Frattaruolo, Gabriele Carullo, Matteo Brindisi, Sarah Mazzotta, Luca Bellissimo, Vittoria Rago, Rosita Curcio, Vincenza Dolce, Francesca Aiello and Anna Rita Cappello

Antioxidants 2019, 8(6), 186; doi 10.3390/antiox8060186

by Chunhe Gu, Kate Howell, Frank R. Dunshea and Hafiz A. R. Suleria

Antioxidants 2019, 8(9), 405; doi 10.3390/antiox8090405

by Spyridon A. Petropoulos, Ângela Fernandes, Maria Inês Dias, Ioannis B. Vasilakoglou, Konstantinos Petrotos, Lillian Barros and Isabel C. F. R. Ferreira

Antioxidants 2019, 8(8), 293; doi 10.3390/antiox8080293

by Rubén Domínguez, Mirian Pateiro, Mohammed Gagaoua, Francisco J. Barba, Wangang Zhang and José M. Lorenzo

Antioxidants 2019, 8(10), 429; doi 10.3390/antiox8100429

Biology:

by Michael H. Hastings, Elizabeth S. Maywood and Marco Brancaccio

Biology 2019, 8(1), 13; doi 10.3390/biology8010013

by Gail D. Schwieterman, Daniel P. Crear, Brooke N. Anderson, Danielle R. Lavoie, James A. Sulikowski, Peter G. Bushnell and Richard W. Brill

Biology 2019, 8(3), 56; doi 10.3390/biology8030056

Biomolecules:

by Shuichi Nakamura and Tohru Minamino

Biomolecules 2019, 9(7), 279; doi 10.3390/biom9070279

by Dmitrii Usoltsev, Vera Sitnikovaandrey Kajava and Mayya Uspenskaya

Biomolecules 2019, 9(8), 359; doi 10.3390/biom9080359

by Gerhard Liebisch, Josef Ecker, Sebastian Roth, Sabine Schweizer, Veronika Öttl, Hans-Frieder Schött, Hongsup Yoon, Dirk Haller, Ernst Holler, Ralph Burkhardt and Silke Matysik

Biomolecules 2019, 9(4), 121; doi 10.3390/biom9040121

by Anna Janaszewska, Joanna Lazniewska, Przemysław Trzepiński, Monika Marcinkowska and Barbara Klajnert-Maculewicz

Biomolecules 2019, 9(8), 330; doi 10.3390/biom9080330

Cells:

by Heng Sheng Sow, Jiang Ren, Marcel Camps, Ferry Ossendorp and Peter ten Dijke

Cells 2019, 8(4), 320; doi 10.3390/cells8040320

by Dinender K. Singla, Taylor A. Johnson and Zahra Tavakoli Dargani

Cells 2019, 8(10), 1224; doi 10.3390/cells8101224

by Laura M. Doyle and Michael Zhuo Wang

Cells 2019, 8(7), 727; doi 10.3390/cells8070727

by Yu Han, Xuezhou Li, Yanbo Zhang, Yuping Han, Fei Chang and Jianxun Ding

Cells 2019, 8(8), 886; doi 10.3390/cells8080886

Genes:

by Sarah B. Kingan, Haynes Heaton, Juliana Cudini, Christine C. Lambert, Primo Baybayan, Brendan D. Galvin, Richard Durbin, Jonas Korlach and Mara K. N. Lawniczak

Genes 2019, 10(1), 62; doi 10.3390/genes10010062

by Katherine E Bohnsack, Claudia Höbartner and Markus T Bohnsack

Genes 2019, 10(2), 102; doi 10.3390/genes10020102

by Laura M. Boykin, Peter Sseruwagi, Titus Alicai, Elijah Ateka, Ibrahim Umar Mohammed, Jo-Ann L. Stanton, Charles Kayuki, Deogratius Mark, Tarcisius Fute, Joel Erasto, Hilda Bachwenkizi, Brenda Muga, Naomi Mumo, Jenniffer Mwangi, Phillip Abidrabo, Geoffrey Okao-Okuja, Geresemu Omuut, Jacinta Akol, Hellen B. Apio, Francis Osingada, Monica A. Kehoe, David Eccles, Anders Savill, Stephen Lamb, Tonny Kinene, Christopher B. Rawle, Abishek Muralidhar, Kirsty Mayall, Fred Tairo and Joseph Ndunguru

Genes 2019, 10(9), 632; doi 10.3390/genes10090632

by Elamin Hafiz Baillo, Roy Njoroge Kimotho, Zhengbin Zhang and Ping Xu

Genes 2019, 10(10), 771; doi 10.3390/genes10100771

Horticulturae:

by Lida Fuentes, Carlos R. Figueroa and Monika Valdenegro

Horticulturae 2019, 5(2), 45; doi 10.3390/horticulturae5020045

by Marta Guarise, Gigliola Borgonovo, Angela Bassoli and Antonio Ferrante

Horticulturae 2019, 5(1), 13; doi 10.3390/horticulturae5010013

Insects:

by Rik Clymans, Vincent Van Kerckvoorde, Eva Bangels, Wannes Akkermans, Ammar Alhmedi, Patrick De Clercq, Tim Beliën and Dany bylemans

Insects 2019, 10(7), 200; doi 10.3390/insects10070200

by Marc Kenis, Hannalene du Plessis, Johnnie Van den Berg, Malick Niango Ba, Georg Goergen, Koffi Eric Kwadjo, Ibrahim Baoua, Tadele Tefera, Alan Buddie, Giovanni Cafà, Lisa Offord, Ivan Rwomushana and Andrew Polaszek

Insects 2019, 10(4), 92; doi 10.3390/insects10040092

by Rafael R. da Costa, Haofu Hu, Hongjie Li and Michael Poulsen

Insects 2019, 10(4), 87; doi 10.3390/insects10040087

International Journal of Molecular Sciences:

by Rüdiger Hardeland

Int. J. Mol. Sci. 2019, 20(5), 1223; doi 10.3390/ijms20051223

by Elise Lévy, Nadine El Banna, Dorothée Baïlle, Amélie Heneman-Masurel, Sandrine Truchet, Human Rezaei, Meng-Er Huang, Vincent Béringue, Davy Martin and Laurence Vernis

Int. J. Mol. Sci. 2019, 20(16), 3896; doi 10.3390/ijms20163896

by Beatriz Herrero-Fernandez, Raquel Gomez-Bris, Beatriz Somovilla-Crespo and Jose Maria Gonzalez-Granado

Int. J. Mol. Sci. 2019, 20(21), 5293; doi 10.3390/ijms20215293

by Claudia Beaurivage, Elena Naumovska, Yee Xiang Chang, Edo D. Elstak, Arnaud Nicolas, Heidi Wouters, Guido van Moolenbroek, Henriëtte L. Lanz, Sebastiaan J. Trietsch, Jos Joore, Paul Vulto, Richard A.J. Janssen, Kai S. Erdmann, Jan Stallen and Dorota Kurek

Int. J. Mol. Sci. 2019, 20(22), 5661; doi 10.3390/ijms20225661

by Maiko Okano, Masanori Oshi, Ali Linsk Butash, Eriko Katsuta, Kazunoshin Tachibana, Katsuharu Saito, Hirokazu Okayama, Xuan Peng, Li Yan, Koji Kono, Toru Ohtake and Kazuaki Takabe

Int. J. Mol. Sci. 2019, 20(17), 4197; doi 10.3390/ijms20174197

by Shaista Afroz, Rieko Arakaki, Takuma Iwasa, Masamitsu Oshima, Maki Hosoki, Miho Inoue, Otto Baba, Yoshihiro Okayama and Yoshizo Matsuka

Int. J. Mol. Sci. 2019, 20(3), 711; doi 10.3390/ijms20030711

Life:

by Márió Gajdács, Zoltán Bátori, Marianna Ábrók, Andrea Lázár and Katalin Burián

Life 2020, 10(2), 16; doi 10.3390/life10020016

by Carla Ferreira, Catarina Almeida, Sandra Tenreiro and Alexandre Quintas

Life 2020, 10(6), 86; doi 10.3390/life10060086

Nutrients:

by Ronald D. Hills, Benjamin A. Pontefract, Hillary R. Mishcon, Cody A. Black, Steven C. Sutton and Cory R. Theberge

Nutrients 2019, 11(7), 1613; doi 10.3390/nu11071613

by Harri Hemilä and Elizabeth Chalker

Nutrients 2019, 11(4), 708; doi 10.3390/nu11040708

by Humaira Jamshed, Robbie A. Beyl, Deborah L. Della Manna, Eddy S. Yang, Eric Ravussin and Courtney M. Peterson

Nutrients 2019, 11(6), 1234; doi 10.3390/nu11061234

Pathogens:

by Israr Kha, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che and Chunjiang Zhang

Pathogens 2019, 8(3), 126; doi 10.3390/pathogens8030126

by Spyridoula-Angeliki Nikou,Nessim Kichik, Rhys Brown, Nicole O. Ponde, Jemima Ho, Julian R. Naglik and Jonathan P. Richardson

Pathogens 2019, 8(2), 53; doi 10.3390/pathogens8020053

by Steven Batinovic, Flavia Wassef, Sarah A. Knowler, Daniel T.F. Rice, Cassandra R. Stanton, Jayson Rose, Joseph Tucci, Tadashi Nittami, Antony Vinh, Grant R. Drummond, Christopher G. Sobey, Hiu Tat Chan, Robert J. Seviour, Steve Petrovski and Ashley E. Franks

Pathogens 2019, 8(3), 100; doi 10.3390/pathogens8030100

Plants:

by Muhammad Hammad Saleem, Johan Potgieter and Khalid Mahmood Arif 

Plants 20198(11), 468; doi 10.3390/plants8110468

by Ida Linić, Dunja Šamec, Jiří Grúz, Valerija Vujčić Bok, Miroslav Strnad and Branka Salopek-Sondi

Plants 20198(6), 155; doi 10.3390/plants8060155

by Marie Agatha Mohn, Besarta Thaqi and Katrin Fischer-Schrader

Plants 20198(3), 67; doi 10.3390/plants8030067

by Chiara Biselliandrea Volante, Francesca Desiderio, Alessandro Tondelli, Alberto Gianinetti, Franca Finocchiaro, Federica Taddei, Laura Gazza, Daniela Sgrulletta, Luigi Cattivelli and Giampiero Valè

Plants 20198(8), 292; doi 10.3390/plants8080292

12 April 2022
Biomolecules | Special Issue Mentor Program

We are pleased to announce the launch of a new initiative, the Special Issue Mentor Program. 

This program intends to provide an opportunity for early-career scientists to enhance their editing, networking, and organizational skills and to work closely with our journal to gain more editorial experience. Early-career scientists who have novel ideas for new Special Issues of Biomolecules (5-Year IF: 5.362, ISSN 2218-273X) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Biomolecules Editorial Board or may be from other well-established research institutes or laboratories, etc. 

If you are interested in this opportunity, please send your Special Issue proposal to the Biomolecules Editorial Office (biomolecules@mdpi.com); we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. When the Special Issue is closed, our office will provide certificates to all of our mentors and to those who complete the program. Younger scholars will be prioritized as candidates for our journal award. 

In addition to the new Special Issue Mentor Program, Biomolecules will continue to welcome all Special Issue proposals based on hot research topics in the field as usual.

29 November 2021
Prof. Dr. Robert V. (Rob) Stahelin Appointed Editor-in-Chief of the Section “Biomacromolecules: Lipids” in Biomolecules

We are pleased to announce that Prof. Dr. Robert V. (Rob) Stahelin has been appointed Editor-in-Chief of the Section “Biomacromolecules: Lipids” in Biomolecules (ISSN 2218-273X). 

Prof. Dr. Robert V. (Rob) Stahelin

Prof. Dr. Robert V. Stahelin is the Retter Professor of Pharmacy and a Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University, West Lafayette, IN, USA. Since receiving his Ph.D. in Chemistry, in 2003, from at the University of Illinois in Chicago in 2003, he has specialized in biological membranes, sphingolipids signaling in cancers, and lipid-binding proteins. His current research is targeted at understanding how viral proteins interact with host cell lipids to hijack host cell membranes for the formation of the viral lipid envelope. The goals of his current research are to identify protein drug targets in the viral life cycle, understanding the structural and biophysical basis of viral assembly and budding, and understanding their biological mechanisms by which viruses alter host lipid metabolism. He has published more than 120 PubMed/SCIE-listed papers on lipids. 

The following is a short Q&A with Prof. Dr. Robert V. Stahelin, who shared his vision for the journal with us, as well as his views on the research area and open access publishing: 

1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?

I have had the pleasure of reviewing articles for Biomolecules, as well as publishing three articles in the journal in recent years. I was excited for the opportunity to help improve the quality of submissions to the lipids section of this journal and ensure that cutting-edge lipid topics are sought after for future submissions. 

2. What motivated you to go into the field of lipids?

When I was an undergraduate researcher, I worked on a bacterial protein that could be inserted into lipid membranes. This was fascinating to me, and the more I learned about lipid membranes and how proteins are associated with lipid headgroups, the more enthusiastic I was about digging deeper into this field. My graduate work with Dr. Wonhwa Cho focused on the basis of lipid-protein interactions and I have been immersed in this field ever since. 

3. What does the future of this field of research look like?

The lipid research field continues to grow and expand into new areas. I expect to see more studies encompassing lipids in precision medicine, cancer biology, host-pathogen interactions, and lipid biophysical properties involved in cell signaling and the molecular basis of disease.  

4. Who will be your main readers? Who should contribute to the journal, and what can readers expect?

Our main readers will be those interested in the biochemical and biophysical properties of lipid molecules and how lipids are involved in health and disease. Readers can expect to find articles that have undergone rigorous peer review and those that present cutting-edge findings in a variety of fields related to lipids. Authors whose work encompasses important and high-quality findings on lipids from diverse scientific backgrounds should consider submitting their work. 

5. What do you think about the development of open access in the publishing field? How do you respond to open access skeptics?

I support open access and making articles accessible to anyone, as opposed to restricting access behind a paywall. One concern of open access, however, is that it usually costs the submitting author higher fees of publication. However, there are often alternative means to assist authors who may not be able to afford the publication cost of open access. 

We extend a warm welcome to Prof. Dr. Robert V. Stahelin as he starts his new role as the Section Editor-in-Chief, and we look forward to him leading Biomolecules to achieve many more milestones. 

Biomolecules Editorial Office

22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio
Abatzoglou, John T.
Abbaszadeh, Mostafa
Acharya, U. Rajendra
Acharya, Viral V.
Agarwal, Ravi P.
Ahn, Myung-Ju
Airoldi, Laura
Ali, Imran
Allakhverdiev, Suleyman I.
Aluko, Rotimi E.
Anasori, Babak
Andersson, Dan I.
Andes, David
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Arqub, Omar Abu
Aschner, Michael
Assaraf, Yehuda G.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Atangana, Abdon
Bahram, Mohammad
Bakris, George L.
Balandin, Alexander A.
Baleanu, Dumitru
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Bansal-Travers, Maansi
Barba, Francisco J.
Barros, Lillian
Basit, Abdul W.
Baskonus, Haci Mehmet
Bassetti, Matteo
Battino, Maurizio
Bell, Jordana T.
Bellomo, Nicola
Benediktsson, Jon Atli
Benelli, Giovanni
Benjakul, Soottawat
Bhatnagar, Amit
Biddle, Stuart J. H.
Biondi, Antonio
Biondi-Zoccai, Giuseppe
Bjarnsholt, Thomas
Blaabjerg, Frede
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boffetta, Paolo
Bogers, Marcel
Bonomo, Robert A.
Bowman, David M.J.S.
Boyer, Cyrille
Brestic, Marian
Brevik, Eric C.
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cai, Jianchao
Calhoun, Vince D.
Calin, George
Cao, Jinde
Cao, Guozhong
Carvalho, Andre F.
Castellanos-Gomez, Andres
Cerqueira, Miguel Ângelo Parente Ribeiro
Chang, Jo-Shu
Chang, Chih-Hao
Chastin, Sebastien
Chau, Kwok-wing
Chemat, Farid
Chen, Xiaobo
Chen, YangQuan
Chen, Jianmin
Chen, Chaoji
Chen, Min
Chen, Qi
Chen, Jun
Chen, Xi
Chen, Peng
Chen, Yulin
Chen, Bo
Chen, Chen
Chen, Zhi-Gang
Chen, Wei-Hsin
Chen, Gang
Chen, Yongsheng
Chen, Xiang
Chen, Yimin
Chen, Runsheng
Chen, Lidong
Chen, Shaowei
Chen, Qian
Chen, Yu
Chen, Shuangming
Chiclana, Francisco
Cho, Sun Young
Choi, Wonyong
Chowdhary, Anuradha
Choyke, Peter L.
Cichocki, Andrzej
Corella, Dolores
Corma, Avelino
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Crommie, Michael F.
Cui, Yi
Cui, Haiying
Cui, Qinghua
Cummings, Kenneth Michael
Dai, Shifeng
Dai, Sheng
Daiber, Andreas
Davis, Steven J.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Decker, Eric Andrew
Dekel, Avishai
Demaria, Marco
Deng, Yong
Deng, Xiangzheng
DePinho, Ronald A.
Desneux, Nicolas
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Dionysiou, Dionysios D.
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Fan
Dou, Shi Xue
Dou, Letian
Du, Qian
Du, Bo
Dube, Shanta Rishi
Dufresne, Alain
Dummer, Reinhard
Dupont, Didier
Edwards, David
Elaissari, Abdelhamid
Elhoseny, Mohamed
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estévez, Mario
Fabbro, Doriano
Facchetti, Antonio
Fan, Zhanxi
Fang, Chuanglin
Fasano, Alessio
Fečkan, Michal
Felser, Claudia
Feng, Liangzhu
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Ferreira, Isabel C. F. R.
Filippi, Massimo
Fisher, Helen
Fortino, Giancarlo
Fosso Wamba, Samuel
Franceschi, Claudio
Fujita, Hamido
Fujita, Masayuki
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gan, Lihua
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Minrui
Gao, Huijun
Gao, Wei
Gao, Huile
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Gasco, Laura
Gautret, Philippe
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghadimi, Noradin
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Glick, Bernard R.
Gnant, Michael
Goel, Ajay
Gogotsi, Yury
Goldewijk, Kees Klein
Gong, Jinlong
Gong, Yongji
Govindan, Kannan
Granato, Daniel
Grancini, Giulia
Green, Douglas R.
Grosso, Giuseppe
Gu, Ke
Guan, Cao
Guastella, Adam J.
Guerrero, Josep M.
Gui, Guan
Guizani, Mohsen
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Habibi-Yangjeh, Aziz
Hagemann, Stefan
Hagger, Martin
Hamblin, Michael R.
Hammoudeh, Shawkat
Han, Heesup
Hanes, Justin
Harrison, Roy M.
Hartung, Hans-Peter
Hasanuzzaman, Mirza
He, Jr-Hau
He, Hongwen
He, Jiaqing
He, Debiao
Henseler, Jörg
Herrera, Francisco
Herrera-Viedma, Enrique
Hetz, Claudio
Ho Kim, Jung
Holmes, Elaine
Hossain, Ekram
Hsueh, Po-Ren
Hu, Xiaosong
Hu, Wenbin
Huang, Jianping
Huang, Hongwei
Huang, Yu
Huang, Jianying
Huang, Peng
Huang, Baibiao
Huang, Shaoming
Hubacek, Klaus

Iqbal, Hafiz M. N.
Ismail, Ahmad Fauzi
Izzo, Angelo A.
Jacobson, Kenneth A.
Jain, Atul
Jankovic, Joseph
Jelezko, Fedor
Ji, Xiaobo
Ji, Guangbin
Jiang, Hai-Long
Jiang, Lei
Jiang, Junjun
Jiang, Qing
Jiang, Shibo
Jin, Shi
Jones, Peter A.
Kalantar-zadeh, Kourosh
Kaner, Richard B.
Kannan, Kurunthachalam
Kappos, Ludwig
Karagiannidis, George K.
Karimi, Hamid Reza
Karimi-Maleh, Hassan
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Keesstra, Saskia
Kepp, Oliver
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kim, Ki-Hyun
Kim, Haegyeom
Kim, Jeonghun
Kim, Jong Seung
Kirkwood, John M.
Kisi, Ozgur
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Konopleva, Marina Y.
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kou, Gang
Krausmann, Fridolin
Krebs, Frederik C.
Kroemer, Guido
Kuca, Kamil
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Devendra
Kumar, Alan Prem
Kumar, Sudhir
Kumar Sangaiah, Arun
Kurths, Juergen
Kuznetsov, Nikolay V.
Kuzyakov, Yakov
Kwan, Mei-Po
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lammers, Twan
Lamuela-Raventos, Rosa M.
Lancellotti, Patrizio
Landi, Francesco
Laurent, Sophie
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Sang Soo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Lei, Ting
Leng, Lijian
Leung, Dennis Y. C.
Leung, Victor C. M.
Levine, Ross
Li, Wei
Li, Jie
Li, Jinghong
Li, Jun
Li, Heng
Li, Gang
Li, Yat
Li, Peng
Li, Hailong
Li, Changpin
Li, Yan
Li, Yurui
Li, Xiaodi
Li, Hong
Li, Shutao
Li, Hongyi
Li, Zhijun
Li, Peiyue
Lin, Yuehe
Lin, Hongjun
Lin, Lin
Lip, Gregory Y. H.
Liu, Jian
Liu, Meng
Liu, Hong
Liu, Tao
Liu, Lei
Liu, Jianxing
Liu, Wei
Liu, Gang
Liu, Yang
Liu, Peide
Lockhart, Shawn R.
Long, Hualou
Löscher, Wolfgang
Lu, Jun
Lu, Jianquan
Lu, Nanshu
Lucey, Brian
Lund, Henrik
Luo, Jun
Luo, Yi
Luo, Jingshan
Luo, Yangchao
Lupton, Deborah
Luque, Rafael
Lv, Wei
Lvov, Yuri M.
Lyons, Timothy W.
Ma, Tianyi
Ma, Jun
Ma, Jiayi
Ma, Wen-Xiu
Ma, Yanming
Maggioni, Aldo Pietro
Mahmood, Nasir
Mahmoudi, Morteza
Mai, Liqiang
Mallavarapu, Megharaj
Mandala, Mario
Mardani, Abbas
Marengo, Jose
Maria Rossolini, Gian
Martinoia, Enrico
Mathiesen, Brian Vad
Mathivanan, Suresh
Mattick, John S.
Matyjaszewski, Krzysztof
McCabe, Matthew E.
McCauley, Darren
McClements, David Julian
Melcher, Karsten
Melenhorst, Jan Joseph
Melero, Ignacio
Mezzetti, Bruno
Mirjalili, Seyedali
Mishchenko, Artem
Mittler, Ron
Moreau, Philippe
Motohashi, Hozumi
Mousavi Khaneghah, Amin
Mu, Shichun
Mueller, Lukas A.
Mueller-Roeber, Bernd
Muenzel, Thomas
Muhammad, Khan
Munger, J. William
Nauen, Ralf
Naushad, Mu.
Negri, Eva
Nemeroff, Charles B.
Newman, David J.
Niaura, Raymond S.
Nie, Feiping
Nieto, Juan J.
Novara, Agata
Nunkoo, Robin
Ogino, Shuji
Olabi, Abdul-Ghani
Ong, Hwai Chyuan
O'Regan, Donal
Orsini, Nicola
Ouyang, Minggao
Ozcan, Aydogan
Pacher, Pal
Pan, Xiaoqing
Pan, Likun
Pan, Quan-Ke
Pang, Huan
Pavela, Roman
Pedrycz, Witold
Pei, Yanzhong
Peng, Shushi
Peng, Qing
Peng, Mugen
Perc, Matjaz
Perez-Alvarez, Jose Angel
Perlin, David S.
Piquero, Alex R.
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Postolache, Mihai
Potenza, Marc N.
Poulter, Benjamin
Preat, Veronique
Prinsep, Michele R.
Pu, Hong-Bin
Putnik, Predrag
Qiu, Jieshan
Qu, Xiaogang
Quiles, José L.
Rabczuk, Timon
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Recio, Isidra
Reiter, Russel J.
Remuzzi, Giuseppe
Ren, Jinsong
Ren, Jun
Riahi, Keywan
Richardson, Paul G.
Rignot, Eric
Rimm, David
Rinn, John L.
Robert, Caroline
Rodriguez, Rosa M.
Rojo, Teofilo
Ros, Emilio
Rosen, Marc A.
Roubaud, David
Russo, Alessandro
Russo, Gian Luigi

Saad, Fred
Saad, Walid
Sadorsky, Perry
Sander, Chris
Santamouris, Mattheos
Santoro, Gabriele
Saraiva, Jorge A.
Sarchiapone, Marco
Scalbert, Augustin
Schloter, Michael
Schneider, Gisbert
Schubert, Ulrich S.
Schulz, Rainer
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scorrano, Luca
Scott, David
Scott, Stuart A.
Scott, Daniel
Serra-Majem, Lluis
Sethi, Gautam
Shabala, Sergey
Shaheen, Sabry M.
Shao, Zongping
Sharma, Gaurav
Shen, Guozhen
Shen, Hao
Sheremet, Mikhail A.
Shi, Peng
Shi, Yumeng
Shoenfeld, Yehuda
Siano, Pierluigi
Sillanpaa, Mika
Simões, Manuel
Simpson, Richard J.
Singh, Bhupinder Pal
Singh, Vijay P.
Smagghe, Guy
Song, Yu
Song, Houbing
Sood, Anil K.
Srivastava, Hari M.
Stadler, Marc
Stadler, Peter F.
Stanley, H. Eugene
Stoumpos, Constantinos C.
Strano, Michael S.
Stunnenberg, Hendrik G.
Su, shiliangsu@whu.edu.cn
Su, Chun-Yi
Subramanian, S. V.
Sun, Zhipei
Sun, Fengchun
Sun, Hongqi
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Szabo, Csaba
Szallasi, Arpad
Szolnoki, Attila
Tacke, Frank
Tan, Weihong
Tan, Chaoliang
Tang, Hua
Tang, Chuyang
Tang, Chuan-He
Tanzi, Rudolph E.
Teichmann, Sarah
Telenti, Amalio
Thakur, Vijay Kumar
Thiele, Holger
Tian, Jie
Tohge, Takayuki
Tran, Lam-Son Phan
Truhlar, Donald G.
Tsao, Rong
Tsuda, Kenichi
Tukker, Arnold
Tung, Chen-Ho
Turskis, Zenonas
Urquhart, Andrew
Valko, Marian
Van Breusegem, Frank
Van de Wiele, Tom
van der Werf, Guido
van Wesemael, Bas
Vangronsveld, Jaco
Varma, Rajender S.
Varsani, Arvind
Varshney, Rajeev K.
Vasilakis, Nikos
Vasilakos, Athanasios V.
Vasquez, Juan C.
Vatanen, Tommi
Ventura, Marco
Vermote, Eric
Veronese, Nicola
Verpoorte, Robert
Vethaak, A. Dick
Vieta, Eduard
Vincent, Jean-Louis
Wagner, Wolfgang
Walton, Vaughn M.
Wan, Jiafu
Wan, Shaohua
Wang, Qi
Wang, Joseph
Wang, Meng
Wang, Tao
Wang, Yuan
Wang, Xin
Wang, Chao
Wang, Yong
Wang, Jun
Wang, Erkang
Wang, Sibo
Wang, Jian
Wang, Ning
Wang, John
Wang, Qin
Wang, Shaojian
Wang, Guoxiu
Wang, Huanting
Wang, Chunsheng
Wang, Gongming
Wang, Zhong Lin
Wang, Lianzhou
Wang, Shaobin
Wang, Yang
Wang, Zifa
Wei, Zhixiang
Wei, Leyi
Weissleder, Ralph
Wen, Guanghui
Wiens, John J.
Wigneron, Jean-Pierre
Willerslev, Eske
Wishart, David S.
Witlox, Frank
Wu, Jun
Wu, Tom
Wu, Hao Bin
Wu, Hui
Wu, Haijun
Wu, Zhongbiao
Wu, Zhong-Shuai
Wu, Zheng-Guang
Xia, Meimei
Xia, Xinhui
Xiang, Quanjun
Xiao, Jianbo
Xiao, Jie
Xie, Jian-Hua
Xin, Sen
Xing, Baoshan
Xiong, Rui
Xu, Bin
Xu, Li Da
Xu, Yi-Jun
Xu, Hui
Xu, Zeshui
Yamauchi, Yusuke
Yan, Huaicheng
Yan, Kai
Yang, Chenguang
Yang, Xiao-Jun
Yang, Bing
Yang, Yun-Gui
Yang, Jie
Yang, Jian
Yang, Xinsong
Yang, Shihe
Yang, Yi
Yang, Yang
Yao, Jen-Chih
Yao, Yonggang
Yazyev, Oleg
Yin, Yulong
Yin, Zongyou
Yin, Shen
Yin, Ya-xia
Yin, Shou-Wei
Ying, Guang-Guo
Young, Allan H.
Yu, Shu-Hong
Yu, Jun
Yu, Guihua
Yu, Wenwu
Yu, Guocan
Yu, Minghao
Zarco-Tejada, Pablo J.
Zavadskas, Edmundas Kazimieras
Zeadally, Sherali
Zhai, Tianyou
Zhang, Wei
Zhang, Binlin
Zhang, Shujun
Zhang, Guoping
Zhang, Zengqiang
Zhang, Yu Shrike
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Guowen
Zhang, Min
Zhang, Yue-Jun
Zhang, Shaoqing
Zhang, Fan
Zhang, Weili
Zhang, Xiaodong
Zhang, Zhien
Zhang, Tierui
Zhang, Hongjie
Zhang, Dengsong
Zhang, Liangpei
Zhang, Dan
Zhang, Yu-Dong
Zhang, Fusuo
Zhao, Yi
Zhao, Guochun
Zhao, Li-Dong
Zheng, Hao
Zheng, Gengfeng
Zhong, Cheng
Zhou, Weiqi
Zhou, Qi
Zhou, Jizhong
Zhu, Hongwei
Zhu, Chengzhou
Zhu, Junfa
Zhu, Zhe
Zhu, Quanxin
Zhuang, Xiaodong
Zhuang, Xiaoying
Zou, Quan

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

16 November 2021
Topical Advisory Panel Established to Support Editorial Board

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in the field related to the journal;
  • Have received a Ph.D. in the last 10 years, approximately;
  • Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

29 October 2021
Recruiting Topical Advisory Panel Members for Biomolecules

 

To expand our biomolecules science community, Biomolecules is launching a new position—Topical Advisory Panel Member.

Biomolecules (ISSN 2218-273X) is an international, peer-reviewed open access journal whose scope lays at the intersection between chemistry, biology, molecular medicine and material sciences. The journal has a strong focus on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications as well as biomaterials and their applications. Biomolecules publishes articles, reviews, communications and editorials. The 2020 impact factor for Biomolecules was 4.879. The Biomolecules website can be accessed here: https://www.mdpi.com/journal/biomolecules.

Should you decide to serve on the Topical Advisory Panel, you would be responsible for some of the following tasks, depending on your availability:

  • Providing regular reviews of manuscripts;
  • Setting up at least one Special Issue (SI) in partnership with a senior researcher within two years of the appointment and proposing a detailed strategic plan for the SI. The topic of the proposal should be within the scope of the journal. The scope of the Special Issue should be broad enough to attract a reasonable number of submissions but narrow enough to provide a cohesive collection of articles. The Special Issue should cover a small part of the scope of the journal, but not its entirety;
  • Providing a detailed strategic plan for the SI including assisting in preparing the Special Issue’s/Topic’s title, aim and scope, summary and keywords, soliciting papers and promoting the SI;
  • Providing support for the Special Issues/Topics related to your expertise when the Guest Editor(s) is not available. This includes SI promotion via social media and giving advice on some scientific cases;
  • Promoting the journal at conferences (adding 1–2 slides into your presentation, distributing flyers, recommending the journal to your colleagues, etc.), on social media and other relevant platforms;
  • Participating in working with Editorial Board Members or the Editorial Office in promoting high-quality/featured papers (for example writing summary or highlights for the editor's selected papers).

If you are interested in this position or know of potential candidates to recommend, or wish to request further information, please contact the Biomolecules Editorial Office (biomolecules@mdpi.com). We look forward to hearing from you soon.

25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

  • 25 October 2021
    Energies journal and Institute of Mechanics, Chinese Academy of Sciences
  • 28 October 2021
    Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
  • 29 October 2021
    Processes journal and Beijing Institute of Technology
  • 29 October 2021
    Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

19 October 2021
Prof. Dr. Jürg Bähler Appointed Editor-in-Chief of Section “Molecular Genetics” in Biomolecules

We are pleased to announce that Prof. Dr. Jürg Bähler has been appointed Editor-in-Chief of the “Molecular Genetics” Section in Biomolecules (ISSN 2218-273X).

Name: Prof. Dr. Jürg Bähler

Affiliation: Department of Genetics, Evolution & Environment and Institute of Healthy Ageing, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK

Interests: gene regulation; genomics; transcriptomics; non-coding RNAs; genome function and evolution; fission yeast; cellular quiescence and aging

 

The following is a short Q&A with Prof. Dr. Jürg Bähler:

  1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?
    Biomolecules make rapid decisions on submitted manuscripts without compromising on scrutiny and peer-review quality.
  2. What is your vision for the journal?
    To further increase the quality, rather than quantity, of published papers in a broad range of topics.
  3. What does the future of this field of research look like?
    The advances in genome editing, like CRISPR/Cas9, are now enabling molecular genetic approaches in many different organisms, beyond the traditional model organisms. Other technological advances are allowing more and more types of large-scale or single-cell analyses. These developments will provide many fresh insights into gene function, genetic diversity, and molecular processes contributing to phenotypes.
  4. What do you think of the development of Open Access in the publishing field?
    It makes no sense to restrict access to scientific publications behind paywalls, and Open Access publishing is a positive development to maximize scientific progress.

We extend a warm welcome to Prof. Dr. Jürg Bähler as he starts his new role as the Section Editor-in-Chief, and we look forward to him leading Biomolecules to achieve many more milestones.

Biomolecules Editorial Office

23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced


Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

  • Adriana Burlea-Schiopoiu;
  • Alban Kuriqi;
  • Álvaro González-Vila;
  • Alessandro Alaimo;
  • Alexey Beskopylny;
  • Alexander Yu Churyumov;
  • Alberto Fernández-Isabel;
  • Andrea Mastinu;
  • Antonios N. Papadopoulos;
  • Anton Rassõlkin;
  • Antonio Humberto Hamad Minervino;
  • Arkadiusz Matwijczuk;
  • Artur Słomka;
  • Baojie He;
  • Bartłomiej Potaniec;
  • Bojan Đurin;
  • Camilo Arturo Rodriguez Diaz;
  • Carmelo Maria Musarella;
  • Chiachung Chen;
  • Chiman Kwan;
  • Cristian Busu;
  • Danil Pimenov;
  • Dan-Cristian Dabija;
  • Delfín Ortega-Sánchez;
  • Demetrio Antonio Zema;
  • Denis Butusov;
  • Elena Lucchi;
  • Gaurab Dutta;
  • Livia Anastasiu;
  • M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

22 September 2021
MDPI Joins SDG Publishers Compact

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

3 August 2021
Announcement on Japanese Consumption Tax (JCT)

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

7 July 2021
Biomolecules | Three New Sections Established

In order to specifically develop different research areas and attract more high-quality papers, we are pleased to announce the addition of the following three new sections in Biomolecules to cover all the disciplines of natural and applied science:

Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload?form[journal_id]=111.

Biomolecules is a peer-reviewed, open access journal on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications, as well as biomaterials and their applications. Biomolecules is published monthly online by MDPI.

30 June 2021
2020 Impact Factors - Released

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

  • 10 journals received their first impact factor
  • 96% of journals increased their impact factor from 2019
  • 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal Impact Factor Rank Category
Cancers 6.639 Q1 • Oncology
Cells 6.600 Q2 • Cell Biology
Pharmaceutics 6.321 Q1 • Pharmacology & Pharmacy
Antioxidants 6.313 Q1 • Food Science & Technology 
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Biomedicines 6.081 Q1 • Medicine, Research & Experimental
• Pharmacology & Pharmacy 
• Biochemistry & Molecular Biology
International Journal of Molecular Sciences 5.924 Q1 • Biochemistry & Molecular Biology
Q2 • Chemistry, Multidisciplinary
Pharmaceuticals 5.863 Q1 • Pharmacology & Pharmacy
• Chemistry, Medicinal
Journal of Fungi 5.816 Q1 • Mycology
• Microbiology
Nutrients 5.719 Q1 • Nutrition & Dietetics
Biosensors 5.519 Q1 • Chemistry, Analytical
• Instruments & Instrumentation
Q2 • Nanoscience & Nanotechnology
Marine Drugs 5.118 Q1 • Chemistry, Medicinal
• Pharmacology & Pharmacy
Biology 5.079 Q1 • Biology
Nanomaterials 5.076 Q1 • Physics, Applied
Q2 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary 
• Nanoscience & Nanotechnology
Viruses 5.048 Q2 • Virology
Journal of Personalized Medicine 4.945 Q1 • Medicine, General & Internal
• Health Care Sciences & Services
Metabolites 4.932 Q2 • Biochemistry & Molecular Biology
Biomolecules 4.879 Q2 • Biochemistry & Molecular Biology
Remote Sensing 4.848 Q1 • Geosciences, Multidisciplinary
Q2 • Remote Sensing
• Imaging Science & Photographic Technology 
• Environmental Sciences
Gels * 4.702 Q1 • Polymer Science
Antibiotics 4.639 Q2 • Infectious Diseases
• Pharmacology & Pharmacy
Toxins 4.546 Q1 • Toxicology
• Food Science & Technology
Vaccines 4.422 Q2 • Immunology
• Medicine, Research & Experimental
Molecules 4.412 Q2 • Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Foods 4.350 Q2 • Food Science & Technology
Polymers 4.329 Q1 • Polymer Science
Journal of Clinical Medicine 4.242 Q1 • Medicine, General & Internal
Toxics 4.146 Q2 • Toxicology
• Environmental Sciences
Catalysts 4.146 Q2 • Chemistry, Physical
Microorganisms 4.128 Q2 • Microbiology
Membranes 4.106 Q1 • Polymer Science
Q2 • Engineering, Chemical
• Materials Science, Multidisciplinary 
• Chemistry, Physical
Genes 4.096 Q2 • Genetics & Heredity
Fermentation * 3.975 Q2 • Biotechnology & Applied Microbiology
Journal of Cardiovascular Development and Disease * 3.948 Q2 • Cardiac & Cardiovascular Systems
Plants 3.935 Q1 • Plant Sciences
Life 3.817 Q2 • Biology
Diagnostics 3.706 Q2 • Medicine, General & Internal
Current Oncology 3.677 Q3 • Oncology
Materials 3.623 Q1 • Metallurgy & Metallurgical Engineering
Q2 • Materials Science, Multidisciplinary
• Chemistry, Physical 
• Physics, Applied 
• Physics, Condensed Matter
Sensors 3.576 Q1 • Instruments & Instrumentation
Q2 • Chemistry, Analytical
• Engineering, Electrical & Electronic
Pathogens 3.492 Q2 • Microbiology
Agronomy 3.417 Q1 • Agronomy
• Plant Sciences
Chemosensors 3.398 Q2 • Instruments & Instrumentation
• Chemistry, Analytical
Q3 • Electrochemistry
Land 3.398 Q2 • Environmental Studies
Brain Sciences 3.394 Q3 • Neurosciences
International Journal of Environmental Research and Public Health 3.390 Q1 • Public, Environmental & Occupational Health (SSCI)
Q2 • Public, Environmental & Occupational Health (SCIE)
• Environmental Sciences (SCIE)
Tomography 3.358 Q2 • Radiology, Nuclear Medicine & Medical Imaging
Fractal and Fractional * 3.313 Q1 • Mathematics, Interdisciplinary Applications
Sustainability 3.251 Q2 • Environmental Sciences (SCIE)
• Environmental Studies (SSCI)
Q3 • Green & Sustainable Science & Technology (SCIE)
• Green & Sustainable Science & Technology (SSCI)
Water 3.103 Q2 • Water Resources
• Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 3.049 Q3 • Business
Energies 3.004 Q3 • Energy & Fuels
Agriculture 2.925 Q1 • Agronomy
ISPRS International Journal of Geo-Information 2.899 Q2 • Geography, Physical
• Computer Science, Information Systems
Q3 • Remote Sensing
Micromachines 2.891 Q2 • Instruments & Instrumentation
• Physics, Applied
Q3 • Chemistry, Analytical
• Nanoscience & Nanotechnology
Coatings 2.881 Q2 • Materials Science, Coatings & Films
• Physics, Applied
Q3 • Materials Science, Multidisciplinary
Children 2.863 Q2 • Pediatrics
Processes 2.847 Q3 • Engineering, Chemical
Separations 2.777 Q3 • Chemistry, Analytical
Insects 2.769 Q1 • Entomology
Animals 2.752 Q1 • Agriculture, Dairy & Animal Science
• Veterinary Sciences
Symmetry 2.713 Q2 • Multidisciplinary Sciences
Atmosphere 2.686 Q3 • Meteorology & Atmospheric Sciences
• Environmental Sciences
Applied Sciences 2.679 Q2 • Engineering, Multidisciplinary
• Physics, Applied
Q3 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary
Photonics 2.676 Q2 • Optics
Buildings * 2.648 Q2 • Construction & Building Technology
• Engineering, Civil
Healthcare 2.645 Q2 • Health Policy & Services (SSCI)
Q3 • Health Care Sciences & Services (SCIE)
Minerals 2.644 Q2 • Mining & Mineral Processing
• Mineralogy
• Geochemistry & Geophysics
Forests 2.634 Q1 • Forestry
Crystals 2.589 Q2 • Crystallography
Q3 • Materials Science, Multidisciplinary
Entropy 2.524 Q2 • Physics, Multidisciplinary
Diversity 2.465 Q2 • Biodiversity Conservation
Q3 • Ecology
Journal of Marine Science and Engineering 2.458 Q2 • Oceanography
• Engineering, Marine 
• Engineering, Ocean
Medicina 2.430 Q2 • Medicine, General & Internal
Machines * 2.428 Q2 • Engineering, Mechanical
Q3 • Engineering, Electrical & Electronic
Electronics 2.397 Q3 • Engineering, Electrical & Electronic
• Computer Science, Information Systems 
• Physics, Applied
Fishes * 2.385 Q2 • Fisheries
• Marine & Freshwater Biology
Metals 2.351 Q2 • Metallurgy & Metallurgical Engineering
Q3 • Materials Science, Multidisciplinary
Horticulturae * 2.331 Q1 • Horticulture
Veterinary Sciences * 2.304 Q1 • Veterinary Sciences
Universe 2.278 Q3 • Physics, Particles & Fields
• Astronomy & Astrophysics
Mathematics 2.258 Q1 • Mathematics
Magnetochemistry 2.193 Q3 • Chemistry, Inorganic & Nuclear
• Chemistry, Physical 
• Materials Science, Multidisciplinary
Current Issues in Molecular Biology 2.081 Q4 • Biochemistry & Molecular Biology
Actuators 1.994 Q3 • Instruments & Instrumentation
• Engineering, Mechanical
Aerospace * 1.659 Q2 • Engineering, Aerospace

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

28 April 2021
Book BuilderCompile a Customized E-Book from Your Favorite MDPI Open Access Content

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

 

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

 



Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"


In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article


At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

  • eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
  • creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
  • promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
  • raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
  • supporting our members in achieving diversity and inclusion within their organizations.

14 December 2020
Article Layout and Templates Revised for Future Volumes

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.


2) In the main text, there is a blank column on the left.


3) Small tables/figures are aligned on the left, large tables/figures are centered.

11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.


Adams, Dave
Agarwal, Ravi P.
Ahn, Choon Ki
Ahn, Myung-Ju
Albrecht, Randy A.
Andersson, Dan I.
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Artaxo, Paulo
Balsamo, Gianpaolo
Barba, Francisco J.
Benediktsson, Jon Atli
Benelli, Giovanni
Bhatnagar, Amit
Bialystok, Ellen
Blaabjerg, Frede
Blay, Jean-Yves
Bogers, Marcel
Bolton, Declan J.
Boyer, Cyrille
Brocca, Luca
Bruix, Jordi
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cabrerizo-Lorite, Francisco Javier
Cai, Jianchao
Calhoun, Vince D.
Cantu, Robert C.
Cerqueira, Miguel
Chang, Jo-Shu
Chau, Kwok-wing
Chemat, Farid
Chen, Jianmin
Chen, Jun
Chen, Min
Chen, Shaowei
Chen, Wei
Chen, Wei-Hsin
Chen, Xiaofeng
Chen, Yangkang
Chen, Zhi-Gang
Chiclana, Francisco
Corella, Dolores
Cortes, Javier
Cortes, Jorge
Cummings, Kenneth Michael
Dai, Shifeng
Decker, Eric A.
DePinho, Ronald A.
Dimopoulos, Meletios-Athanasios
Dincer, Ibrahim
Du, Yihong
Dupont, Didier
Edwards, David
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estruch, Ramón
Fang, Chuanglin
Fasano, Alessio
Fernandez-Lafuente, Roberto
Ferreira, Isabel
Fortino, Giancarlo
Galluzzi, Lorenzo
Galvano, Fabio
Gandomi, Amir H.
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Wei
Garbe, Claus
García, Hermenegildo
Geschwind, Daniel H.
Giampieri, Francesca
Giralt, Sergio A.
Glanz, Karen
Goldewijk, Kees Klein
Gössling, Stefan
Govindan, Kannan
Granato, Daniel
Grosso, Giuseppe
Grosso, Giuseppe
Guerrero, Josep M.
Haase, Dagmar
Hagger, Martin S.
Hamblin, Michael R.
Han, Heesup
Jankovic, Joseph
Janotti, Anderson

Jiang, Hai-Long
Kalaji, Hazem M.
Kalantar-Zadeh, Kourosh
Kaner, Richard B.
Karimi, Hamid Reza
Kataoka, Kazunori
Keesstra, Saskia
Kepp, Oliver
Kerminen, Veli-Matti
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kim, Ki-Hyun
Klemeš, Jiří Jaromír
Klenk, Hans-Peter
Konopleva, Marina Y.
Krammer, Florian
Krebs, Frederik C.
Kroemer, Guido
Kudo, Masatoshi
Kurths, Juergen
Kurzrock, Razelle
Kuznetsov, Nikolay V.
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lancellotti, Patrizio
Lee, Sangmoon
Leung, Victor C. M.
Li, Jinghong
Li, Yurui
Lindahl, José M. Merigó
Lip, Gregory Y. H.
Loh, Xian Jun
Long, Hualou
Lund, Henrik
Luo, Jingshan
Luque, Rafael
Lyons, Timothy W.
Ma, Jun
Ma, Wen-Xiu
Ma, Yanming
Maeda, Keisuke
Makarova, Kira
Mantovani, Alberto
Martín-Belloso, Olga
Martinoia, Enrico
Marzband, Mousa
Masclaux-Daubresse, Celine
Masson, Patrick
Mateos, María Victoria
Mathiesen, Brian Vad
Matyjaszewski, Krzysztof
McArthur, Grant A.
McCauley, Darren
Medlock, Jolyon M.
Melero, Ignacio
Mezzetti, Bruno
Miroshnichenko, Andrey E.
Moran, Daniel
Mueller, Lukas A.
Mueller-Roeber, Bernd
Naushad, Mu
Nemeroff, Charles B.
Nieto, Juan J.
O'Donnell, Colm
Ogino, Shuji
Olabi, Abdul-Ghani
O'Regan, Donal
Orsini, Nicola
Oswald, Isabelle P.
Ozcan, Aydogan
Pahl-Wostl, Claudia
Pang, Huan
Payne, James E.
Peng, Shushi
Perc, Matjaz
Perez-Alvarez, Jose Angel
Piquero, Alex R.
Ploss, Alexander
Postolache, Mihai
Pradhan, Biswajeet
Prinsep, Michele R.
Qian, Dong
Qu, Xiaogang
Reiter, Russel J.
Riahi, Keywan
Richter, Andreas
Rignot, Eric
Robert, Caroline
Ros, Emilio
Rosell, Rafael

Rosen, Marc A.
Rossolini, Gian Maria
Saad, Fred
Saad, Walid
Sadorsky, Perry
Sakthivel, Rathinasamy
Schwab, Matthias
Scolyer, Richard A.
Serra-Majem, Lluis
Sethi, Gautam
Seto, Karen C.
Settele, Josef
Seymour, John F.
Shi, Peng
Siano, Pierluigi
Sillanpää, Mika
Simal-Gandara, Jesus
Smagghe, Guy
Srivastava, Hari M.
Stadler, Peter F.
Sun, Fengchun
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Tan, Weihong
Teixeira, José António
Thakur, Vijay Kumar
Tong, Shilu
Tornabene, Francesco
Tsao, Rong
Tukker, Arnold
Turskis, Zenonas
Uversky, Vladimir N.
van Wesemael, Bas
Van Zwieten, Lukas
Vangronsveld, Jaco
Varma, Rajender S.
Varshney, Rajeev K.
Vasquez, Juan C.
Velicogna, Isabella
Vieta, Eduard
Wade, Timothy J.
Wagner, Wolfgang
Wamba, Samuel Fosso
Wang, Chunsheng
Wang, Guoxiu
Wang, Joseph
Wang, Qi
Wang, Tao
Wang, Yuan
Wiens, John J.
Wu, Hao Bin
Wu, Hui
Wu, Tom
Wu, Zhongbiao
Xia, Xinhui
Xiao, Wenjiao
Xin, Sen
Xiong, Rui
Xu, Bin
Xu, Zeshui
Yan, Huaicheng
Yang, Bing
Yang, Hongxing
Yang, Jie
Yang, Xiao-Jun
Yin, Shen
Ying, Guang-Guo
Young, Allan H.
Yu, Guihua
Zarco-Tejada, Pablo J.
Zavadskas, EdmundasKazimieras
Zeadally, Sherali
Zhang, Fan
Zhang, Liangpei
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Yue-Jun
Zhao, Guochun
Zhao, Li-Dong
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan

The full list of 2020 Highly Cited Researchers  can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/

--- Highly Cited Researchers (HCR) is a Clarivate product.

13 October 2020
4th Free Webinar on Biomolecules: Recent advances on lysosomal storage disorders pathogenesis: an emerging Gaucher disease paradigm shift — 23rd October 2020

MDPI has provided several free open platforms that may help accelerate scientific exchange and support academics during this particularly difficult period. Thanks to our brilliant technical support, we are pleased to report that the fourth Free Webinar on Biomolecules: Recent advances on lysosomal storage disorders pathogenesis: an emerging Gaucher disease paradigm shift is coming soon.

Date & Time: 23 October 2020 03:00pm (CEST)

Duration: Maximum 2 hours

Webinar ID: 825 9187 3796

Register for Free Here: https://biomolecules-4.sciforum.net/

Chair: Dr. Enrico Moro

Department of Molecular Medicine, University of Padova, Padova, Italy.

Dr. Enrico Moro is an Associate Professor of Cell Biology at the Medical School of the University of Padova (Italy). He authored 60 full-length publications in peer-reviewed journals, including several high impact journals, such as Endocrine Reviews, Lancet, Developmental Cell, Cell Reports and PNAS. He was co-editor of two Special Issues of the Journal of Endocrinological Investigation, and he is currently Guest Editor of a Special Issue on Lysosomal Disorders in Biomolecules. His research publications present a total impact factor of 336 and a mean impact factor of 5.6; he has an h-index of 27. His research has been funded by different entities (Italian Ministry of Health 2010-2013, Genzyme-Sanofi 2012-2017 and MPS society 2019-2021). Dr. Moro has been invited as a speaker in several international and national meetings. He is also a member of the Scientific Advisory Board for the International Society for Mannosidosis & Related Diseases (ISMRD). He has a strong background in human cell biology, mouse and zebrafish manipulation, and his current research focuses on the study of lysosomal storage disorders, particularly Gaucher disease and Hunter Syndrome (Mucopolysaccharidosis type II).

Speakers: Dr. Ricardo A. Feldman, Dr. Andrea Dardis

Dr. Ricardo A. Feldman

Department of Microbiology and Immunology, University of Maryland School of Medicine (UMSOM), Baltimore, USA.

Dr. Ricardo A. Feldman is an Associate Professor at the University of Maryland School of Medicine (UMSOM). Dr. Feldman received his PhD from the Department of Cell Biology at New York University School of Medicine, working with Drs. Takashi Morimoto and David D. Sabatini. After that he was a post-doctoral fellow in Dr. Hidesaburo Hanafusa's laboratory at the Rockefeller University, where he identified several new tyrosine kinase oncogenes that had been captured by RNA tumor viruses, and their cellular homologs. Dr. Feldman then moved to the lab of Dr. Doug Lowy at the National Cancer Institute (NCI, USA). He then joined the faculty of the UMSOM Department of Microbiology and Immunology, where he currently studies the developmental and cellular abnormalities caused by GBA1 mutations in Gaucher disease and GBA1-associated Parkinson’s disease. Using patient-derived induced pluripotent stem cells (iPSC), his laboratory identified the Wnt/B-catenin and mTORC1 pathways as critical targets of the sphingolipid imbalance caused by GCase deficiency. Dr. Feldman is a founding member of The Center for Stem Cell Biology and Regenerative Medicine at UMSOM.

Dr. Andrea Dardis

Laboratory of the Regional Coordinator Centre for Rare Diseases, University Hospital of Udine, Italy.

Dr. Andrea Dardis is Head of the Laboratory of the Regional Coordinator Centre for Rare Diseases, Udine, Italy. She obtained her PhD in Molecular Biology from the University of Buenos Aires, Argentina and continued her training as a post-doctoral fellow at the Metabolic Unit, University of California, San Francisco, USA. During her training she was awarded Fellowship of the Lawson Wilkins Pediatric Endocrine Society. She then moved to Italy where she got a Specialist Degree in Medical Genetics at the University of Genoa. In 2003 she joined the Metabolic Diseases Unit, Pediatric Hospital “Burlo Garofolo”, Trieste, Italy, as a Research Scientist. In 2009 she moved to the Regional Coordinator centre for Rare Diseases in Udine, Italy, where she became Head of the laboratory. Dr. Dardis laboratory is mainly focused in the biochemical and molecular diagnosis of lysosomal storage diseases, the functional characterization of defective lysosomal enzymes and the study of molecular mechanisms involved in the pathogenesis of lysosomal storage disorders. Dr. Dardis is a board member of the European Working Group of Gaucher Disease and member of the board of trustees of the international Niemann Pick disease registry (INPDR).

Webinar Program

Presentation

Time

Dr. Enrico Moro

"Blowin’ in the Wnt: how glucocerebrosidase may shape a cell differentiation program"

03:00 pm (CEST)

Q&A

03:20 pm (CEST)

Dr. Ricardo A. Feldman

"GBA1 mutations cause neurodevelopmental defects and lysosomal dysfunction"

03:30 pm (CEST)

Q&A

03:50 pm (CEST)

Dr. Andrea Dardis

"Cellular models for the study of the pathogenic cascade in Gaucher disease"

04:00 pm (CEST)

Q&A

04:20 pm (CEST)

Discussion and Concluding Remarks

04:30 pm (CEST)

For any questions about the webinar, please send an email to webinars@mdpi.com.

13 October 2020
3rd Free Webinar on Biomolecules: Role of Nrf2 in Neurodegeneration: Novel Molecular Mechanisms and Therapeutic Approaches—16th October 2020

MDPI has provided several free open platforms that may help accelerate scientific exchange and support academics during this particularly difficult period. Thanks to our brilliant technical support, we are pleased to report that the third Free Webinar on Biomolecules: Role of Nrf2 in Neurodegeneration: Novel Molecular Mechanisms and Therapeutic Approaches is coming soon.

Date: 16 October 2020 03:00pm (CEST)

Duration: Maximum 2 hours

Webinar ID: 863 2534 8347

Register for Free Here: https://biomolecules-3.sciforum.net/

Chair: Prof. Dr. Isabel Lastres-Becker

Department of Biochemistry, School of Medicine, Universidad Autonoma de Madrid, Madrid, Spain.

Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Investigación Sanitaria La Paz (IdiPaz), Instituto de Investigaciones Biomédicas "Alberto Sols", UAM-CSIC, Madrid, Spain.

Dr. Lastres-Becker has more than 20 years of experience in the field of neurodegenerative diseases. The study of neurodegenerative diseases has been at the focus from the beginning of her doctoral thesis and until now, the thread that has guided her entire scientific career. Her work is focused on the molecular bases of neurodegeneration related to proteinopathy, neuroinflammation, and oxidative stress. She is the head of the laboratory of “New therapeutic strategies in neurodegenerative diseases: Parkinson's disease (PD), tauopathies and amyotrophic lateral sclerosis (ALS)”. The research projects she has developed have a multidisciplinary approach that combines basic and translational research, using cell culture techniques, murine models (transgenic mice and adeno-associated viral vectors), and postmortem samples from patients with AD, PD, and ALS. She is engaged in the development of advanced biological markers, new drugs, and appropriate technology toward establishing treatments for those diseases.

Speakers: Prof. Dr. Bianca Marchetti, Prof. Dr. Manuela G. López, Dr. Fabio Di Domenico

Prof. Dr. Bianca Marchetti

Department of Biomedical and Biotechnological Sciences (BIOMETEC), Pharmacology Section, University of Catania Medical School, Italy.

Dr. Bianca Maria Marchetti is a Full Professor of Pharmacology at the School of Medicine, University of Catania, Italy, and directs the research activities of the Molecular and Experimental Neuropharmacology Section at the OASI Institute—IRCCS-Troina. Studies of the last decades concentrated on glia-neuron dialogue in Parkinson’s disease with a specific focus on Nrf2/Wnt-signaling axis, its crosstalk with inflammatory and survival pathways in neuroprotection, the activation of adult neurogenesis, and the development of therapeutic strategies to counteract progressive neuronal degeneration and boost the inherent self-protective and reparative capacities of the aged, injured brain.

Prof. Dr. Manuela G. López

Instituto Teófilo Hernando for Drug Discovery, Universidad Autónoma de Madrid, Madrid, Spain.

Dr. Manuela G. Lopez is a Full Professor of Pharmacology at the School of Medicine, Autonomous University of Madrid (UAM), Spain. She is the current Director of the Institute Teofilo Hernando for R&D of drugs and trustee of the Foundation Teofilo Hernando. Her research focuses on the R&D of neuroprotective drugs for neurodegenerative diseases and cerebral ischemia, from the identification of new potentially therapeutic targets to the dissection of the mechanism of action of drugs already marketed or newly synthesized. She has published over 150 scientific articles and has an h-index of 48. She is a co-inventor of 11 patents related to neuroprotective compounds for neurodegenerative diseases and stroke and has participated in over thirty research projects as IP or collaborator. At the UAM, she has promoted the teaching of pharmacology, coordinates the Master’s Degree in Pharmacological Research, and has mentored 17 Ph.D. theses and 16 Master’s theses.

Dr. Fabio Di Domenico

Department of Biochemical Sciences, Sapienza University of Rome, Italy.

Dr. Di Domenico graduated at Sapienza University of Rome where he also obtained his PhD degree in Biochemistry in 2009. Dr. Di Domenico’s research is currently focused on understanding the role of defective proteostasis in the development of Alzheimer’s-like dementia in order to propose novel effective therapeutic approaches that might ameliorate cognitive decline. Collected data from Dr. Di Domenico’s laboratory postulate that aberrant proteostasis, observed in both Alzheimer’s and Down syndrome patients, is strictly associated with the increase of oxidative damage as result of compromised antioxidant response and faulty protein degradative systems. Recently, his studies revealed that chronic induction of the unfolded protein response has a prominent role in the development of AD-like dementia in DS brain. Indeed, the pharmacological rescue of UPR function leads to the reduction in neuropathological hallmarks and to decrease in protein oxidation in a mechanism involving the Nrf2 antioxidant response.

Webinar Program

Presentation

Time

Prof. Dr. Isabel Lastres-Becker

Introduction

03:00 pm (CEST)

Prof. Dr. Bianca Marchetti

"Resilience of Nrf2-ARE axis and Wnt/β-catenin intertwined signaling cascades to fight ageing and nigrostriatal degeneration in Parkinson’s disease"

03:20 pm (CEST)

Q&A

03:40 pm (CEST)

Prof. Dr. Manuela G. López

"NRF2: a therapeutic target for Alzheimer's disease"

03:50 pm (CEST)

Q&A

04:10 pm (CEST)

Dr. Fabio Di Domenico

"The aberrant crosstalk between PERK and Nrf2 in Down syndrome: A novel target for therapeutic intervention"

04:20 pm (CEST)

Q&A

04:40 pm (CEST)

Discussion and Concluding Remarks

04:50 pm (CEST)

For any questions about the webinar, please send an email to webinars@mdpi.com.

17 September 2020
10th Anniversary of Biomolecules

This year marks the 10th anniversary of the open access MDPI journal Biomolecules. To celebrate this important occasion, we are delighted and proud to celebrate with a series of Special Issues and events. To date, the journal has received more than 6000 contributions and published more than 2600 articles, and the journal website attracts more than 26,483 monthly page views. We would like to express our sincerest thanks to our readers, innumerable authors, anonymous peer reviewers, editors, and all the people working in some way for the journal who have made substantial contributions for years. Without your support, we would never have made it.

Anniversary Special Issues

To celebrate the 10th anniversary of Biomolecules, we have launched a series of Anniversary Special Issues.

10th Anniversary of Biomolecules—Recent Advances in Protein Evolution

10th Anniversary of Biomolecules—Recent Advances in Understanding of Molecular Pathology and Therapeutics of Cancer

10th Anniversary of Biomolecules—Advances in Biomarkers, Therapeutics and Prevention

10th Anniversary of Biomolecules—Recent Advances in Peptide and Protein Therapeutics

10th Anniversary of Biomolecules—Recent Advances in Cardiomyopathy

Anniversary Awards

Biomolecules 2020 Best Paper Awards for Anniversary Special Issues

text

Biomolecules Best Cover Awards

text

Collection of Excellent Works

text                                        text

26 August 2020
Recruiting Editors for Biomolecules

Biomolecules is recruiting Editorial Board members who would like to become involved in one of the sections listed below:

These sections will expand the Editorial Board and cover areas that are less well represented by the current team. If you are interested in this position or know of potential candidates to recommend, please contact us (biomolecules@mdpi.com) by 31 December 2020.

Biomolecules provides an advanced forum for studies related to biogenic substances and their biological functions, structures, and interactions with other molecules and the microenvironment as well as biological systems. The 2019 Journal Impact Factor for Biomolecules is 4.082. The website of Biomolecules can be accessed here.

As an Editorial Board member, you have the following responsibilities:

  • Leading at least one Special Issue related to your research field every two years;
  • Promoting Biomolecules and increase its visibility at related academic conferences;
  • Inviting at least two high-quality papers from senior scholars, or help to send call-for-paper emails for Special Issues or Sections related to your research field;
  • Pre-screening submissions and making decisions on whether a manuscript can be accepted or not based on the reports we collect

To apply or request further information, please contact the Biomolecules Editorial Office (biomolecules@mdpi.com). We look forward to hearing from you soon.

25 August 2020
2nd Free Webinar on Biomolecules: Understanding the Potential of Host Defense Peptides in Treating Cancer—26 August 2020

MDPI has provided several free open platforms that may help accelerate scientific exchange and support academics during this particularly difficult period. Thanks to our brilliant technical support, we are pleased to report that the Second Free Webinar on Biomolecules: Understanding the Potential of Host Defense Peptides in Treating Cancer is coming soon.

Date & Time: 26 August 2020 10:00am (PT) | 2:00pm (ADT) | 7:00pm (CEST)

Duration: Maximum 2 hours

Webinar ID: 843 6975 2868

Register for Free Here: https://sciforum.net/conference/biomolecules-2

Webinar Chairs

Dr. Melanie R. Power Coombs

Department of Biology, Acadia University, Wolfville, Canada

Department of Pathology, Dalhousie University, Halifax, Canada

Dr. Melanie Coombs’s research interests include the investigation of the anti-cancer and immunomodulatory effects of natural products such as phytochemicals and anti-microbial peptides at the cellular and molecular level. A recent focus of hers has been to examine the anti-microbial peptide mastoparan from wasp venom, as well as its derivatives, to study the mechanisms of action of killing cancer cells as well as effects on immune cell function. Investigations will examine the potential of these as future anti-cancer or immunomodulatory treatments.

Prof. Dr. David W. Hoskin

Departments of Pathology, Microbiology and Immunology, and Surgery, Dalhousie University, Halifax, Canada

Dr. David Hoskin has found that a fragment of milk protein known as lactoferricin triggers the death of cancer cells obtained from a wide range of human malignancies, including breast, colon and ovarian tumors and various leukemias and lymphomas. Recent studies from the Hoskin laboratory have focused on the anticancer activity of pleurocidins. Dr. Hoskin is currently working on methods to deliver these anti-cancer peptides directly to cancer cells.

Special Invited:

Prof. Dr. Hans J. Vogel

Biochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada

Dr. Vogel completed his original academic training at the University of Groningen in the Netherlands, which was followed by a PhD degree from the University of Alberta in Edmonton, Canada. After a postdoctoral fellowship at the University of Lund, Sweden, he joined the University of Calgary, where he was appointed in 1985, and promoted to Full Professor in 1991. Over the years, he has led an active and successful research group, working in different research areas, such as calcium- and iron-binding proteins, metabolomics and host-defense peptides. His group published more than 450 widely cited scientific publications. His research on antimicrobial peptides has recently expanded into the areas of antibiofilm, antifungal and anticancer activities.

Prof. Dr. Valerie Booth

Department of Biochemistry, Department of Physics and Physical Oceanography, Memorial University of Newfoundland, Canada

Since she could not decide what to be when she grew up, Valerie Booth became a biophysicist and now enjoys working at the interface between biochemistry and physics. She holds a BSc in Physics from the University of Victoria, an MSc in Biophysics from the University of Waterloo, and a PhD in Medical Biophysics from the University of Toronto. She has been a professor at Memorial University of Newfoundland since 2005, where she researches lung surfactant, antimicrobial peptides, and molecular crowding.

Dr. Evan Haney

Hancock Lab, Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada

Dr. Haney graduated in 2004 with a BSc (Honours) in Biochemistry and received his doctoral degree in 2011, both from the University of Calgary, Canada. His PhD work, under the supervision of Dr. Hans Vogel, focused on the structural and biophysical characterization of antimicrobial peptides to elucidate their antibacterial mechanism of action. He is currently a research associate in the laboratory of Dr. Robert Hancock (University of British Columbia, Vancouver, Canada), where he investigates host defense peptides and their potential as therapeutics—in addition to their antimicrobial effects, they also possess immunomodulatory, antibiofilm, and antitumorigenic properties.

Webinar Program

Presentation

Time

Welcome

2:00 pm (ADT)

Prof. Dr. David W. Hoskin and Dr. Melanie R. Power Coombs:

Introduction

2:05 pm (ADT)

Prof. Dr. Hans J. Vogel:

"Selective Anticancer Activities of Trp- and Arg-rich Antimicrobial Peptides"

2:10 pm (ADT)

Q&A

2:20 pm (ADT)

Prof. Dr. Valerie Booth:

"Histidine-rich HDPs and HDP-induced Membrane Disruption of Intact Cells as Studied by NMR"

2:25 pm (ADT)

Q&A

2:55 pm (ADT)

Dr. Evan Haney:

"Designing Synthetic Host Defense Peptides with Improved Selectivity for Cancer Cells"

3:00 pm (ADT)

Q&A

3:20 pm (ADT)

Discussion and Concluding Remarks

3:25 pm (ADT)

For any questions about the webinar, please email webinars@mdpi.com.

9 July 2020
Open Access Agreement Between Jisc Collections and MDPI

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

Jisc logo

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact helen.dobson@jisc.ac.uk.

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at ioap@mdpi.com.

1 July 2020
1st Free Webinar on Biomolecules: Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease—1 July 2020

MDPI has provided several free open platforms that may help accelerate scientific exchange and support academics during this particularly difficult period. Thanks to our brilliant technical support, we are pleased to report that the First Free Webinar on Biomolecules: Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease is coming soon.

Date: 1 July 2020 3:00 p.m. (CEST) | 9:00 a.m. (EDT) | 9:00 p.m. (CST Asia)

Duration: Maximum 1 hour 45 minutes

Webinar ID: 827 4661 3931

Register for Free Here: https://sciforum.net/conference/biomolecules-1

Chair: Prof. Dr. Dmitry Lim

Prof. Dr. Dmitry Lim

Guest Editor of Special Issue "Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease"

Interests: calcium signaling; biosensors for calcium; neuroscience; neurodegeneration; Alzheimer’s disease; glial cells; astrocytes; CNS homeostasis

Co-chairs: Dr. Sara Merlo, Dr. Simona Federica Spampinato

Dr. Sara Merlo

Guest Editor of Special Issue "Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease"

Interests: Alzheimer’s disease; beta-amyloid toxicity; neurodegeneration; neuroinflammation; glial–neuron crosstalk; microglia; sirtuins; melatonin; estrogens

Dr. Simona Federica Spampinato

Guest Editor of Special Issue "Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease"

Interests: neurodegeneration; neuroinflammation; BBB; astrocytes; endothelial cells; glial cells; beta amyloid; estrogens; sphingosine 1-phosphate; metabotropic glutamate receptors

Special Invited:

Mr. Shun Fat Lau, Dr. Maria Grazia Morgese, Dr. Eleni K. Argyrousi

Mr. Shun Fat Lau

Shun Fat Lau is currently a second-year Ph.D. student with the laboratory of Prof. Nancy Ip (The Hong Kong University of Science and Technology—HKUST). His research focuses on the functional roles of neuroimmunity in neurodegenerative diseases, such as Alzheimer’s disease (AD). Specifically, he investigates how modulating cytokine milieus, such as through interleukin-33 administration, in the central nervous system drives the functional state transition of microglia, resulting in the amelioration of AD pathology.

Dr. Maria Grazia Morgese

Maria Grazia Morgese is a Tenure Track Assistant Professor of Pharmacology with the Department of Clinical and Experimental Medicine of the University of Foggia, Italy. Her main research interests include the neurochemistry of neurodegenerative diseases. She is interested in the pharmacological modulation of neurotransmitter systems and the role of oxidative stress in neuropsychiatric disorders. More recently, she started investigating the preventive role of n-3 polyunsaturated fatty acids in these pathologies.

Dr. Eleni K. Argyrousi

Eleni K. Argyrousi is a Postdoctoral Research Scientist with the laboratory of Prof. Ottavio Arancio, Taub Institute, Columbia University, USA. Her main research interests are neurodegenerative diseases, pathogenesis in Alzheimer’s disease, phosphodiesterase inhibitors, tau pathology, memory processes, and plasticity mechanisms.

Webinar Program

Presentation

Time

Chair Introduction: Prof. Dr. Dmitry Lim

3:00 p.m. (CEST)

Dr. Sara Merlo:

"Beta-amyloid and microglia: mechanisms for neuroprotection"

3:05 p.m. (CEST)

Q&A

3:25 p.m. (CEST)

Mr. Shun Fat Lau:

"The functional roles of IL33/ST2 signaling in modulating microglial phenotypes in Alzheimer's disease"

3:30 p.m. (CEST)

Q&A

3:50 p.m. (CEST)

Dr. Maria Grazia Morgese:

"Depressive like behavior associated with amyloid beta: protective role of n-3 polyunsaturated fatty acids"

3:55 p.m. (CEST)

Q&A

4:15 p.m. (CEST)

Dr. Eleni K. Argyrousi:

"Amyloid-beta-induced impairment of long-term synaptic plasticity and memory is tau independent"

4:20 p.m. (CEST)

Q&A

4:40 p.m. (CEST)

Concluding remarks

4.45 p.m. (CEST)

For any questions about the webinar, please email webinars@mdpi.com.

29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

  • Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
  • 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
  • Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).

First Impact Factors

Journal Impact Factor Rank Category Details
Actuators 1.957 31/64 (Q2) • Instruments & Instrumentation Link
Agriculture 2.072 25/91 (Q2) • Agronomy Link
Biology 3.796 19/93 (Q1) • Biology Link
Biomedicines  4.717 30/138 (Q1)
36/270 (Q1)
• Medicine, Research & Experimental
• Pharmacology & Pharmacy
Link
Biosensors 3.240 24/86 (Q2) • Chemistry, Analytical Link
Chemosensors 3.108 16/64 (Q1)
27/86 (Q2)
13/27 (Q2)
• Instruments & Instrumentation
• Chemistry, Analytical
• Electrochemistry
Link
Children 2.078 50/128 (Q2) • Pediatrics Link
Healthcare 1.916 62/102 (Q3)
45/87 (Q3)
• Health Care Sciences & Services (SCIE)
• Health Policy & Services (SSCI)
Link
Journal of Fungi 4.621 5/29 (Q1)
31/135 (Q1)
• Mycology
• Microbiology
Link
Journal of Personalized Medicine 4.433 24/165 (Q1)
10/102 (Q1)
• Medicine, General & Internal
• Health Care Sciences & Services
Link
Land 2.429 58/123 (Q2) • Environmental Studies (SSCI) Link
Life 2.991 26/93 (Q2)
109/267 (Q2)
• Biology
• Microbiology
Link
Magnetochemistry 1.947 22/45 (Q2)
109/159 (Q3)
201/314 (Q3)
• Chemistry, Inorganic & Nuclear
• Chemistry, Physical
• Materials Science, Multidisciplinary
Link
Membranes 3.094 53/143 (Q2)
129/314 (Q2)
23/89 (Q2)
• Engineering, Chemical
• Materials Science, Multidisciplinary
• Polymer Science
Link
Pharmaceuticals 4.286 49/270 (Q1) • Pharmacology & Pharmacy Link
Photonics 2.140 48/97 (Q2) • Optics Link
Separations 1.900 53/86 (Q3) • Chemistry, Analytical Link
Toxics 3.271 32/92 (Q2)
92/265 (Q2)
• Toxicology
• Environmental Sciences
Link

Updated Impact Factors

Journal Impact Factor Rank Category Details
Agronomy 2.603 18/91 (Q1)
65/234 (Q2)
• Agronomy
• Plant Sciences
Link
Animals 2.323 10/63 (Q1)
14/142 (Q1)
• Agriculture, Dairy & Animal Science
• Veterinary Sciences
Link
Antibiotics 3.893 23/93 (Q1)
64/270 (Q1)
• Infectious Diseases
• Pharmacology & Pharmacy
Link
Antioxidants 5.014 10/139 (Q1)
56/297 (Q1)
7/61 (Q1)
• Food Science & Technology
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Link
Applied Sciences 2.474 161/314 (Q3)
32/91 (Q2)
88/177 (Q2)
62/154 (Q2)
• Materials Science, Multidisciplinary
• Engineering, Multidisciplinary
• Chemistry, Multidisciplinary
• Physics, Applied
Link
Atmosphere 2.397 48/93 (Q3) • Meteorology & Atmospheric Sciences Link
Biomolecules 4.082 98/297 (Q2) • Biochemistry & Molecular Biology Link
Brain Sciences 3.332 113/271 (Q2) • Neurosciences Link
Cancers 6.126 37/244 (Q1) • Oncology Link
Catalysts 3.520 65/159 (Q2) • Chemistry, Physical Link
Cells 4.366 70/195 (Q2) • Cell Biology Link
Coatings 2.436 10/21 (Q2) • Materials Science, Coatings & Films Link
Crystals 2.404 10/26 (Q2)
165/314 (Q3)
• Crystallography
• Materials Science, Multidisciplinary
Link
Diagnostics 3.110 39/165 (Q1) • Medicine, General & Internal Link
Diversity 1.402 119/168 (Q3) • Ecology Link
Electronics 2.412 125/266 (Q2) • Engineering, Electrical & Electronic Link
Energies 2.702 63/112 (Q3) • Energy & Fuels Link
Entropy 2.494 33/85 (Q2) • Physics, Multidisciplinary Link
Foods 4.092 27/139 (Q1) • Food Science & Technology Link
Forests 2.221 17/68 (Q1) • Forestry Link
Genes 3.759 53/177 (Q2) • Genetics & Heredity Link
Insects 2.220 18/101 (Q1) • Entomology Link
International Journal of Environmental Research and Public Health (IJERPH) 2.849 58/193 (Q2)

32/170 (Q1)

105/265 (Q2)
• Public, Environmental & Occupational Health (SCIE)
• Public, Environmental & Occupational Health (SSCI)
• Environmental Sciences (SCIE)
Link
International Journal of Molecular Sciences (IJMS) 4.556 74/297 (Q1)
48/177 (Q2)
• Biochemistry & Molecular Biology
• Chemistry, Multidisciplinary
Link
ISPRS International Journal of Geo-Information (IJGI) 2.239 31/50 (Q3)
18/30 (Q3)
• Geography, Physical
• Remote Sensing
Link
Journal of Clinical Medicine 3.303 36/165 (Q1) • Medicine, General & Internal Link
Journal of Marine Science and Engineering 2.033 31/66 (Q2) • Oceanography Link
Marine Drugs 4.073 16/61 (Q2) • Chemistry, Medicinal Link
Materials 3.057 132/314 (Q2) • Materials Science, Multidisciplinary Link
Mathematics 1.747 28/324 (Q1) • Mathematics Link
Medicina 1.205 107/165 (Q3) • Medicine, General & Internal Link
Metabolites 4.097 95/297 (Q2) • Biochemistry & Molecular Biology Link
Metals 2.117 18/79 (Q1)
185/314 (Q3)
• Metallurgy & Metallurgical Engineering
• Materials Science, Multidisciplinary
Link
Micromachines 2.523 56/92 (Q3)
23/64 (Q2)
• Nanoscience & Nanotechnology
• Instruments & Instrumentation
Link
Microorganisms 4.152 37/135 (Q2) • Microbiology Link
Minerals 2.380 6/21 (Q2)
11/30 (Q2)
• Mining & Mineral Processing
• Mineralogy
Link
Molecules 3.267 70/177 (Q2)
141/297 (Q2)
• Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Link
Nanomaterials 4.324 89/314 (Q2)
42/103 (Q2)
• Materials Science, Multidisciplinary
• Nanoscience & Nanotechnology
Link
Nutrients 4.546 17/89 (Q1) • Nutrition & Dietetics Link
Pathogens 3.018 65/135 (Q2) • Microbiology Link
Pharmaceutics 4.421 44/270 (Q1) • Pharmacology & Pharmacy Link
Plants 2.762 58/234 (Q1) • Plant Sciences Link
Polymers 3.426 16/89 (Q1) • Polymer Science Link
Processes 2.753 59/143 (Q2) • Engineering, Chemical Link
Remote Sensing 4.509 9/30 (Q2) • Remote Sensing Link
Sensors 3.275 22/86 (Q2)
77/266 (Q2)
15/64 (Q1)
• Chemistry, Analytical
• Engineering, Electrical & Electronic
• Instruments & Instrumentation
Link
Sustainability 2.576 120/265 (Q2)
26/41 (Q3)

53/123 (Q2)
6/8 (Q3)
• Environmental Sciences (SCIE)
• Green & Sustainable Science & Technology (SCIE)
• Environmental Studies (SSCI)
• Green & Sustainable Science & Technology (SSCI)
Link
Symmetry 2.645 29/71 (Q2) • Multidisciplinary Sciences Link
Toxins 3.531 21/92 (Q1)
34/139 (Q1)
• Toxicology
• Food Science & Technology
Link
Universe 1.752 18/29 (Q3)
42/68 (Q3)
• Physics, Particles & Fields
• Astronomy & Astrophysics
Link
Vaccines 4.086 57/158 (Q2)
50/138 (Q2)
• Immunology
• Medicine, Research & Experimental
Link
Viruses 3.816 12/37 (Q2) • Virology Link
Water 2.544 31/94 (Q2) • Water Resources Link

Source: Clarivate 2020, InCites Journal Citation Reports®.

13 May 2020
COVID-19 Academic Resources Center


Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.

The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.

COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.

For more information, please visit: https://www.mdpi.com/covid-19

9 April 2020
Free Open Platforms to Support Academics During the COVID-19 Pandemic

As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.

Scholarly Community—Encyclopedia

Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

Comprehensive and Free Literature DatabaseScilit

Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.

Display Academic AchievementsSciProfiles

SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.

Organize and Participate in Conferences OnlineSciforum

Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.

Post Early Versions of Research OutputsPreprints

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.

***

MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.

31 March 2020
Biomolecules Reaches 2000 Article Milestone

Biomolecules (ISSN 2218-273X) is an international, peer reviewed, and open access journal focusing on biogenic substances, and published monthly online by MDPI. Biomolecules has passed another milestone by publishing the 2000th article since its inception in 2011.

Biomolecules is now indexed in Science Citation Index Expanded (Web of Science), Scopus, and PubMed. Biomolecules received an Impact Factor of 4.694 in 2019, which corresponds to a ranking of 58 out of 298 (80.70%, Q1) in the JCR category 'Biochemistry and Molecular Biology'. Biomolecules’ current CiteScore in Scopus is 5.72, ranking 33 out of 407 (Q1) in the category 'Biochemistry' and 44 out 375 (Q1) in the category 'Molecular Biology'.

Our sincere thanks to the Editor-in-Chief of Biomolecules, Dr. Vladimir N. Uversky, and all Editorial Board members as well as Guest Editors of Special Issues, who ensure the continued significance of the journal.

25 March 2020
MDPI Comment on the COVID-19 Virus

The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.

MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.

Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.

Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.

We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.

20 March 2020
MDPI Backs Open Pharma Statement on Open Access

MDPI has endorsed Open Pharma’s Position Statement in support of open access publishing with the aim of advancing medical science and ultimately, improving patient care. Open pharma is a group of research funders, healthcare professionals, publishers, academics, and other healthcare stakeholders.

Since its inception in 1996, MDPI’s efforts have aligned with Open Pharma’s vision of more effective and transparent publishing, collaborating internationally with experts to deliver peer-reviewed online research journals to the scientific community and the general public. MDPI publishes 56 journals in the field of Medicine and Pharmacology and is planning to hold the World Pharma Forum in Basel in 2021.

Published under a Creative Commons License, MDPI’s articles can be freely shared and their content re-used, upon proper attribution. In support of the statement, MDPI will continue to uphold its open access policy and provide fast editorial services to ensure that new medical evidence can be read by everyone, without paywall restrictions.

20 March 2020
Meet us at the 43rd Annual Meeting of the Spanish Society of Biochemistry & Molecular Biology (SEBBM 2020) in Barcelona, Spain, 20–23 July 2020


MDPI will be attending SEBBM 2020, held in Barcelona, Spain, 20th–23rd July 2020.

La Sociedad Española de Bioquímica y Biología Molecular (SEBBM) is committed to promoting research links, encouraging years of study, promoting the dissemination of knowledge, improving teaching, and promoting young scientists among Spanish researchers for the international development of Spanish science and to contribute to scientific aspects of the public interest.

The following MDPI journals will be represented:

If you are also attending this conference, feel free to stop by our booth (Booth #17). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please see the following link:

https://www.sebbm.es/web/es/congresos/congresos-de-la-sebbm/3311-43-congreso-de-la-sebbm-barcelona-2020

18 March 2020
MDPI Co-Signed Position Statement on Transformative Agreements

The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.

Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.

MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.

As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.

Read the position paper here

16 March 2020
Encyclopedia Outstanding Contributor Awards 2020 - Open for Application

We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.

Prize for Winners

  1. An official certificate;
  2. A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.


Application Deadline

31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: office@encyclopedia.pub)

Candidate Requirements

  1. Have a Ph.D. degree;
  2. Have more than three qualified entries published in Encyclopedia in 2020.

Evaluation Standards

  1. Number of entries published in Encyclopedia in 2020;
  2. Quality of entries online (including length, figure quality, and novelty);
  3. Impact of entries (including the number of likes, discussion contents, views, and downloads).

If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.

16 December 2019
Meet Us at SFFRI in Taoyuan, Taiwan, 17–20 March 2020


MDPI will be attending the 20th Biennial Meeting for the Society for Free Radical Research International (SFRRI 2020), Taoyuan, Taiwan, 17-20 March 2020.

The Society for Free Radical Research, founded in the United Kingdom in 1982, is an International Society and operates as a charitable voluntary, non-profit institution. The aims and objectives of the International Society are to advance education in free radical processes with particular reference to their industrial and medical importance, informing education for the benefit of the public. The Society promotes interest in all aspects of research into the reactions and properties of free radicals and into their physical, chemical, biological, medical, and industrial roles. Founded in 1982, and now with over 2500 members worldwide, the Society consists of five autonomous regional groups: SFRR Asia, SFRR Europe, SFRR Australasia, Society for Free Radical Biology and Medicine (SFRR Americas), and SFRR Africa. A number of regional groups have also been established within these areas.

The following MDPI journals will be represented:


If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the website: http://www.sfrri2020.org/.

20 November 2019
Meet Us at ICoFF2019 and ISNFF2019 in Kobe, Japan, 1–5 December 2019


MDPI will be attending the 7th International Conference on Food Factors and the 12th International Conference and Exhibition on Nutraceuticals and Functional Foods (ICoFF2019 / ISNFF2019) in Kobe, Japan, 1–5 December 2019.

With the mission of promoting research into all aspects of basic and applied Food and Nutritional Science, ICoFF held its first conference in 1995 and has continued to hold every four years. ICoFF is one of the largest international conferences for researchers, scientists, professors and students in the field of food factors and their health-promoting effects. ISNFF, founded in 2007, has been focusing on the research and development on materials that can be used as functional foods.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth #34). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: http://icoff2019.umin.jp/index.html.

11 October 2019
Introducing SciProfiles, an Academic Social Network

MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.

The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.

SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.

The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.

To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.

SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:

MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net

SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.

Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman

2 October 2019
Winners of the 2019 MDPI Writing Prize

We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.

As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.

Congratulations to all of the participants and especially the winners. The winners are:

1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]

2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]

3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]

The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.

20 September 2019
MDPI Now Gives Scholars the Possibility to Endorse and Recommend Articles

MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.

MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).

MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.

In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.

In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.

The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.

Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director

11 September 2019
Meet Us at ASCB|EMBO 2019 in Washington DC, 7–11 December 2019


We are glad to inform you that MDPI will be attending the 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO). The 2019 joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) will focus on cell biology as the fundamental basis of biology, and will offer sessions on emerging topics such as nontraditional model organisms, and the use of computational modeling and biophysics to "Build the Cell from the Ground Up".

Representatives of the following open-access journals will attend:

Biology
Biomolecules
Brain Sciences
Cancers
Cells
Genes
Healthcare
IJMS
Metabolites
Pathogens
Plants
Processes
Vaccines

If you are also attending this conference, please feel free to stop by our booth (Booth #132). Our delegates look forward to meeting you in person to answer any questions you may have.

11 September 2019

Create an Entry in Encyclopedia to Get a 100 CHF Voucher in Publishing in MDPI Journals

Encyclopedia is pleased to announce that certain well-prepared entries are eligible for a 100 CHF voucher, which can be used for paper publication in any journals in MDPI. We believe that your contribution would be a great help in keeping up with scientific developments. Do not miss the chance to publish with us. Please clink here to find the detailed guideline.

Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via office@encyclopedia.pub.

30 August 2019
Biomolecules Reaches 1000 Articles Milestone

Biomolecules, MDPI's open access journal of biogenic substances, has published more than one thousand papers since its inception in 2011. Biomolecules is covered in the Science Citation Index Expanded in Web of Science and received its first Impact Factor of 4.694 for 2018. The journal ranks 33/407 (Q1) in 'Biochemistry' and 44/375 (Q1) in 'Molecular Biology'.

The main focus of the journal remains on biogenic substances including but not limited to proteins, nucleic acids, polysaccharides, membranes, lipids, metabolites, etc.

Biomolecules publishes original research including but not limited to the following topical areas: small molecules; monomers; polymers.

Our sincere thanks go to the Editors of Biomolecules, Dr. Vladimir N. Uversky, Dr. Prakash Kulkarni, Dr. Lukasz Kurgan, and Assoc. Prof. Dr. Irina Nesmelova as well as to the numerous Guest Editors of Special Issues, who have ensured the continued significance of the journal.

6 August 2019
Preprints Reaches 10,000 Posted Articles Milestone

We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.

You can find further details at https://www.preprints.org/announcement/show/37.

2 August 2019
DeepGreen Partnering with Publishers and Universities in Distributing Open Access Content to Institutional Repositories

Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.

DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.

In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de

Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.

SAGE Publishing  was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.

MDPI  is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.

Frontiers  is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.

De Gruyter  is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.

There is promising communication with other publishers.

DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.

If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.

17 July 2019
First Basel Sustainable Publishing Forum

The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.

The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).

The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.

For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess

20 June 2019
Biomolecules Receives First Journal Impact Factor of 4.694

 

We are pleased to announce that Biomolecules has received a first Impact Factor in the latest Edition of the Journal Citation Reports®, published by Clarivate Analytics in June 2019.

Biomolecules is covered in the Science Citation Index Expanded (SCIE) in Web of Science and received a first Impact Factor of 4.694. The journal ranks 58/298 (Q1) in the 'BIOCHEMISTRY & MOLECULAR BIOLOGY' category.

The Journal Citation Reports®, 2019 release, is a Clarivate Analytics product.

18 June 2019
Meet Us at the 42nd Congress of the Spanish Society of Biochemistry and Molecular Biology in Madrid, Spain, 16–19 July 2019


We will be attending the 42nd Congress of the Spanish Society of Biochemistry and Molecular Biology. The conference aims to organize a balanced and top-quality scientific program, holding Plenary talks delivered by leading voices in Biochemistry and Molecular Biology, three parallel sessions of Symposia, workshops of the multiple scientific groups of the Society, and participation of many students and postdocs with contributed talks and posters. Representatives of the following open access journals will attend:

Cells
Healthcare
Plants
Cancers
Genes
Biomolecules

If you are also attending this conference, please feel free to stop by our booth (Booth #15). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://congresosebbm.madrid2019.es/welcome/.

11 April 2019
Meet Us at the 46th Controlled Release Society Annual Meeting & Exposition

We will be attending the 46th Controlled Release Society Annual Meeting & Exposition. It is one of the biggest events in pharmaceutical field. Representatives of the following open access journals will attend:

Pharmaceutics
JCM
Biomolecules
Materials
IJMS
Molecules
Nanomaterials
Pharmaceuticals
Scientia Pharmaceutica
Vaccines
JPM
Genes
JFB
IJERPH
Biomedicines
Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth #303). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.controlledreleasesociety.org/

2 April 2019
The Spanish Society for Biochemistry and Molecular Biology (SEBBM) is Now an Affiliated Society Member of Biomolecules, Cells and Genes

In January 2019, the the Spanish Society for Biochemistry and Molecular Biology (SEBBM) became affiliated to Biomolecules, Cells and Genes. As part of this collaboration, all members of SEBBM enjoy a discount on the article processing charges (APC) when submitting articles to these three journals.

The Spanish Society for Biochemistry and Molecular Biology (SEBBM), founded in 1963, currently has more than 3’700 members and is Spain's main scientific association coordinating activities related to the broad field of Biochemistry and Molecular Biology. The SEBBM is one of the founding societies of FEBS (the Federation of European Biochemical Societies) and COSCE (the Confederation of Scientific Societies of Spain).

Among the major goals of the society are to facilitate interaction among researchers in this field as well as between researchers and life science companies; to encourage young scientists; and to give scientists, and more particularly biochemists and molecular biologists, a voice in society.

SEBBM is a professional organization whose functions are highly relevant to the scope of Biomolecules, Cells and Genes. We look forward to collaborating with SEBBM and publishing state-of-the-art research from its members in this field.

20 March 2019
Fostering Open Access Publishing Worldwide: New IOAP Participants in February and March 2019

We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.


James Madison University (JMU), Harrisonburg USA
Loughborough University UK
Lublin University of Technology Poland
Marquette University, Milwaukee USA
Massey University, Palmerston North New Zealand
Medical College of Wisconsin USA
Nicolaus Copernicus University, Toruń Poland
Poznań University of Life Sciences Poland
Robert Koch-Institut, Berlin Germany
Rothamsted Research, Harpenden UK
Santa Clara University (SCU)  USA
Technical University of Applied Sciences Wildau Germany
University of Aveiro Portugal
University of Brasília Brazil
University of Duisburg-Essen Germany
University of Greifswald Germany
University of Molise Italy
University of Naples Parthenope Italy
University of São Paulo (USP) - São Carlos Institute of Physics Brazil
University of Szczecin Poland
University of Warmia and Mazury, Olsztyn Poland
University West, Trollhättan Sweden
UTP University of Science and Technology, Bydgoszcz Poland
VTT - Technical Research Centre of Finland Finland


Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at ioap@mdpi.com.

8 March 2019
Meet Us at the ACS National Meeting & Exposition in Orlando, 31 March 4 April 2019


We will be attending the ACS 2019 National Meeting & Exposition. It is an interdisciplinary forum open to anyone with an interest in chemistry and related disciplines. Representatives of the following open access journals will attend:

Biomolecules
Catalysts
Diagnostics
Fibers
Inorganics
Materials
Membranes
Micromachines
Molbank
Molecules
Pharmaceuticals
Processes

If you are also attending this conference, please feel free to stop by our booth (Booth #1123). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.acs.org/content/acs/en/meetings/national-meeting.html

5 March 2019
MDPI Joins Jisc’s Publications Router Service

We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.

Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.

The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.

For more information about Publications Router, you may contact Jisc’s central helpdesk at help@jisc.ac.uk. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at ioap@mdpi.com, which would be very happy to hear from further UK institutions.

1 February 2019
2018 MDPI Top Reviewer AwardWinners Announced


Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:

  • Ali Behnood
  • Andrea Pezzuolo
  • Angela Gorgoglione
  • Anna D'Auria
  • Antonio D'Andrea
  • Azhar Abbas
  • Bogdan Zagajewski
  • Chunhui Chen
  • Dominika Głąbska
  • Dominika Guzek
  • Dragan Pamucar
  • Francisco J. G. Silva
  • Frank Li
  • Gianluca Serafini
  • Gyorgy Szekely
  • Haozhi Pan
  • Helvi Heinonen-Tanski
  • José Manuel Gómez-Soberón
  • Kathy Lewis
  • Klara Kosova
  • Luis N. López De Lacalle
  • M. Z. Naser
  • Malwina Tytła
  • Masoume Amirkhani
  • Matteo Ghidelli
  • Moretti Laura
  • Petra Schneider
  • Roberto Cerchione
  • Spyros Papaefthymiou
  • Ştefan Cristian Gherghina

24 January 2019
JAMS Journals: A Low-Cost Publishing Platform


Since 2010, MDPI has run its own online submission system. More recently, we have made the software, with accompanying publishing services, available to other publishers as JAMS (Journal and Article Management System). We are now delighted to announce the launch of JAMS Journals, a standardized platform for operating open access journals at low cost.

JAMS Journals provides a comprehensive service, including a shared submission website, journal websites hosted at a URL provided by the publisher, and a full production service. There is a small setup fee and the cost for each published paper is just a few hundred Swiss francs.

The platform demonstrates that running an open access journal can be straightforward and affordable. The JAMS Journals platform is suitable for

  • small publishers or groups of scholars looking to launch their own journal;
  • existing publishers or societies seeking to explore open access options;
  • publishers looking to convert an existing subscription journal to open access.

JAMS journals launches with two journals from Canadian-based publisher Etcetera Publications:

Dr AJ Al-Rajab (President of Etcetera Publications) comments:

“In the past few months, we were working on our project to launch new open access scientific journals in the field of agricultural and environmental sciences. We decided to go with JAMS for this venture because of the high quality of their services, reasonable prices, professionalism and easy communication. Our portfolio is expected to grow rapidly during 2019 to include more titles covering different areas in agriculture and environment. MDPI earned already our complete satisfaction and we are looking for a long term cooperation.”

Alongside the new platform, we continue to provide flexible, tailored journal management solutions for existing publishers. For any questions or to request a quotation, contact Dr. Constanze Schelhorn (constanze.schelhorn@mdpi.com).

24 January 2019
Popularity of Preprints Continues to Grow

2018 was a great year for preprints, with increasing numbers of authors looking to make their papers available online before peer review. Along with other preprint servers, our platform Preprints.org  saw an increase in the uptake from authors, and more than double the number of announced papers compared to 2017. In fact, we recently passed two important milestones: 8000 preprints online and 30,000 authors. 

We believe that the whole research community has the opportunity to benefit from work being available online as early as possible. We thank and congratulate our authors for supporting us to make this goal a reality.

In 2019, we will be looking carefully at how to provide better value for authors, maintain efficiency while growing in size, and make sure we remain well-connected with the research community. 

If you want to participate, you can consider screening preprints or joining our advisory board. And, of course, posting your own work.

9 January 2019
Open Access Agreement between the Austrian Academic Library Consortium (KEMÖ), the Austrian Science Fund (FWF), and MDPI

We are delighted to announce the establishment of our national Open Access agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Through this national agreement, the Austrian institutions listed below as well as FWF will cover the Article Processing Charges (APC) of manuscripts published by eligible corresponding or funded authors in MDPI journals as long as central funds are available.

All participating institutions have gained access to the MDPI online submission system where they can find full article metadata and pricing information as well as Funder and Grant ID details for easy identification and additional transparency. At the same time eligible authors are benefited from an APC discount which comes at no cost for the institutions.

Eligible corresponding authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email address. To claim their discount, FWF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript. The institutions will then crosscheck the information and confirm the APC funding.

Eligible authors that have their APC covered by their institution or funder are advised to include the following sentence in their acknowledgments: "Open Access Funding by the [name of the institution/funder]".

The full text of the agreement is openly available online at: http://doi.org/10.5281/zenodo.2536007

For any questions about the agreement, please contact the KEMÖ Consortium at emedien@obvsg.at, FWF at Katharina.Rieck@fwf.ac.at, or the MDPI IOAP team at ioap@mdpi.com.

The Austrian institutions participating in this agreement are:

  • Austrian Science Fund (FWF)
  • University for Continuing Education Krems
  • University of Applied Sciences BFI Vienna
  • University of Applied Sciences Upper Austria
  • University of Applied Sciences Technikum Wien
  • Vorarlberg University of Applied Sciences
  • International Institute for Applied Systems Analysis (IIASA)
  • Institute of Science and Technology Austria
  • MCI Management Center Innsbruck
  • University of Graz
  • University of Linz
  • University of Salzburg
  • Graz University of Technology
  • TU Wien
  • University of Veterinary Medicine Vienna
  • University of Vienna

This is our first collective agreement with a national library consortium, while the individual institutions around the world participating in our IOAP are now more than 500 - see details here: https://www.mdpi.com/about/ioap. We would be mostly interested in discussing about possible collaborations with other consortia, funders, and institutions in our mutual efforts to accelerate Open Access.

2 January 2019
Encyclopedia—the Scholarly Community Encyclopedia

We are pleased to announce the new platform Encyclopedia, which is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

We encourage authors of review articles to quote and adapt the content of their published papers to create Encyclopedia entries. You can create completely new entries on topics in which you have knowledge and expertise. There is no limit on the topics or research fields. All of science and the humanities are included. Each entry will be published directly after submission.

We also have prepared a DOI application function in Encyclopedia. Once a DOI application is approved, the entry website will announce the DOI number and a pdf version with DOI information will be automatically created.

We look forward to your contributions and hope you will make use of this service. Find more about the service at: https://encyclopedia.pub/

18 December 2018
Intrinsically Disordered Proteins and the Janus Challenge

On behalf of the Editors-in-Chief, Dr. Prakash Kulkarni and Dr. Vladimir N. Uversky, we are pleased to present the Janus Challenge.

The Janus Challenge consists in identifying an intrinsically disordered protein (IDP), naturally occurring or synthetic, that has catalytic activity. Meeting this challenge may not only shed new light and even provide an alternative to the RNA world hypothesis, but may also serve as an impetus for technological advances with important biomedical applications. As a reward, we offer to publish the research article reporting results that meet this challenge in Biomolecules free of charge.

A more comprehensive description of the Janus Challenge and the selection criteria for the reward was published as an Editorial in the journal Biomolecules: https://www.mdpi.com/2218-273X/8/4/179

In order to support the Janus Challenge and improve the communication within the IDP community, we have opened the discussion group “Intrinsically Disordered Proteins and the Janus Challenge”, which is publicly available at the following Sciforum site: https://sciforum.net/discussiongroup/display/IDPs_and_the_janus_challenge. Therewith, we aim to set in motion a debate in which every scientist can share their interesting ideas and points of views regarding the science behind the Janus Challenge.

30 October 2018
Institutional Open Access Agreement between Bill and Melinda Gates Foundation and MDPI


We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.

We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage. 

To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.

For any questions about the BMGF agreement, please contact the funder at support@chronos-oa.com or the MDPI IOAP team at ioap@mdpi.com.

11 October 2018
Meet Us at the NanoBio&Med2018 conference in Barcelona, Spain, 20–22 November 2018

MDPI will be attending NanoBio&Med2018, to be held in Barcelona, Spain, 20–22 November 2018.

This conference presents the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Emerging and future trends of the converging fields of Nanotechnology, Biotechnology and Medicine will be discussed among industry, academic, governmental and non-governmental institutions and the conference will provide a platform for multidisciplinary communication.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any question you may have. For more information about the conference, please visit: http://www.nanobiomedconf.com/NBM18/index.php

2 October 2018
MDPI Welcomes Plan S

Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.

We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.

30 August 2018
MDPI establishes Open Access agreement with Qatar National Library

We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.

Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.

Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".

For more information, please visit Open Access at QNL or email the QNL Open Access team at openaccess@qnl.qa.

6 June 2018
Dr. Vladimir N. Uversky Appointed Editor-In-Chief of Biomolecules

We are pleased to announce that Dr. Vladimir N. Uversky has been appointed Editor-in-Chief of the open access journal Biomolecules (ISSN 2218-273X). Vladimir N. Uversky is an Associate Professor at the Department of Molecular Biology at the University of South Florida. He has a PhD in Biophysics (Moscow Institute of Physics and Technology, 1991), as well as a DSc in Biophysics (Institute of Experimental and Theoretical Biophysics, Russian Academy of Sciences, 1998).

In addition to being the Editor-in-Chief of Biomolecules, Vladimir serves as a Co-Editor-in-Chief for the “Molecular Biophysics” Section of the International Journal of Molecular Sciences (IJMS), an Executive Editor of the Biochemistry and Biophysics Reports; Section Editor for the Biochemistry, Biophysics, Molecular Biology Section of the PeerJ, an Academic Editor for Protein and Peptide; an Associate Editor for the Biochimica et Biophysica Acta—Proteins and Proteomics, Current Protein and Peptide Science, and Frontiers in Protein Folding, Misfolding and Degradation; and an Editorial Board Member of more than 10 journals in the fields of protein science and bioinformatics. He was a Co-Founder and one of the first council members (2007–2010) of the Intrinsically Disordered Proteins Subgroup of the Biophysical Society. He also co-founded the “Intrinsically Disordered Proteins” Gordon Research Conference.

Vladimir’s research interests include experimental studies on protein folding, misfolding and aggregation, as well as experimental and computational characterization of intrinsically disordered proteins (i.e., biologically active without unique structures). His work on different aspects of protein physics has received international recognition. Each year from 2014–2017, he was selected as a Thomson Reuters Highly Cited Researcher.

We warmly welcome Dr. Vladimir N. Uversky as our Editor-in-Chief and look forward to his valuable input for the continued success of Biomolecules.

31 May 2018
Biomolecules 2017 CiteScore™ Announced - 5.72

We are pleased to report Biomolecules received a CiteScore of 5.72 for 2017. The metric reflects citation activity in 2017 in Scopus for papers published in the period 2014‒2016.

Biomolecules ranks in the Top 10% of journals in the 'Biochemistry' category.

For the full details in the current CiteScore release, please see the journal's Source profile. To check the full list of MDPI journals receiving CiteScores, please see here.

31 May 2018
2017 CiteScore™ Metrics Released

The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.

Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.

To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.

Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.

According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).

CiteScore Data for MDPI Journals

Journal Rank (Quartile)
Category Link CiteScore 2017
2016

2015
SNIP 2017
Aerospace 43/116 (Q2) • Aerospace Engineering Link 1.23 - -  1.152
Agriculture 69/309 (Q1)

91/398 (Q1)
78/255 (Q2)
• Agronomy and Crop Science
• Plant Science
• Food Science
Link 1.93 - -  1.133
Agronomy 46/309 (Q1) • Agronomy and Crop Science Link 2.38 - -  1.115
Algorithms 22/46 (Q2)
61/125 (Q2)

60/107 (Q3)

64/114 (Q3)
• Numerical Analysis
• Computational Mathematics
• Computational Theory and Mathematics
• Theoretical Computer Science
Link 1.03 1.15 1.07  0.749
Animals 12/154 (Q1) *
48/367 (Q1)
• General Veterinary
• Animal Science and Zoology
Link 2.02 1.46 1.66  1.099
Antibiotics 6/68 (Q1) *


62/263 (Q1)
55/230 (Q1)
31/108 (Q2)
47/134 (Q2)
139/398 (Q2)
• General Pharmacology, Toxicology and Pharmaceutics
• Infectious Diseases
• Pharmacology (medical)
• Microbiology (medical)
• Microbiology
• Biochemistry
Link 2.85 1.65 -  0.975
Antibodies 43/143 (Q2)
61/164 (Q2)
85/189 (Q2)
• Drug Discovery
• Immunology and Allergy
• Immunology
Link 2.85 - -  0.844
Antioxidants 23/119 (Q1)
35/169 (Q2)
100/398 (Q2)
119/367 (Q2)
102/264 (Q2)
• Clinical Biochemistry
• Physiology
• Biochemistry
• Molecular Biology
• Cell Biology
Link 3.42 - -  1.361
Applied Sciences 48/270 (Q1)
15/66 (Q1)

31/116 (Q2)
18/53 (Q2)

151/434 (Q2)

186/535 (Q2)
• General Engineering
• Fluid Flow and Transfer Processes
• Instrumentation
• Process Chemistry and Technology
• General Materials Science
• Computer Science Applications
Link 1.90 - -  0.801
Biology 12/177 (Q1)*

32/186 (Q1)


10/40 (Q1)
• General Agricultural and Biological Sciences
• General Biochemistry, Genetics and Molecular Biology
• General Immunology and Microbiology
Link 3.48 3.02 2.78  0.961
Biomolecules 31/398 (Q1) *
41/367 (Q1)
• Biochemistry
• Molecular Biology
Link 5.72 1.67 3.08  1.542
Biosensors 20/119 (Q1) • Clinical Biochemistry Link 3.59 2.83 2.37  1.122
Brain Sciences 47/111 (Q2) • General Neuroscience Link 2.56 - -  0.695
Cancers 26/323 (Q1) *
23/191 (Q1)
• Oncology
• Cancer Research
Link 5.82 5.02 4.07  1.567
Catalysts 32/151 (Q1)

21/46 (Q2)
• Physical and Theoretical Chemistry
• Catalysis
Link 3.23 3.44 3.45  0.954
Crystals 76/272 (Q2)

140/434 (Q2)

127/398 (Q2)

26/64 (Q2)
• General Chemical Engineering
• General Materials Science
• Condensed Matter Physics
• Inorganic Chemistry
Link 1.97 1.89 1.47  0.745
Diagnostics 49/119 (Q2) • Clinical Biochemistry Link 2.43 - -  0.788
Diversity 30/124 (Q1)

14/52 (Q2)


83/306 (Q2)
11/29 (Q2)
• Nature and Landscape Conservation
• Agricultural and Biological Sciences (miscellaneous)
• Ecology
• Ecological Modelling
Link 2.15 2.03 1.96  1.300
Electronics 109/644 (Q1)

26/148 (Q1)

42/224 (Q1)

50/259 (Q1)

23/96 (Q1)
• Electrical and Electronic Engineering
• Hardware and
Architecture
• Control and Systems Engineering
• Computer Networks and Communications
• Signal Processing
Link 2.97 - -  1.227
Energies 6/73 (Q1) *
31/192 (Q1)

103/644 (Q1)

4/16 (Q1)
47/140 (Q2)
• Control and Optimization
• Energy Engineering and Power Technology
• Electrical and Electronic Engineering
• Energy (miscellaneous)
• Renewable Energy, Sustainability and the Environment
Link 3.11 2.50 2.87  1.340
Entropy 35/202 (Q1) • General Physics and Astronomy Link 2.41 1.87 1.99  1.189
Forests 17/129 (Q1) • Forestry Link 2.31 2.06 1.76  0.990
Future Internet 132/259 (Q3) • Computer Networks and Communications Link 1.25 - - -
Games 132/187 (Q3)
78/110 (Q3)

305/418 (Q3)
• Statistics and Probability
• Statistics, Probability and Uncertainty
• Applied Mathematics
Link 0.61 0.87 0.57  1.038
Genes 21/91 (Q1)
74/311 (Q1)
• Genetics (clinical)
• Genetics
Link 3.49 3.62 3.18  0.374
Geosciences 32/182 (Q1)

• General Earth and Planetary Sciences Link 1.97 1.67 1.29  0.856
Information 143/251 (Q3) • Information Systems Link 1.16 0.78 0.94  1.146
Insects 27/135 (Q1) • Insect Science Link 1.85 1.81 1.38  0.719
International Journal of Environmental Research and Public Health (IJERPH) 80/478 (Q1)


34/106 (Q2)
• Public Health, Environmental and Occupational Health
• Health, Toxicology and Mutagenesis
Link 2.41 2.38 2.42  0.931
International Journal of Molecular Sciences (IJMS) 7/69 (Q1) *
61/535 (Q1)

20/163 (Q1)
9/64 (Q1)
26/151 (Q1)

89/367 (Q2)
17/46 (Q2)
• Spectroscopy
• Computer Science Applications
• Organic Chemistry
• Inorganic Chemistry
• Physical and Theoretical Chemistry
• Molecular Biology
• Catalysis
Link 3.86 3.73 3.37  0.998
ISPRS International Journal of Geo-Information (IJGI) 79/605 (Q1)

22/82 (Q2)

13/36 (Q2)
• Geography, Planning and Development
• Earth and Planetary Sciences (miscellaneous)
• Computers in Earth Sciences
Link 2.10 1.62 1.52  1.062
Journal of Clinical Medicine (JCM) 10/841 (Q1) * • General Medicine Link 7.07 - -  1.535
Journal of Functional Biomaterials (JFB) 43/199 (Q1)
23/77 (Q2)
• Biomedical Engineering
• Biomaterials
Link 3.47 - -  1.344
Journal of Low Po-
wer Electronics and Applications (JLPEA)
301/644 (Q2) • Electrical and Electronic Engineering Link 1.12 0.98 0.83  0.367
Journal of Personalized Medicine (JPM) 54/189 (Q2) • Medicine (miscellaneous) Link 2.61 - -  0.944
Land 50/124 (Q2)

129/306 (Q2)
36/65 (Q3)
• Nature and Landscape Conservation
• Ecology
• Global and Planetary Change
Link 1.44 - -  0.658
Life 4/94 (Q1) *
70/561 (Q1)

40/186 (Q1)


20/80 (Q2)
• Palaeontology
• Ecology, Evolution, Behavior and Systematics
• General Biochemistry, Genetics and Molecular Biology
• Space and Planetary Science
Link 3.16 2.95 1.68  0.935
Marine Drugs 17/146 (Q1) • Drug Discovery Link 4.58 3.83 3.66  1.537
Materials 83/434 (Q1) • General Materials Science Link 3.02 3.26 3.11  1.285
Membranes 5/18 (Q2)

15/53 (Q2)

4/10 (Q2)
• Chemical Engineering (miscellaneous)
• Process Chemistry and Technology
• Filtration and Separation
Link 2.69 2.19 2.95  0.880
Metabolites 47/209 (Q1)

103/398 (Q2)
127/367 (Q2)
• Endocrinology, Diabetes and Metabolism
• Biochemistry
• Molecular Biology
Link 3.35 - -  0.925
Metals 155/434 (Q2) • General Materials Science Link 1.87 - -  0.955
Micromachines 105/554 (Q1)
154/644 (Q1)

64/224 (Q2)
• Mechanical Engineering
• Electrical and Electronic Engineering
• Control and Systems Engineering
Link 2.31 1.83 1.78  0.987
Minerals 33/175 (Q1)


45/208 (Q1)
• Geotechnical Engineering and Engineering Geology
• Geology
Link 2.21 2.13 1.77  1.149
Molecules 4/25 (Q1)

25/172 (Q1)
18/104 (Q1)
31/163 (Q1)
30/151 (Q1)

31/146 (Q1)
55/160 (Q2)
• Chemistry (miscellaneous)
• Pharmaceutical Science
• Analytical Chemistry
• Organic Chemistry
• Physical and Theoretical Chemistry
• Drug Discovery
• Molecular Medicine
Link 3.27 3.09 2.65  1.146
Nutrients 11/255 (Q1) *
9/112 (Q1) *
• Food Science
• Nutrition and Dietetics
Link 4.35 4.29 4.07  1.403
Pathogens 38/263 (Q1)
20/108 (Q1)
9/40 (Q1)

40/164 (Q1)
110/367 (Q2)
• Infectious Diseases
• Microbiology (medical)
• General Immunology and Microbiology
• Immunology and Allergy
• Molecular Biology
Link 3.52 - -  1.166
Pharmaceuticals 14/172 (Q1) *
33/160 (Q1)
• Pharmaceutical Science
• Molecular Medicine
Link 4.12 4.90 3.64  1.370
Pharmaceutics 21/172 (Q1) • Pharmaceutical Science Link 3.68 3.83 2.68  1.092
Photonics 30/116 (Q1)
80/270 (Q2)

53/160 (Q2)
• Instrumentation
• Radiology Nuclear Medicine and Imaging
• Atomic and Molecular Physics, and Optics
Link 1.96 - -  0.817
Plants 73/561 (Q1)

48/389 (Q1)
44/306 (Q1)
• Ecology, Evolution, Behavior and Systematics
• Plant Science
• Ecology
Link 3.13 - -  0.969
Polymers 17/142 (Q1)
63/359 (Q1)
• Polymers and Plastics
• General Chemistry
Link 3.30 3.74 3.37  1.213
Religions 26/389 (Q1) * • Religious Studies Link 0.56 - -  0.676
Remote Sensing 13/182 (Q1) * • General Earth and Planetary Sciences Link 4.03 3.56 3.76  1.559
Resources 19/142 (Q1)

39/261 (Q1)
• Nature and Landscape Conservation
• Management, Monitoring, Policy and Law
Link 2.69 - -  1.387
Scientia Pharmaceutica 92/172 (Q3) • Pharmaceutical Science Link 0.86 - -  0.513
Sensors 9/116 (Q1) *
25/160 (Q1)

100/644 (Q1)

19/104 (Q1)
113/398 (Q2)
• Instrumentation
• Atomic and Molecular Physics, and Optics
• Electrical and Electronic Engineering
• Analytical Chemistry
• Biochemistry
Link 3.23 2.78 2.21  1.550
Social Sciences 81/213 (Q2) • General Social Sciences Link 0.60 - -  0.445
Sustainability 61/605 (Q1) *

55/261 (Q1)

60/140 (Q2)
• Geography, Planning and Development
• Management, Monitoring, Policy and Law
• Renewable Energy, Sustainability and the Environment
Link 2.37 1.96 1.78  1.030
Symmetry 44/327 (Q1)
17/45 (Q2)

16/40 (Q2)

14/25 (Q2)
• General Mathematics
• Computer Science (miscellaneous)
• Physics and Astronomy (miscellaneous)
• Chemistry (miscellaneous)
Link 1.32 1.12 0.95  0.802
Toxins 18/106 (Q1)

21/111 (Q1)
• Health, Toxicology and Mutagenesis
• Toxicology
Link 3.32 3.34 3.76  1.136
Vaccines 5/230 (Q1) *
13/263 (Q1) *
18/302 (Q1) *
11/146 (Q1) *
32/189 (Q1)
• Pharmacology (medical)
• Infectious Diseases
• Pharmacology
• Drug Discovery
• Immunology
Link 4.88 1.23 3.76  1.255
Viruses 29/263 (Q1)
16/68 (Q1)
• Virology
• Infectious Diseases
Link 3.88 3.60 3.74  1.130
Water 66/605 (Q1)

37/191 (Q1)

43/199 (Q1)
193/398 (Q2)
• Geography, Planning and Development
• Water Science and Technology
• Aquatic Science
• Biochemistry
Link 2.29 2.05 1.96  1.007

30 May 2018
MDPI sponsors the latest issue of CHIMIA

To promote Open Access, MDPI has sponsored the latest issue (5/2018) of CHIMIA, published by the Swiss Chemical Society, and made it openly available for free. MDPI has its roots in the Swiss chemical research, as it is also reflected in the logo, and we are very happy to participate in and collaborate with this Society. For that matter, MDPI´s founder and president, Dr. Shu-Kun Lin, wrote a few lines about the beginning of the company and its development over the last 20 years. You can find this on the Swiss Chemical Society website here.

28 May 2018
Deadline Extension: Special Issue on "Biomolecules for Translational Approaches in Cardiology"

The deadline submission for the special issue "Biomolecules for Translational Approaches in Cardiology" (Editors: Dr. Mahir Karakas, Prof. Dr. Tanja Zeller) has been extended to 31 July 2018.

For more information about the special issue, please visit: https://www.mdpi.com/journal/biomolecules/special_issues/Biomol_Card.

30 April 2018
Winners of the First MDPI Writing Prize

We are pleased to announce the results of the first MDPI Writing Prize. We received a large number of entries from across the globe on the theme of “The Global Benefits of Open Research”. It was a pleasure to read so many original, well-researched and well-presented ideas, and the final choice was not an easy one. We are pleased to announce that the winners are as follows:

1st prize (500 CHF, Swiss knife and certificate)

Edmond Sanganyado, Shantou University, China

2nd prizes (250 CHF, Swiss knife and certificate)

Kamala T. Rajahgopal, Asia e University, Malaysia
Yin Zhixuan, Qingdao University of Technology, China

3rd prizes (100 CHF, Swiss knife and certificate)

Alexandra Ticea, Carol Davila University of Medicine and Pharmacy, Romania
Ankur Sarker, University of Virginia, USA
Daniel Attoye, United Arab Emirates University, UAE

Congratulations to all of them! The winning entries can be downloaded by clicking on the names above. A compilation of all entries will soon be available as an open access book.

The writing prize is sponsored by the MDPI English editing service.

23 March 2018
Check for Updates: A New Function in the Article PDF Version

At MDPI, we always want to keep you up to date. Even for already published articles, some corrections or minor changes may occur. To prevent you from missing any updates, from now on you will be able to access the latest version of any manuscript by clicking on the “check for updates” logo that you can find in the PDF file, even if you have saved the file on your computer.

13 March 2018
MDPI Becoming a Member of UKSG

We are proud to announce that MDPI is now a member of UKSG, the UK´s largest scholarly communications community. Through UKSG, different stakeholders share their knowledge and experience in order to improve the knowledge and information environment for researchers. UKSG´s members include universities, publishers, content providers, intermediaries, and other similar organisations. Members participate in discussions and events on issues around scholarly communications.

The UKSG Annual Conference and Exhibition is a flagship initiative from the UKSG and one of the most stimulating events in the scholarly communications calendar. It is held annually and attracts a large number of delegates. More information is available at https://www.uksg.org/events/annualconference

MDPI is delighted to be a part of this active community and we look forward to making our own contribution. We will continue to support organisations and initiatives that boost collaboration and vision within scholarly communication.

More information about UKSG can be found at https://www.uksg.org/. The full membership list is available at: https://www.uksg.org/members.

23 February 2018
Biomolecules (ISSN 2218-273X) Accepted for Coverage in the Science Citation Index Expanded

We are pleased to announce that Biomolecules (ISSN 2218-273X) has been accepted for inclusion in the Science Citation Index Expanded (SCIE) and BIOSIS Previews in Web of Science.

coatings-logo

Biomolecules is an international, peer-reviewed open access journal focusing on biogenic substances and their biological functions, structures, interactions with other molecules, and their microenvironment as well as biological systems.

To view a list of Special Issues currently open for submitting papers, please see here.

Science Citation Index Expanded, BIOSIS Previews and Web of Science™ are Clarivate Analytics products.

1 February 2018
MDPI Signed the San Francisco Declaration on Research Assessment (DORA)

The DORA initiative addresses the need for advanced approaches in the evaluation and measurement of the quality of scientific research outputs. It is a worldwide initiative covering all scholarly disciplines. MDPI proudly joins a list of more than 400 organizations around the world which support DORA’s recommendations for improving the way the quality of research results is evaluated.

More info can be found at http://www.ascb.org/dora/

19 December 2017
Announcing the MDPI English Writing Prize

 

The competition is still open until end of March! Please check out the banner for more details: https://mdpi-res.com/data/english-prize.pdf

15 December 2017
UCL Press Adopts the MDPI Editorial Platform JAMS

We are delighted to announce that UCL Press has adopted MDPI's Journal Article & Management System, JAMS, including production services. JAMS is a modular, integrated editorial platform for academic publishers. It offers flexibility, ease-of-use, and is a fully integrated solution for the end-to-end management of scholarly journals. JAMS is based on the software used to publish MDPI’s portfolio of journals. 

Ian Caswell, UCL Press Journals Manager, says he is "excited to see UCL Press and MDPI partner together to implement the JAMS submission system for all UCL Press journals. The system offered a flexible, efficient and straightforward solution for our processes from author submission to ready for publication. I am grateful for the valuable experience and support MDPI have offered and look forward to developing our programme with an effective submission system in place.” Dr Martyn Rittman, MDPI’s Publishing Services Manager, adds, “We are proud to support one of the UK’s premier university presses in their publishing operation. This is an excellent way for us at MDPI to share our experience and knowledge, and benefit the research community beyond our own journals.”

JAMS combines services that are kept separate for many publishers. The entire editorial process, production and invoicing (e.g. for open access article processing charges) are fully integrated into a single platform. This allows for efficient, fast manuscript processing. For further information about JAMS, see https://www.mdpi.com/publishing_services

23 November 2017
New Participants in the Institutional Open Access Program (IOAP)

We are pleased to welcome new participants to MDPI's Institutional Open Access Program (IOAP), designed to help institutions manage the transition to the Open Access publishing model. Researchers affiliated with participating universites benefit from a 10% discount on the Article Processing Charges (APC) for any paper published in an MDPI journal, while the participating library or university incurs no basic fee for participating in the program.

The IOAP set of free services, provided by MDPI to institutions that sign up, include:
  • No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
  • Authors affiliated with the university will receive a 10% discount on the APC.
  • The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
  • By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
  • Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.

More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap

Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form

The following North American universities have signed up to the IOAP program recently:

Connecticut College, USA
Emory University, USA
Florida International University, USA
Johns Hopkins University, USA
Mississippi State University, USA
Northeastern University, USA
Rice University, USA
University of Ontario Institute of Technology, Canada
University of Rhode Island, USA
University of Texas Southwestern Medical Center, USA
University of Toronto, Canada
University of Windsor, Canada
University of Wisconsin–Madison, USA
Wellesley College, USA
West Virginia University, USA

Many prestigious institutions from Europe and Asia have joined as well:

Asia Pacific University of Technology & Innovation, Malaysia
Czech Technical University in Prague, Czech Republic
Gdansk University of Technology, Poland
Martin-Luther-Universität Halle-Wittenberg, Germany
National Chung Hsing University, Taiwan
Newcastle University, UK
Northumbria University, UK
Southwest University, China
Technical University of Crete, Greece
University Malaya, Malaysia
University of Antwerp, Belgium
University of Cyprus, Cyprus
University of Manchester, UK
University of Reading, UK
University of Sussex, UK
University of Warwick, UK
West Pomeranian University of Technology Szczecin, Poland

We offer a warm welcome to the new participants!

10 November 2017
Available Journal Awards at MDPI

In order to reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields, for example, Young Investigator Awards, Travel Awards, Best Paper Awards, and Best Poster Awards, etc. The awardees range from PhD students to junior scientists.

Currently, the following 44 awards given by MDPI journals are accepting applications. Please click on the award title below to check whether you are eligible for it and start the application process.

Subject

Journal

Award

Intended Awardee

Biology & Life Sciences

Animals

Travel Award 2018

PhD students or postdoctoral researchers

Antioxidants

Travel Awards 2018

Postdoctoral researchers or PhD students

Biology

Travel Award 2018

PhD or postdoctoral fellows

Forests

2019 Travel award

Postdocs or PhD students

International Journal of Molecular Sciences (IJMS)

Outstanding Contribution Awards 2018

Ground-breaking contribution in the fields of Molecular Biology, and Molecular Pathology

Journal of Fungi (JoF)

Travel Awards 2018

PhD graduate students, and postdoctoral fellows

Life

Travel Award 2018

PhD students or postdoctoral fellows

Metabolites

Travel Award 2018

PhD students

Pharmaceuticals

Travel Award 2018

PhD students

Toxins

Travel Award 2018

Postdoctoral fellows

Viruses

Best Oral Presentation Award 2018

Viruses 2018 participants

Viruses

Best Poster Award 2018

Viruses 2018 participants

Water

2018 Young Investigator Award

Young investigators

Chemistry & Materials Science

Biomimetics

 

Travel Award 2018

Graduate Student or Postdoctoral Trainee / Research Associate

Catalysts

Travel Award 2018

PhD students

Chemosensors

Travel Award 2018

PhD or postdoctoral fellows

Entropy

Young Investigator Award 2018

Young investigators

Fibers

2018 Travel award

Postdocs or PhD students

Magnetochemistry

Travel Award 2018

Postdocs

Materials

Travel Award 2018

PhD or postdoctoral fellows

Metals

Travel Award 2018

PhD or postdoctoral fellows

Minerals

Travel Awards 2018

PhD or postdoctoral fellows

Sensors

Travel Award 2018

PhD or postdoctoral fellows

Sensors

Outstanding Reviewer Awards 2017

Sensors' reviewers in 2017

Sensors

Young Investigator Award 2018

Young investigators

Technologies

Travel Award 2018

PhD students

Computer Science & Mathematics

Multimodal Technologies and Interaction (MTI)

Travel Awards 2018

Postdoctoral researchers or PhD students

ISPRS International Journal of Geo-Information(IJGI)

2018 Travel Award

Postdocs

Journal of Sensor and Actuator Networks (JSAN)

Travel Award 2018

Postdoctoral fellows and PhD students

Journal of Imaging

Travel Award 2018

Postdoctoral fellows and PhD students

Engineering

Actuators

Travel Award 2018

PhD or postdoctoral fellows

Remote Sensing

Best Paper Awards 2019

Authors

Machines

Travel Award 2018

PhD or postdoctoral fellows

Micromachines

Travel Awards 2018

PhD or postdoctoral fellows

Fluids

Travel Award 2018

Postdoctoral fellows and PhD students

ChemEngineering

Travel Award 2018

Postdoctoral researchers and PhD students

Environmental & Earth Sciences

Diversity

Travel Awards 2018

Postdoctoral fellows

International Journal of Environmental Research and Public Health (IJERPH)

Best Paper Award 2018

Authors who submit from 1 Nov 2017 to 31 Oct 2018

Resources

Travel Award 2018

Postdocs or PhD students

Geosciences

Travel Award 2018

Postdoctoral fellows and PhD students

Physical Sciences & Astronomy

Galaxies

Travel Award 2018

Ph.D. students, postdoctoral fellows, or lecturers in cosmology or galaxies physics

Applied Science

Travel Award 2018

Postdocs

Medicine & Pharmacology; Public Health & Healthcare

Journal of Clinical Medicine (JCM)

2018 Travel Award

PhD or postdoctoral fellows

Medicines

Travel Award 2018

Postdocs

7 November 2017
MDPI has signed the Jussieu Call for Open Science and Bibliodiversity

The Jussieu Call aims to develop and implement alternative models to meet the aims of open science while promoting bibliodiversity. In particular it wishes to promote new business models for funding open access publication. It was drafted on the Jussieu campus in Paris by a group of French researchers and scientific publishing professionals.

MDPI supports scholarly communities and initiatives that innovate and further promote Open Access publishing. There is a need to explore different frameworks to fund open access in ways that ensure that excessive funds are not diverted from research towards publishing. Many fair funding models already exist, and they can be further developed and extended. These include institutional support, library contributions or subsidies, premium services, participatory funding, etc. For this reason, MDPI has signed up to the Jussieu call and welcomes its aims.

More information can be found at http://jussieucall.org/ (archived here)

 

6 October 2017
Dr. Franck Vazquez, MDPI CEO, Interviewed by Scholarly Kitchen

The Society for Scholarly Publishing’s popular blog about topics in academic publishing, Scholarly Kitchen, recently interviewed MDPI’s CEO, Dr. Franck Vazquez. He shared some thoughts and information on the past and future of MDPI and open access publishing in general:

“In the long run, we aim to anchor MDPI in research communities. We recently developed and launched the preprint platform Preprints, revamped our free-to-use conference hosting platform Sciforum, and are working on other projects, such as Scilit, our bibliographic database.”

Read the full interview here.

2 October 2017
Meet Us at the ASHG 2017 Conference in Orlando

We will attend the American Society of Human Genetics (ASHG 2017) Conference that will be held in Orlando, FL, USA 17–21 October 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:

Biomolecules
Genes
Journal of Personalized Medicine
High-Throughput

Please stop by booth 534 to chat with our delegates about the journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Orlando!

For more information on the conference, please visit:
http://www.ashg.org/2017meeting/

25 September 2017
Meet Us at the ICONAN 2017 Conference in Barcelona

We will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2017) that will be held in Barcelona, Spain, 25–27 September 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:

Bioengineering
Biomedicines
Biomimetics
Biomolecules
Journal of Functional Biomaterials
Journal of Personalized Medicine
High-Throughput
Medical Sciences
Scientia Pharmaceutica

Please stop by our booth to chat with our delegates about our journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Barcelona!

For more information on the conference, please visit:
http://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/

19 September 2017
A Warm Welcome to the New IOAP Participants

We are delighted to have welcomed 24 new participants to our Institutional Open Access Programme (IOAP) since the beginning of September this year. These are University libraries and Research Institutions located around the world; from the USA and Canada to the UK, and from Norway and Spain to Greece. Well respected Universities, such as the University of Denver, the University of Colorado Boulder, and the University of Arizona in the US, have signed up, while their researchers can now benefit from a 10% discount on the Article Processing Charges (APC) for any papers they publish in MDPI journals, at no cost for the library or the University.

We are more than happy to see the Open Access movement growing stronger and wider every day and we appreciate the vital role which librarians, repository managers, and other scholarly communications professionals play in the field. Our communication with and service to this community is, therefore, one of our principal priorities. The IOAP is our way to support academic and scientific Institutions as well as their scholars in managing, administrating, and publishing research in an Open Access world.

The IOAP set of free services, provided by MDPI to institutions that sign up, include:

  • No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
  • Authors affiliated with the university will receive a discount on the article processing charge (APC).
  • The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
  • By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
  • Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.

More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap

Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form

 The full list of the Institutions that signed up in September is as follows:

  1. University of Denver, USA
  2. University of Colorado Boulder, USA
  3. University of Arizona, USA
  4. Institute of Metrology of Bosnia and Herzegovina, Bosnia and Herzegovina
  5. Middlebury College, USA
  6. Touro College, USA
  7. University of New Orleans, USA
  8. University of Leicester, UK
  9. Indiana University-Purdue University Indianapolis, USA
  10. University of Strathclyde, UK
  11. Cranfield University, UK
  12. Hope College, USA
  13. Oregon State University, USA
  14. Drew University, USA
  15. Swansea University, UK
  16. University of South Florida, USA
  17. University of Georgia, USA
  18. Arizona State University, USA
  19. University of Southern Mississippi, USA
  20. Université du Québec à Chicoutimi, Canada
  21. Grinnell College, USA
  22. Norwegian University of Science and Technology, Norway
  23. University of Patras, Greece
  24. Public University of Navarre, Spain

23 June 2017

Congratulations for Publishing the 100,000th Peer-Reviewed Article

Congratulations to the authors Javier Monroy and Javier Gonzalez-Jimenez from Universidad de Malaga, Spain, Victor Hernandez-Bennets, Han Fan and Achim Lilienthal from Örebro University, Sweden for publishing the 100,000th peer-reviewed article.

The article is published in the Chemical Sensors section of Sensors.

GADEN: A 3D Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments

Evermore pressing environmental concerns have led global actors and decision-makers to search for stricter emission monitoring approaches. As part of novel monitoring systems, robots with gas and environmental sensors are a promising solution. However, validation of such robotic inspectors is expensive, time consuming, and plagued by repeatability issues. In this article, we present GADEN (the short form for Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments), which combines gas dispersion and robotics simulation in a common framework. Developed under the widely used Robot Operating System (ROS), GADEN enables validation of sensing strategies with gas dispersion being simulated using computational fluid dynamics and filament dispersion theory. GADEN allows simulating complex, realistic, 3D environments for reproducible testing of robotic gas sensing algorithms. Through qualitative and quantitative evaluations, we show that GADEN is a versatile and user-friendly evaluation tool and emphasize its enormous potential for the mobile robot olfaction community.

 

Read the full article here: https://www.mdpi.com/1424-8220/17/7/1479/htm

6 June 2017
CiteScore™ Metrics Released for Scopus Journals

The CiteScore, the new citation metric for journals covered in the Scopus® database, was released on 1 June 2017, reflecting the citation activity in 2016 for articles published during the three previous years. Please note that the list below does not contain all MDPI journals covered in Scopus. For the CiteScore to serve as a reliable metric at least three volumes of articles need to be indexed in Scopus; journals which have not met this criterion have been omitted here.

Ten MDPI journals received a CiteScore which is in the Top 10% of scores in at least one of the categories, while a further 21 journals exhibit scores that are in the first quartile of the respective categories.

CiteScore Data for MDPI Journals

Journal Rank Category Link CiteScore 2016
2015

2014
Algorithms 44/112 (Q2)
49/111 (Q2)
19/42 (Q2)

52/113 (Q2)
• Numerical Analysis
• Computational Mathematics
• Computational Theory and Mathematics
• Theoretical Computer Science
Link 1.15 1.07 1.06
Animals 69/343 (Q1)
21/146 (Q1)
• Animal Science and Zoology
• General Veterinary
Link 1.46 1.66 0.74
Biology 13/92 (Q1)

34/81 (Q1)

10/75 (Q1)

• General Agricultural and Biological Sciences
• General Biochemistry, Gene-
tics and Molecular Biology
• General Immunology and Microbiology
Link 3.02 2.78 1.74
Biomolecules 234/382 (Q3)
260/353 (Q3)
• Biochemistry
• Molecular Biology
Link 1.67 3.08 1.00
Biosensors 36/118 (Q2)
209/2156 (Q1)
• Clinical Biochemistry
• General Medicine
Link 2.83 2.37 2.04
Cancers 29/196 (Q1)
27/321 (Q1)
• Cancer Research
• Oncology
Link 5.02 4.07 2.31
Catalysts 18/44 (Q2)
27/144 (Q1)
• Catalysis
• Physical and Theoretical Chemistry
Link 3.44 3.45 2.17
Crystals 70/270 (Q2)

25/64 (Q2)
118/398 (Q2)
131/424 (Q2)
• General Chemical Engineering
• Inorganic Chemistry
• Condensed Matter Physics
• General Materials Science
Link 1.89 1.47 1.03
Diversity 10/41 (Q1)

9/25 (Q2)
76/291 (Q2)
24/109 (Q1)
• Agricultural and Biological Sciences (miscellaneous)
• Ecological Modelling
• Ecology
• Nature and Landscape Conservation
Link 2.03 1.96 1.82
Energies - - Link 2.50 2.87 2.66
Entropy 51/198 (Q2) • General Physics and Astronomy Link 1.87 1.99 1.69
Forests 17/127 (Q1) • Forestry Link 2.06 1.76 1.84
Games 204/398 (Q3)
83/181 (Q2)
48/105 (Q2)
• Applied Mathematics
• Statistics and Probability
• Statistics, Probability and Uncertainty
Link 0.87 0.57 0.64
Genes 62/300 (Q1)
18/90 (Q1)
• Genetics
• Genetics (clinical)
Link 3.62 3.18 1.33
Geosciences 36/169 (Q1)

• General Earth and Planetary Sciences Link 1.67 1.29 1.13
Information 156/237 (Q3) • Information Systems Link 0.78 0.94 0.74
Insects 28/131 (Q1) • Insect Science Link 1.81 1.38 1.23
International Journal of Environmental Research and Public Health (IJERPH) 67/446 (Q1)

31/102 (Q2)
• Public Health, Environmental and Occupational Health
• Health, Toxicology and Mutagenesis
Link 2.38 2.42 2.47
International Journal of Molecular Sciences (IJMS) 23/157 (Q1)
8/64 (Q1)
90/353 (Q1)
22/144 (Q1)

16/44 (Q1)
8/62 (Q1)
• Organic Chemistry
• Inorganic Chemistry
• Molecular Biology
• Physical and Theoretical Chemistry
• Catalysis
• Spectroscopy
Link 3.73 3.37 3.06
ISPRS International Journal of Geo-Information 12/29 (Q2)
28/79 (Q2)

96/587 (Q1)
• Computers in Earth Sciences
• Earth and Planetary Sciences (miscellaneous)
• Geography, Planning and Development
Link 1.62 1.52 -
Journal of Low Power Electronic Applications (JLPEA) 301/645 (Q2) • Electrical and Electronic Engineering Link 0.98 0.83 0.83
Life 65/525 (Q1)

36/186 (Q1)

5/92 (Q1)
20/80 (Q2)
• Ecology, Evolution, Behavior and Systematics
• General Biochemistry, Gene-
tics and Molecular Biology
• Palaeontology
• Space and Planetary Science
Link 2.95 1.68 1.20
Marine Drugs 18/145 (Q1) • Drug Discovery Link 3.83 3.66 3.59
Materials 63/424 (Q1) • General Materials Science Link 3.26 3.11 2.69
Membranes 103/424 (Q1) • Materials Science Link 2.19 2.95 2.42
Micromachines 173/645 (Q2)

69/211 (Q2)

113/526 (Q1)
• Electrical and Electronic Engineering
• Control and Systems Engineering
• Mechanical Engineering
Link 1.83 1.78 2.10
Minerals 45/206 (Q1)
29/167 (Q1)
• Geology
• Geotechnical Engineering and Engineering Geology
Link 2.13 1.77 -
Molecules 32/157 (Q1) • Organic Chemistry Link 3.09 2.65 2.62
Nutrients 12/247 (Q1) • Food Science Link 4.29 4.07 3.78
Pharmaceuticals 8/168 (Q1)
21/158 (Q1)
• Pharmaceutical Science
• Molecular Medicine
Link 4.90 3.64 1.92
Pharmaceutics 19/168 (Q1) • Pharmaceutical Science Link 3.83 2.68 2.46
Polymers 13/138 (Q1)
44/354 (Q1)
• Polymers and Plastics
• General Chemistry
Link 3.74 3.37 4.10
Remote Sensing 13/169 (Q1) • General Earth and Planetary Sciences Link 3.56 3.76 3.23
Sensors 25/96 (Q2)
25/159 (Q1)

124/382 (Q2)
103/645 (Q1)
• Analytical Chemistry
• Atomic and Molecular Physics, and Optics
• Biochemistry
• Electrical and Electronic Engineering
Link 2.78 2.21 2.40
Sustainability 49/129 (Q2)

68/587 (Q1)

56/236 (Q1)
• Renewable Energy, Sustai-nability and the Environment
• Geography, Planning and Development
• Management, Monitoring, Policy and Law
Link 1.96 1.78 1.52
Symmetry 17/42 (Q2)
49/111 (Q2)
• Numerical Analysis
• Computational Mathematics
Link 1.12 0.95 1.02
Toxins 16/102 (Q1)

16/108 (Q1)
• Health, Toxicology and Mutagenesis
• Toxicology
Link 3.34 3.76 2.85
Vaccines 146/184 (Q4)
151/250 (Q3)
93/145 (Q3)
186/299 (Q3)
130/232 (Q3)
• Immunology
• Infectious Diseases
• Drug Discovery
• Pharmacology
• Pharmacology (medical)
Link 1.23 3.76 2.85
Viruses 15/68 (Q1)
34/250 (Q1)
• Virology
• Infectious Diseases
Link 3.60 3.74 3.80
Water 33/184 (Q1)

48/195 (Q1)
62/587 (Q1)

198/382 (Q3)
• Water Science and Technology
• Aquatic Science
• Geography, Planning and Development
• Biochemistry
Link 2.05 1.96 1.45

17 May 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the Goethe University of Frankfurt, the Technical University of Hamburg (TU Hamburg-Harburg), as well as the Humboldt University of Berlin, in Germany, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

          

 

4 May 2017
MDPI Supports the Initiative for Open Citations (I4OC)

As an open access publisher, we are keen to support openness and transparency in the research process. Citation data is very important for assessing the value of individual papers and the contribution of researchers. As such, we support the recently launched Initiative for Open Citations (I4OC). The initiative recognizes that citations should be freely available and machine-readable. By doing so, authors gain the maximum benefit from having their work cited.

MDPI now uploads citation data with metadata uploaded to Crossref when registering digital object identifiers (DOIs) for published papers. We are delighted to take this step to support a truly open research environment.

2 May 2017
Publons Peer Review Academy Goes Live

Getting high quality review reports is critical for any journal’s editorial process. At MDPI we have put in place several measures to motivate reviewers and reward them for their work. We are proud of the quality of reviewer reports we receive and grateful for the hours put in by active researchers from across the globe.

Reviewers of MDPI’s largest journals can get recognition via Publons, a website dedicated to rewarding peer reviewers. They have now taken this one step further and launched the Publons Reviewer Academy to help train reviewers to provide useful feedback. Through the academy, researchers can be trained and tutored in various aspects of how to provide structured feedback that will be of genuine help to editors and authors. We support this initiative and recommend it to potential MDPI reviewers, especially early career researchers. See the Publons announcement for further information.

More information on reviewing for MDPI, including how to volunteer as a reviewer, can be found here.

24 April 2017
Two New Institutional Memberships Established

Inst Member

We are pleased to announce that the following universities have joined MDPI's institutional membership program: Trinity University, San Antonio, Texas, USA and the University of New South Wales (UNSW), Sydney, Australia. Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 Trinity    UNSW

 

30 March 2017
Credit for Preprints Comments via Publons

Preprints.org is a platform run by MDPI that allows authors to make early versions of manuscripts available before peer review has been completed.

One of the major benefits of putting a preprint online is to get feedback before journal submission. Until now, however, the feedback has been on a voluntary basis. Preprints is delighted to be the first preprint server to collaborate with Publons to acknowledge substantial comments as reviews and give commentators the opportunity to receive credit for their efforts. 

When you add a comment to any article, there is a check box to click for it to appear on Publons. If you have already linked your account it will be passed on automatically. If you don't already have a Publons account, you will be contacted soon afterwards with instructions on how to create one.

We appreciate the enthusiasm and cooperation of Publons in this project and expect it to be of great benefit to authors and commenters alike.

20 March 2017
MDPI 2016 Annual Report Released

We are pleased to announce that our annual report for the year 2016 has now been published. 

It contains information regarding company and journal performance, conferences and other publishing services that we provided throughout 2016. 

To read the report in full or download a copy, please click here.

15 March 2017
Our 100,000th Article Could be Yours!

After the 20th anniversary of MDPI in 2016, we will reach another milestone this year and will publish the 100,000th peer-reviewed article in one of our 170+ open access journals.

100,000th

We would like you to be part of this great achievement and so are offering to publish the 100,000th accepted paper free of charge.

To be in with a chance, select a journal in one of our 10 scientific subject areas and submit your paper.

Access the live tracker on published articles here.

100000tracker

 

 

3 March 2017
1000 Preprints Online

We are delighted that Preprints now has 1000 papers online since its launch on 3 May 2016.

For more information, see the editorial here.

 

9 February 2017
Minister and State Secretaries Visit MDPI Office at STP, Belgrade, Serbia

Earlier this week the Science Technology Park in Belgrade, Serbia was visited by Swiss Secretary of State Dr. Mauro Dell’Ambrogio, as well as Serbian Minister of Public Administration and Local Self-Government Ana Brnabic, State Secretary Dr. Vladimir Popovic and Mayor of Belgrade Mr. Siniša Mali.

During the visit to the STP they had a short presentation from MDPI’s CEO Dr. Franck Vazquez and IT Manager Mr. Miloš Čučulović, and further discussed important issues such as Open Access and Open education. Dr. Dell'Ambrogio said he was impressed with the potential for development and ideas for business.

For more information please see:

http://bit.ly/2kpIu7k and http://bit.ly/2kpUQfz

   

7 February 2017
The 6th World Sustainability Forum: Final Press Release

Basel, 29 January 2017

The 6th World Sustainability Forum #WSF2017SA: African universities critical to achieving the Sustainable Development Goals

Jeffrey and Sonia Sachs win first World Sustainability Award.

Universities need to take the lead in solving the greatest challenges the world faces today, particularly in Africa. They need to do this not only through education – teaching the next generation to think critically and creatively to find sustainable solutions – but also through research that cuts across a range of disciplines. To ensure these solutions are implemented, they need to partner with the private sector and with government.

This was the key message from the 6th World Sustainability Forum (WSF2017), which took place in Cape Town on 27 and 28 January 2017. Sponsored by MDPI and the journal Sustainability under the patronage of the Universities of the Western Cape (UWC), Cape Town (UCT), University of Basel and the National Research Foundation (NRF) of South Africa, the conference was attended by key national and international speakers, including world-leading economist Professor Jeffrey D. Sachs, senior United Nations (UN) advisor and director of the Earth Institute at Columbia University.

The WSF is an annual sustainability conference which addresses research in a range of areas related to sustainable development and sustainability globally. This was the first WSF to take place on the African continent. Discussions at the 2017 conference were driven by the 17 sustainable development goals (SDGs) adopted as part of the 2030 Agenda for Sustainable Development by the UN in September 2015.

Achieving the SDGs “is the moonshot for our generation,” said Sachs. “Like the moonshot [moon landing] of the 1960s, these are tough, bold and achievable objectives.”

This is a nasty, tough world we live in, and our world agrees on very little. So when 193 governments agree on something, that is important. And when they agree on something as important as sustainable development, that is really something for us to grab hold of – that is a lifeline.”

There was agreement at the WSF that the SDGs are particularly important for Africa, and that African universities in particular have a role to play in achieving them.

Said Professor Tyrone Pretorius, vice-chancellor of UWC: “The quest for sustainable development can only be met through education. Universities today are the oil that fuels the knowledge economy.”

As part of the drive to develop academic capacity to provide the knowledge needed to meet the SDGs, WSF2017 was preceded by the 1st Postgraduate Forum on Sustainability. “A series of workshops for postgraduate education linked to WSF are important, in order to equip postgraduates with the skills necessary to promote sustainability,” said Professor Thandi Mgwebi, director for research at UWC. A second postgraduate forum will take place alongside the WSF2018 in Beijing.

This capacity development is particularly critical to Africa. Said Sachs: “African universities need to do research to find solutions to Africa’s development challenges, because no other university will.”

The UN set a target of achieving the SDGs by 2030: “I regard this as the breakthrough period to end extreme poverty on the continent,” said Sachs, “and for Africa to become one of the most dynamic centres of the world economy.”

It is a critical time for South African universities, said Professor Mamokgethi Phakeng, deputy vice-chancellor for research and internationalisation at UCT: “Higher education is at a crossroads, and there is much polarisation. We need to think carefully about how this sustainable development agenda is owned by all so that it is inclusionary.”

There was also strong emphasis on public–private partnerships – for universities, business and government to work together to achieve the goals.

Said Professor Francis Petersen, deputy vice-chancellor at UCT and vice-chancellor designate at the University of the Free State: “Business sustainability has become critical, because there is increasing demand and complexity of demand on business from the natural, social and economic environment. Sustainability cannot be a standalone issue, divorced from business as usual. Sustainability needs to be embedded into business.”

Environmental crises and climate change was also high on the WSF agenda. In his keynote address, Sachs noted the irreversibility of the climate- and environmental-related challenges.

If we don’t get our act together, we lose the chance of safety,” he said.

Said Professor Mark New, pro vice-chancellor and director of the African Climate and Development Initiative at UCT: “We have a fundamental challenge in responding to climate change, and we must go further than just putting a plaster on a wound. We need to address the deep structural issues, to move from our current model of development into climate-compatible development.”

This requires researchers to find the evidence for the correct development pathways to take, and then support the ability of policymakers at all levels to enable the shift to climate-compatible development planning.”

Said Dr. Aldo Stroebel, executive director of international relations and cooperation at the NRF, in closing: “We have seen over the past two days an urgency towards the next step of thinking, that critical type of framework that we all must engage with, not only from an academic perspective, but further up into the policy environment and into rural-based environments where one can clearly see the links and effectiveness of the work.”

World Sustainability Awards

The first World Sustainability Award and the first Emerging Sustainability Leader Awards were presented by Prof. Thandi Mgwebi, Director of Research at UWC, and Dr. Franck Vazquez, CEO of MDPI, during the ceremony on 27 January 2017 as part of the gala dinner of the 6th World Sustainability Forum in South Africa.after day one of proceedings of the 2017 World Sustainability Forum South Africa.

Professor Jeffrey D. Sachs and Dr. Sonia Ehrlich Sachs are the joint recipients of the first World Sustainability Award. Jeffrey Sachs is a world-renowned economist and senior United Nations (UN) advisor and director of the Earth Institute at Columbia University. Sonia Sachs is a paediatrician and public health specialist, and director of the Health Centre at the Centre for Sustainable Development, also at Columbia University.

The joint recipients of the first Emerging Sustainability Leader Award are Dr. Esther Ngumbi and Dr. Xiaosong Hu. Esther Ngumbi is a postdoctoral researcher at Auburn University in Alabama USA and serves as a 2015 Clinton Global University Mentor for agriculture. Xiaosong Hu is a professor at the Chongqing University in China and specialises in automotive control systems and mechanical engineering.

The World Sustainability Award and the Emerging Sustainability Leader Awards are funded to encourage new initiatives and developments in sustainability with the ultimate aim of fostering the transition to sustainable practices and societies.

The World Sustainability Award is funded by the MDPI Sustainability Foundation, and included a monetary prize of USD 100,000 to Jeffrey and Sonia Sachs. The Emerging Sustainability Leader Award is funded by the journal Sustainability, awarded to researchers under 40, and included a monetary prize of USD10,000.

Issued jointly by: UCT Global Strategy and Visibility, Research Office, UWC Communications & Media and MDPI AG

Conference photos are free available at: https://sciforum.net/conference/wsf-6/page/175 Photo credit: Matthias Burkhalter

Carla Bernardo
Tel: (021) 650 1277
Cell: 071 407 6105
E-mail: carla.bernardo@uct.ac.za
University of Cape Town

Luthando Tyhalibongo
Tel: (021) 959 2625
Cell: 082 472 69 61
079 880 4655
E-mail: xtyhalibongo@uwc.ac.za
University of the Western Cape

Matthias Burkhalter
Conferences Manager
MDPI AG - www.mdpi.com
St. Alban-Anlage 66, 4052 Basel,
Switzerland
Tel. +41 61 683 77 34
Email: burkhalter@mdpi.com

Banner

31 January 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the Chalmers University of Technology, Sweden, the University of Manitoba, Canada and the Technical University of Cartagena, Spain, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

Tex      HIT    

 

Darmstadt  

27 January 2017
6th World Sustainability Forum under way in South Africa

The 6th World Sustainability Forum is currently being held at the Cape Sun Hotel until 28 January 2017. 

The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100,000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10,000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI.

Here are some pictures from the forum so far:

To see the full WSF2017 program and schedule, please see here: https://sciforum.net/conference/wsf-6/page/schedule

19 January 2017
Cape Town to Host the 6th World Sustainability Forum

Banner

Cape Town will host the 6th World Sustainability Forum at the Cape Sun Hotel on 27 and 28 January 2017. This prominent event, held for the first time in Africa, will include many illustrious South African and international experts, such as Her Excellency Graça Machel (Sustainable Development Advocate for the United Nations, Mozambique), Joyene Isaacs (HoD Agriculture Western Cape Government), Jeffrey Sachs (Columbia University, USA), Max Bergman (SRaM, University of Basel), Mark New (Pro Vice-Chancellor, University of Cape Town), Frans Swanepoel (FutureAfrica, University of Pretoria) and Francis Petersen (Vice-Chancellor-designate, University of the Free State). The Forum will provide a stage for national and international debates on sustainability in South Africa, the African continent, and about international perspectives on sustainability. It brings together researchers and representatives from government and the business sector to discuss a wide-ranging set of issues associated with sustainability, including food security, water and energy scarcity, mining, poverty reduction, climate change, and urbanisation.

The next few decades will be marked by profound changes in the relationships between global economics, national societies, and the environment. We have entered what some call the Anthropocene, an age in which human activity dominates the climate and the environment. These changes will have numerous consequences on societies around the globe. South Africa and Africa will play a central role, for better or worse, in creating opportunities and risks during these changing times as Africa is profoundly influencing and being influenced by global developments.

The adoption of the 17 United Nations Sustainable Development Goals and the 2030 Agenda for Sustainable Development in September 2015 was accompanied by what insiders considered an optimism they have not experienced in relation to UN resolutions before. The relative efficiency in the drafting, the lack of trenches between East and West, or between North and South, and the unanimity of support of the 193 countries speak volumes. In stark contrast, sustainability seems to go against a changing economic and political tide, where waves of nationalism and protectionism from some of the most powerful countries risk the wellbeing of the rest of the world. The 6th World Sustainability Forum will enable fruitful exchanges, which sensitise South African and international communities to the global urgency and specifics of sustainability.

The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100 000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10 000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI. The World Sustainability Forum is preceded by the Postgraduate Forum on Sustainability, which will introduce more than 100 young scholars from South Africa and the African continent to sustainability research. Both events are organized and sponsored by the University of Cape Town, the University of the Western Cape, the University of Basel, MDPI, and by the National Research Foundation of South Africa.

Contacts:

Scientific Matters: Prof Manfred Max Bergman, Social Research and Methodology Group (SRaM), University of Basel, Switzerland; Email:  max.bergman@unibas.ch

Press Accreditation and General Enquiries: Mr Matthias Burkhalter, MDPI AG, Basel, Switzerland; Email: burkhalter@mdpi.com; Tel. +41 61 683 77 34 

Follow us on Twitter

twitter logo

#WSF2017SA

 

6 January 2017
MDPI Supports the OA2020 Initiative

MDPI is now a proud supporter of the OA2020 Initiative.

Open Access 2020 is an international initiative that aims to induce the swift, smooth and scholarly-oriented transformation of today’s scholarly journals from subscription to open access publishing.

MDPI is participating in the upcoming Berlin13 conference in March 2017, where we are contributing to the initiative by aiding in the design of the roadmap which will make OA the default publishing model.

For more information please see here.

 

5 January 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the University of Texas at Arlington, USA, the Harbin Institute of Technology, China and TU Darmstadt, Germany, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Tex      HIT    Darmstadt  

22 December 2016
Happy Festive Season!

Season's greetings from everyone at MDPI!

22 December 2016
Two New Institutional Memberships Established

Inst Member

We are pleased to announce that the Otto-von-Guericke-Universität Magdeburg, Germany and the University of California, Berkeley, USA, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

  

19 December 2016
MDPI and Wellcome Trust Compliance

The Wellcome Trust has, for a number of years, required that the results of its funded projects are published in open access format. Recently it announced criteria that publishers must fulfil for publication fees to be paid by the Trust. MDPI is pleased to have been added to the list of compliant publishers.

Only publishers who have confirmed their compliance by 16 December 2016 will be eligible to receive payment of APCs by the Wellcome Trust as of 1 April 2017. For more information on the criteria and a full list of publishers that meet them, see here.

13 December 2016
Meet MDPI at the 2016 AGU Fall Meeting

MDPI is currently attending the 2016 AGU Fall Meeting (12–16 December, 2016)

If you are also attending the conference, please feel free to stop by our booth (Booth #1147) and meet the representative editors.

Conference details:

2016 AGU Fall Meeting
12–16 December 2016
Moscone Center
747 Howard St
San Francisco, CA 94103, USA

 

8 December 2016
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that Purdue University, USA, the Universitat Politécnica de Valencia, Spain and the Queensland University of Technology, Australia, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UNM            UPM             ShanghaiJT  

16 November 2016
World Sustainability Award - Final Extension

The deadline for the World Sustainability Award has been extended for one last time! You now have one more month to nominate an individual researcher, group or project! The final deadline for nominations will be December 15, 2016. 

For full details, please visit here.

11 November 2016
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the University of Minnesota, USA, the Universidad Politécnica de Madrid, Spain and Shanghai Jiao Tong University, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UNM            UPM             ShanghaiJT  

4 November 2016
MDPI Joins the United Nations Global Compact

MDPI has become a member of the United Nations Global Compact to support corporate sustainability and have committed ourselves to the ten principles associated with the Compact.

Sustainability has always been at the core of MDPI’s values, starting with the collection and preservation of rare chemical samples that started in 1996 and led to the first journal, Molecules. Sustainability has become one of our flagship journals and we have supported and organized several conferences and events based on Sustainability, including the upcoming 6th World Sustainability Forum. As a global enterprise, we see it as our duty to promote responsible practices that will ensure a bright future for our planet. Given this, the choice to join the Global Compact was an easy one and we will do our utmost to fully implement it.

 

3 November 2016
MDPI Now a Member of SPARC Europe

We are delighted to announce that MDPI has become a member of SPARC Europe, an organization that works for open scholarship in Europe, including support of open access publication.

As one of the few publishers to join SPARC Europe to date, MDPI looks forward to making a contribution that puts open scholarship on a positive and sustainable path. We fully support the goals of open scholarship that allow the largest number of people possible to benefit from work of researchers in all disciplines. We hope that our membership will enable us to work with other stakeholders to find the best possible solution.

2 November 2016
World Sustainability Award Deadline Extension

The deadline for the World Sustainability Award has been extended! You now have until November 15, 2016 to nominate an individual researcher, group or project!

For full details, please visit here.

.

26 October 2016
Four New Institutional Memberships Established

Inst Member

We are pleased to announce that the Wuppertal Institut, Germany, the University of Girona, Spain and Central South University and Huazhong University of Science and Technology, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

CSUCSU

CSU  CSU

24 October 2016
International Open Access Week 2016

Meet us during International Open Access Week 2016! We will be presenting at various locations in Europe and China. 

To get involved and for full details see the complete list of events organised by MDPI here.

 

18 October 2016
Institutional Membership established with Universitat Pompeu Fabra, Spain and Aalto University, Finland

Inst Member

We are pleased to announce that the Universitat Pompeu Fabra, Spain and Aalto University, Finland, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Pompeu   Aalto

12 October 2016
Institutional Membership Established with Iowa State University and the University of North Texas, USA

Inst Member

We are pleased to announce that the Iowa State University and the University of North Texas, USA, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Iowa  UNT

7 October 2016
MDPI at Open Access Days in Munich, 10-11 October 2016

Meet MDPI during the Open Access Days held from 10-11 October 2016 at Ludwig Maximilian University of Munich, Germany. 

The two-day event will feature experts from the open access sector, scientists from all disciplines, publishing representatives and supporters of scientific research and communication from libraries as well as research institutes and funding institutions. Join us!

For more information about the event and to see the program, visit the event webpage.

OATageMunich

7 October 2016
Institutional Membership Established with the University of Sevilla and the University of Alicante, Spain

Inst Member

We are pleased to announce that the University of Sevilla and the University of Alicante, Spain have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Sevilla  Alicante

29 September 2016
Institutional Membership Established with the University of Delaware

Inst Member

We are pleased to announce that the University of Delaware, USA, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Delaware

19 September 2016
Peer Review Week 2016

As an open access publisher indebted to the work of our peer reviewers, we are proud to support Peer Review Week 2016. As part of the week's activities and to celebrate this year's theme "Recognition for Review", MDPI will host two webinars that anyone can join.

These webinars will explore the role and value of reviewers and the recognition they receive from a publishers perspective, with examples from MDPI's experience in publishing nearly 80,000 peer reviewed papers, along with evidence from reviewer surveys. It will also touch upon potential changes in how review is carried out and tips for early career researchers who want to be involved in the review process.

Details and links to join can be found below:

Wednesday September 21, 08:00 (CEST)

Friday September 23, 16:00 (CEST)

For more information about all the activites taking place, please visit the Peer Review Week website.

 

6 September 2016
Institutional Membership established with Kansas State University and Northwestern University, USA

Inst Member

We are pleased to announce that Kansas State University and Northwestern Universty, USE, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

KState  NWest

5 September 2016
Institutional Membership Established with University College Cork

Inst Member

We are pleased to announce that University College Cork, Ireland, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UCC

22 August 2016
MDPI New Office Location

We are pleased to announce that MDPI has now moved to a new permanent address:

MDPI AG
St. Alban Anlage 66
CH-4052 Basel
Postfach, CH-4020 Basel
Switzerland

Telephone and fax numbers remain unchanged.

18 August 2016
Antibiotics, Biomolecules and Brain Sciences Accepted for Coverage in Scopus

We are pleased to announce that the journals Antibiotics (ISSN 2079-6382), Biomolecules (ISSN 2218-273X) and Brain Sciences (ISSN 2076-3425) were recently selected to be included in Scopus. Citations are expected to be available in Scopus soon.

Scopus is the largest abstract and citation database of peer-reviewed literature and is published by Elsevier B.V. This means that the research you publish with AntiobioticsBiomolecules and Brain Sciences will be more visible than ever. 

Antibio Logo Biomol LogoBrainsci Logo

17 August 2016
MDPI is Attending the 252nd American Chemical Society National Meeting & Exposition

We are pleased to announce that MDPI will be attending the 252nd American Chemical Society National Meeting & Exposition (21-25 August, 2016) representing the following open access journals:

Molecules
Materials
Marine Drugs
IJMS
Polymers
Applied Sciences
Membranes
Metabolites
Pharmaceuticals
Biomolecules
Symmetry

If you are also attending this conference, please feel free to stop by our booth (Booth 411) and meet our representatives.

Conference details:

ACS - American Chemical Society Fall Meeting 2016
21-25 August, 2016

Pennsylvania Convention Center
1101 Arch St
Philadelphia
PA 19107
USA

10 August 2016
Institutional Membership established with the University of Texas at Austin, USA, the Wroclaw University of Science and Technology, Poland and the University of Granada and the Compultense University of Madrid, Spain

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in August 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

            

18 July 2016
Institutional Membership established with Louisiana State University and Florida State University, USA, Royal College of Surgeons, Ireland, University of Rostock, Germany, AGH University of Science and Technology, Poland and Southeast University, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in July 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

                    

12 July 2016
MDPI Moving to New Office Location in Basel (Switzerland) in August 2016

As of 20 August 2016, MDPI's new address in Basel will be:

MDPI AG
St. Alban-Anlage 66
CH-4052 Basel
Switzerland

Telephone and fax numbers remain unchanged.

St. Alban-Anlage 66 was built from 1947 to 1948 and initially the home of the "Bühler AG", a book printing business. 

 


For more information about this building, see: https://www.mdpi.com/about/headquarters

21 June 2016
"Behind the Scenes of Academic Publishing—A Publisher's Perspective" - MDPI's Lecture at the University of Basel

From the 15-16 September, 2016, MDPI will run a course on Academic Publishing at the University of Basel.

In this two day workshop, MDPI will look in detail at the role performed by academic journal publishers and how they interact with academics. Ethical dimensions, what happens when problems occur and how the publisher coordinates all aspects of the submission process will also be covered. 

For more detailed information about the program, trainers and registration please visit the course webpage.

 

 

14 June 2016
2015 Impact Factors Released

We are pleased to report the 2015 Journal Impact Factors in the latest Journal Citation Reports® Science Edition, published by Thomson Reuters in June 2016. Twenty out of 25 journals have seen an increase in their Impact Factor and two journals (Crystals and IJGI) received a first Impact Factor. Coatings was recently added to SCIE and will receive its first Impact Factor in next year’s JCR.

Updated Impact Factors for Journals in the Science Citation Index Expanded (SCIE)

Journal 2015 Impact Factor Details Category Rank
Applied Sciences 1.726 Link 83/163 (Q3) in ‘Chemistry, Multidisciplinary’;
129/271 (Q2) in ‘Materials Science, Multidisciplinary’;
64/145 (Q2) in ‘Physics, Applied’
Atmosphere 1.221 Link 66/84 (Q4) in ‘Meteorology & Atmospheric Sciences’
Catalysts 2.964 Link 53/144 (Q2) in ‘Chemistry, Physical’
Energies 2.077 Link 43/88 (Q2) in ‘Energy & Fuels’
Entropy 1.743 Link 25/79 (Q2) in ‘Physics, Multidisciplinary’
Forests 1.583 Link 19/66 (Q2) in ‘Forestry’
Genes 3.242 Link 60/165 (Q2) in ‘Genetics & Heredity’
International Journal of Environmental Research and Public Health (IJERPH) 2.035 Link 101/225 (Q2) in ‘Environmental Sciences’
International Journal of Molecular Sciences (IJMS) 3.257 Link 110/289 (Q2) in ‘Biochemistry & Molecular Biology’;
51/163 (Q2) in ‘Chemistry, Multidisciplinary’
Marine Drugs 3.345 Link 13/59 (Q1) in ‘Chemistry, Medicinal’
Materials 2.728 Link 63/271 (Q1) in ‘Materials Science, Multidisciplinary’
Metals 1.574 Link 18/73 (Q1) in ‘Metallurgy & Metallurgical Engineering’;
145/271 (Q3) in ‘Materials Science, Multidisciplinary’
Micromachines 1.295 Link 30/56 (Q3) in ‘Instruments & Instrumentation’
63/83 (Q4) in ‘Nanoscience & Nanotechnology’
Minerals 1.468 Link 9/21 (Q2) in ‘Mining & Mineral Processing;
14/29 (Q2) in ‘Mineralogy’
Molecules 2.465 Link 24/59 (Q2) in ‘Chemistry, Organic’
Nanomaterials 2.690 Link 64/271 (Q1) in ‘Materials Science, Multidisciplinary’;
36/83 (Q2) in ‘Nanoscience & Nanotechnology’
Nutrients 3.759 Link 16/78 (Q1) in ‘Nutrition & Dietetics’
Polymers 2.944 Link 20/85 (Q1) in ‘Polymer Science’
Remote Sensing 3.036 Link 5/28 (Q1) in ‘Remote Sensing’
Sensors 2.033 Link 36/75 (Q2) in ‘Chemistry, Analytical’;
16/27 (Q3) in ‘Electrochemistry’;
12/56 (Q1) in ‘Instruments & Instrumentation’
Sustainability 1.343 Link 146/225 (Q3) in ‘Environmental Sciences’;
22/29 (Q4) in ‘Green & Sustainable Science & Technology’
Symmetry 0.841 Link 31/63 (Q2) in ‘Multidisciplinary Sciences’
Toxins 3.571 Link 16/89 (Q1) in ‘Toxicology’
Viruses 3.042 Link 14/33 (Q2) in ‘Virology’
Water 1.687 Link 33/85 (Q2) in ‘Water Resources’

Journals with First Impact Factors

Journal 2015 Impact Factor Details Category Rank
Crystals 2.075 Link 13/26 (Q2) in ‘Crystallography’
ISPRS International Journal of Geo-Information 0.651 Link 45/49 (Q4) in ‘Geography, Physical’;
26/28 (Q4) in ‘Remote Sensing’.

 

26 May 2016
Institutional Membership established with University of Bremen, Germany, Koç University, Turkey, IIASA, Austria and Jilin University and Kunming Institute of Botany, CAS, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in May 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

                

23 May 2016
Institutional Membership Established with the KTH Royal Institute of Technology, Sweden and the South China University of Technology, Beijing University of Technology and Southern Medical University, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in April and May 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

            

26 April 2016
New Section on www.mdpi.com - Latest Books

You may have noticed a new section that is now visible on our home page. This section is called "Latest Books" and showcases recent publications from MDPI Books, our book publishing service.

Books Section

By clicking on the hyperlink "More Books" you will be taken to the MDPI Books Home Page. There you will find more information about the service, as well as the "Recent Publications" list. 

Clicking on any of the book images in this list will take you to detailed information about that book (shown below). Here you can also download a PDF version of the book, or order a hardcover printed copy.

For further information about the MDPI Books service, please visit the webpage or contact books@mdpi.com.

 Individual Book Page

 

31 March 2016
Axioms, Behavioral Sciences, Photonics, Separations and Toxics added to the Emerging Sources Citation Index in Web of Science

We are pleased to announce that the journals Axioms, Behavioral Sciences, Photonics, Separations and Toxics were recently accepted for inclusion in the newly launched Emerging Sources Citation Index (ESCI) in Web of Science.

ESCI serves to highlight promising journals which are still under consideration for the Science Citation Index Expanded (SCIE) or the Social Sciences Citation Index (SSCI).

 

The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index
(SSCI), and Web of Science™ (WoS) are Thomson Reuters products.

Thomson Reuters Logo

 

 

 

30 March 2016
Institutional Membership established with the University of Winchester, UK, Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China

Inst Member

We are pleased to announce that the University of Winchester, UK, the Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China, have joined our Institutional Membership program. Primary authors from these universities will benefit from a 10% discount on article processing charges.

Additional details can be found on our institutional membership page.

Winchester Silesian Beijing Jiaotong Zhejiang

24 March 2016
New Editorial Office in Barcelona, Spain

We are excited to announce the opening of our new editorial office in Barcelona, Spain. The launch team is led by a Senior Editor and comprises further staff holding doctoral degrees with several years of research experience. The new editorial team will help us to get closer to European research communities and progress Sciforum, the platform to support the scientific community via conference hosting and other functions. They will also help spread the word about Open Access and meet academics at scientific events.

We are in the process of hiring more doctoral and masters graduates to join the editorial team and welcome applications via jobs@mdpi.com. For contact details about the office, see our contact page.

22 February 2016
Membership Established with the Max Planck Society

We are pleased to announce that the Max Planck Digital Library (MPDL) has signed an agreement with MDPI to support authors associated with the Max Planck Society (Max-Planck-Gesellschaft). As of 22 February 2016, corresponding authors will receive full funding from the MPDL for articles published in MDPI journals, with a 10% discount applied to the Article Processing Charges. Additional details can be found at our institutional membership page.

Founded in 1948, The Max Planck Society is one of Germany’s leading research organizations, and is currently made up of 83 institutes conducting basic research in natural sciences, life sciences, social sciences and humanities. 18 Nobel laureates have emerged from its ranks of scientists and the society has more than 15,000 publications in scientific journals each year.

 

5 February 2016
Institutional Membership Extension: Wageningen University, CSIC, University of Zürich, ETH Zürich, University of Tübingen and Osnabrück University

We are pleased to announce that Wageningen University, the Netherlands, the Spanish National Research Council (CSIC), Spain, the University of Zürich and ETH Zürich, Switzerland, and the University of Tübingen and Osnabrück University, Germany, have not only renewed their institutional memberships with MDPI after two years of successful cooperation, but have also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.

Additional details can be found on our institutional membership page.

WageningenCISCZurich ETHZurichTuebingen Osnabrück 

5 February 2016
Institutional Membership established with Brock University, Canada and the University of Pisa, Italy

Inst Member

We are pleased to announce that Brock University, Cananda, and the University of Pisa, Italy, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges as of 01 February 2016. 

Additional details can be found on our institutional membership page.

Brock Pisa

25 January 2016
MDPI Sponsors diss:kurs with the University of Basel

 

MDPI is pleased to announce its newly established sponsorship of diss:kurs, an event coordinated by the University of Basel to support their doctorate program. For more information about the event and how to register, please visit the diss:kurs webpage.

 

7 January 2016
New Institutional Memberships Established with Tsinghua University, the Chinese Society of Micro-Nano Technology, Ruhr University Bochum and the University of Ulm

We are pleased to announce that the following institutions have joined MDPI's institutional membership program as of 1 January 2016:

  • Tsinghua University, China
  • Chinese Society of Micro-Nano Technology (CSMNT)
  • Ruhr University Bochum, Germany
  • University of Ulm, Germany

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

 

5 January 2016
Safety, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae Released Their First Issue in December 2015

We are pleased to announce that MDPI's open access journals Safety, Journal of Imaging, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae released their first issue at the end of December 2015.

  

23 December 2015
Happy Festive Season!

Season's greetings from everyone at MDPI!

style="width:304px;height:228px;"

17 December 2015
Institutional Membership Extension: University of Bern, Switzerland

We are pleased to announce that the University of Bern, Switzerland has not only renewed their institutional membership with MDPI after two years of successful cooperation, but also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.

 

17 December 2015
Institutional Membership with the University of Ulm and Helmholtz Zentrum Munich

We are pleased to announce that University of Ulm, Germany and Helmholtz Zentrum Munich, Germany has joined MDPI's institutional membership program:

Primary authors from the University of Ulm and Helmholtz Zentrum Munich will benefit from a 10% discount on the article processing charges as of 1 January 2016. Additional details can be found on our institutional membership page.

 

style="width:150px;height:228px;"         style="width:304px;height:228px;"

9 December 2015
Membership Established with the Virginia Polytechnic Institute and State University (Virginia Tech)

We are pleased to announce that Virginia Tech has joined MDPI's institutional membership program. Authors from Virginia Tech will benefit from a 10% discount on the article processing charges as of 1 December 2015. Additional details can be found on our institutional membership page.

1 December 2015
Membership Established with the Technical University of Denmark and the University of North Florida

We are pleased to announce that the following universities have joined MDPI's institutional membership program:

  • Technical University of Denmark (as of 1 November 2015)
  • University of North Florida, USA (as of 15 November 2015)

Primary authors from the Technical University of Denmark and the University of North Florida will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

16 November 2015
Emerging Sources Citation Index (ESCI) Launched in Web of Science™

The Emerging Sources Citation Index (ESCI) has been launched by Thomson Reuters as a new index in Web of Science™ alongside the established Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Web of Science™ thereby continues to reflect the growing importance of Open Access scholarly literature as nearly half of the newly incorporated journals are Open Access journals.

We are pleased to announce that 32 journals published by MDPI were selected for inclusion in the Emerging Sources Citation Index (ESCI). Articles published after 1 January 2015 now appear in ESCI and Web of Science™. This will bring higher visibility to the published research, while they will continue to be under evaluation for SCIE or SSCI.

The following MDPI journals are covered by ESCI:

Journal Title
Established About the Journal
Algorithms 2008 Link
Agriculture 2011 Link
Agronomy 2011 Link
Biomolecules 2011 Link
Brain Sciences 2011 Link
Diagnostics 2011 Link
Membranes 2011 Link
Metabolites 2011 Link
Antibiotics 2012 Link
Antibodies 2012 Link
Antioxidants 2012 Link
Arts 2012 Link
Computers 2012 Link
Electronics 2012 Link
Foods 2012 Link
Journal of Clinical Medicine 2012 Link
Pathogens 2012 Link
Plants 2012 Link
Atoms 2013 Link
Chemosensors 2013 Link
Climate 2013 Link
Computation 2013 Link
Economies 2013 Link
Fibers 2013 Link
International Journal of Financial Studies 2013 Link
Journal of Developmental Biology 2013 Link
Mathematics 2013 Link
Processes 2013 Link
Publications 2013 Link
Risks 2013 Link
Systems 2013 Link
Vaccines 2013 Link

 

The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), and Web of Science™ (WoS) are Thomson Reuters products.

Thomson Reuters Logo

2 October 2015
Membership Established with the University of Freiburg and the University of Regensburg

We are pleased to announce that the following universities have joined MDPI's institutional membership program:

University of Freiburg, Germany
University of Regensburg, Germany

Primary authors from the University of Freiburg and the University of Regensburg will benefit from a 10% discount on the article processing charges as of 1 October 2015 and 1 November 2015.

Additional details can be found on our institutional membership page.

Back to TopTop